Details of the Drug Combination

General Information of Drug Combination (ID: DC5Z19F)

• Drug Combination Name: Crizotinib + Arsenic trioxide
• Indication: Plasma cell myeloma; Status: Investigative [1]
• Component Drugs:
  Crizotinib (DM4F29C): Small molecular drug
  Arsenic trioxide (DM61TA4): Small molecular drug
• High-throughput Screening Result:
  Testing Cell Line: RPMI-8226
  Zero Interaction Potency (ZIP) Score: 11.03
  Bliss Independence Score: 13.67
  Loewe Additivity Score: 4.42
  LHighest Single Agent (HSA) Score: 2.31

Molecular Interaction Atlas of This Drug Combination

Indication(s) of Crizotinib

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Approved	[2]

Crizotinib Interacts with 4 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
Proto-oncogene c-Met (MET)	TTNDSF4	MET_HUMAN	Modulator	[8]
ALK tyrosine kinase receptor (ALK)	TTPMQSO	ALK_HUMAN	Modulator	[8]
Proto-oncogene c-Ros (ROS1)	TTSZ6Y3	ROS1_HUMAN	Modulator	[8]
HGF/Met signaling pathway (HGF/Met pathway)	TTKA5LP	NOUNIPROTAC	Inhibitor	[9]

Crizotinib Interacts with 3 DTP Molecule(s)

DTP Name	DTP ID	UniProt ID	Mode of Action	REF
P-glycoprotein 1 (ABCB1)	DTUGYRD	MDR1_HUMAN	Substrate	[10]
Organic anion transporting polypeptide 1B1 (SLCO1B1)	DT3D8F0	SO1B1_HUMAN	Substrate	[11]
Organic anion transporting polypeptide 1B3 (SLCO1B3)	DT9C1TS	SO1B3_HUMAN	Substrate	[11]

Crizotinib Interacts with 2 DME Molecule(s)

DME Name	DME ID	UniProt ID	Mode of Action	REF
Cytochrome P450 3A4 (CYP3A4)	DE4LYSA	CP3A4_HUMAN	Metabolism	[12]
Cytochrome P450 3A5 (CYP3A5)	DEIBDNY	CP3A5_HUMAN	Metabolism	[12]

Crizotinib Interacts with 45 DOT Molecule(s)

DOT Name	DOT ID	UniProt ID	Mode of Action	REF
Cytochrome P450 3A4 (CYP3A4)	OTQGYY83	CP3A4_HUMAN	Increases Expression	[13]
ATP-dependent translocase ABCB1 (ABCB1)	OTEJROBO	MDR1_HUMAN	Decreases Activity	[14]
Hepatocyte growth factor receptor (MET)	OT7K55MU	MET_HUMAN	Increases Response To Substance	[6]
ALK tyrosine kinase receptor (ALK)	OTV3P4V8	ALK_HUMAN	Decreases Response To Substance	[15]
Prominin-1 (PROM1)	OTBHV8NX	PROM1_HUMAN	Decreases Expression	[5]
CD44 antigen (CD44)	OT9TTJ41	CD44_HUMAN	Decreases Expression	[5]
Epithelial cell adhesion molecule (EPCAM)	OTHBZK5X	EPCAM_HUMAN	Decreases Expression	[5]
Cytidine deaminase (CDA)	OT3HXP6N	CDD_HUMAN	Decreases Expression	[5]
Insulin-induced gene 1 protein (INSIG1)	OTZF5X1D	INSI1_HUMAN	Increases Expression	[16]
Acyl-CoA 6-desaturase (FADS2)	OTUX531P	FADS2_HUMAN	Increases Expression	[16]
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR)	OTRT3F3U	HMDH_HUMAN	Increases Expression	[16]
Caspase-3 (CASP3)	OTIJRBE7	CASP3_HUMAN	Increases Activity	[16]
Fatty acid synthase (FASN)	OTFII9KG	FAS_HUMAN	Increases Expression	[16]
Caspase-7 (CASP7)	OTAPJ040	CASP7_HUMAN	Increases Activity	[16]
Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMGCS1)	OTCO26FV	HMCS1_HUMAN	Increases Expression	[16]
Sterol regulatory element-binding protein 2 (SREBF2)	OTBXUNPL	SRBP2_HUMAN	Increases Expression	[16]
Potassium voltage-gated channel subfamily H member 2 (KCNH2)	OTZX881H	KCNH2_HUMAN	Decreases Activity	[16]
Acetyl-CoA carboxylase 1 (ACACA)	OT5CQPZY	ACACA_HUMAN	Increases Phosphorylation	[16]
Voltage-dependent L-type calcium channel subunit alpha-1C (CACNA1C)	OT6KFNMS	CAC1C_HUMAN	Decreases Activity	[16]
Sodium channel protein type 5 subunit alpha (SCN5A)	OTGYZWR6	SCN5A_HUMAN	Decreases Activity	[16]
Baculoviral IAP repeat-containing protein 5 (BIRC5)	OTILXZYL	BIRC5_HUMAN	Decreases Expression	[6]
Bcl-2-like protein 11 (BCL2L11)	OTNQQWFJ	B2L11_HUMAN	Increases Expression	[6]
Follitropin subunit beta (FSHB)	OTGLS283	FSHB_HUMAN	Decreases Secretion	[17]
Lutropin subunit beta (LHB)	OT5GBOVJ	LSHB_HUMAN	Decreases Secretion	[17]
Tyrosine-protein kinase Lck (LCK)	OT883FG9	LCK_HUMAN	Decreases Activity	[18]
Poly polymerase 1 (PARP1)	OT310QSG	PARP1_HUMAN	Increases Cleavage	[19]
Tissue factor (F3)	OT3MSU3B	TF_HUMAN	Increases Expression	[20]
Histone H2AX (H2AX)	OT18UX57	H2AX_HUMAN	Increases Phosphorylation	[19]
Alanine aminotransferase 1 (GPT)	OTOXOA0Q	ALAT1_HUMAN	Increases Secretion	[21]
Mitogen-activated protein kinase 3 (MAPK3)	OTCYKGKO	MK03_HUMAN	Decreases Phosphorylation	[22]
Mitogen-activated protein kinase 1 (MAPK1)	OTH85PI5	MK01_HUMAN	Decreases Phosphorylation	[22]
RAC-alpha serine/threonine-protein kinase (AKT1)	OT8H2YY7	AKT1_HUMAN	Decreases Phosphorylation	[23]
Signal transducer and activator of transcription 3 (STAT3)	OTAAGKYZ	STAT3_HUMAN	Decreases Phosphorylation	[24]
Ras GTPase-activating-like protein IQGAP1 (IQGAP1)	OTZRWTGA	IQGA1_HUMAN	Decreases Phosphorylation	[25]
Small ribosomal subunit protein eS6 (RPS6)	OTT4D1LN	RS6_HUMAN	Decreases Phosphorylation	[24]
Baculoviral IAP repeat-containing protein 2 (BIRC2)	OTFXFREP	BIRC2_HUMAN	Decreases Expression	[6]
Caspase-8 (CASP8)	OTA8TVI8	CASP8_HUMAN	Increases Cleavage	[26]
Echinoderm microtubule-associated protein-like 4 (EML4)	OTJC45TA	EMAL4_HUMAN	Increases Mutagenesis	[22]
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2)	OTW8V2V1	ABCG2_HUMAN	Decreases Activity	[14]
GTPase KRas (KRAS)	OT78QCN8	RASK_HUMAN	Decreases Response To Substance	[27]
Pro-epidermal growth factor (EGF)	OTANRJ0L	EGF_HUMAN	Decreases Response To Substance	[23]
Epidermal growth factor receptor (EGFR)	OTAPLO1S	EGFR_HUMAN	Decreases Response To Substance	[27]
Mast/stem cell growth factor receptor Kit (KIT)	OTHUY3VZ	KIT_HUMAN	Decreases Response To Substance	[15]
Proheparin-binding EGF-like growth factor (HBEGF)	OTLU00JS	HBEGF_HUMAN	Decreases Response To Substance	[23]
Protransforming growth factor alpha (TGFA)	OTPD1LL9	TGFA_HUMAN	Decreases Response To Substance	[23]

Indication(s) of Arsenic trioxide

Disease Entry	ICD 11	Status	REF
Acute lymphoblastic leukaemia	2A85	Approved	[3]
Leukemia	N.A.	Approved	[4]
Refractory plasma cell neoplasm	N.A.	Approved	[4]
Endometrial carcinoma	N.A.	Investigative	[4]

Arsenic trioxide Interacts with 1 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)	TTJ3E9X	IKKB_HUMAN	Inhibitor	[74]

Arsenic trioxide Interacts with 2 DTP Molecule(s)

DTP Name	DTP ID	UniProt ID	Mode of Action	REF
Multidrug resistance-associated protein 2 (ABCC2)	DTFI42L	MRP2_HUMAN	Substrate	[75]
P-glycoprotein 1 (ABCB1)	DTUGYRD	MDR1_HUMAN	Substrate	[76]

Arsenic trioxide Interacts with 2669 DOT Molecule(s)

DOT Name	DOT ID	UniProt ID	Mode of Action	REF
ATP-binding cassette sub-family C member 2 (ABCC2)	OTJSIGV5	MRP2_HUMAN	Decreases Expression	[77]
ATP-dependent translocase ABCB1 (ABCB1)	OTEJROBO	MDR1_HUMAN	Decreases Expression	[78]
Heat shock 70 kDa protein 4 (HSPA4)	OT5HR0AR	HSP74_HUMAN	Increases Expression	[79]
DnaJ homolog subfamily B member 1 (DNAJB1)	OTCOSEVH	DNJB1_HUMAN	Increases Expression	[80]
Protein c-Fos (FOS)	OTJBUVWS	FOS_HUMAN	Decreases Expression	[35]
Heat shock 70 kDa protein 1-like (HSPA1L)	OTC2V1K6	HS71L_HUMAN	Increases Expression	[44]
Cellular tumor antigen p53 (TP53)	OTIE1VH3	P53_HUMAN	Decreases Expression	[81]
Heat shock protein HSP 90-alpha (HSP90AA1)	OTLG1WPK	HS90A_HUMAN	Increases Expression	[60]
Caspase-3 (CASP3)	OTIJRBE7	CASP3_HUMAN	Decreases Expression	[82]
Trefoil factor 1 (TFF1)	OTCYQH4F	TFF1_HUMAN	Increases Expression	[83]
Protein GREB1 (GREB1)	OTU6ZA26	GREB1_HUMAN	Increases Expression	[83]
Glutathione S-transferase A1 (GSTA1)	OTA7K5XA	GSTA1_HUMAN	Increases Expression	[79]
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A)	OTDRV63V	GA45A_HUMAN	Increases Expression	[79]
DNA damage-inducible transcript 3 protein (DDIT3)	OTI8YKKE	DDIT3_HUMAN	Increases Expression	[79]
Cyclin-dependent kinase 4 inhibitor B (CDKN2B)	OTAG24N1	CDN2B_HUMAN	Decreases Methylation	[84]
Unconventional myosin-Ib (MYO1B)	OTGZUJ0I	MYO1B_HUMAN	Decreases Expression	[85]
Argininosuccinate synthase (ASS1)	OT4ZMG0Q	ASSY_HUMAN	Decreases Expression	[85]
Heat shock protein beta-1 (HSPB1)	OTHFZ8ED	HSPB1_HUMAN	Decreases Expression	[85]
Eosinophil peroxidase (EPX)	OTFNDFOK	PERE_HUMAN	Increases Expression	[85]
Defensin alpha 4 (DEFA4)	OTOQWE4C	DEF4_HUMAN	Increases Expression	[85]
Cytochrome b-245 light chain (CYBA)	OT16N9ZO	CY24A_HUMAN	Increases Expression	[85]
Neutrophil cytosol factor 1 (NCF1)	OTMHT3G6	NCF1_HUMAN	Increases Expression	[85]
Gap junction alpha-1 protein (GJA1)	OTT94MKL	CXA1_HUMAN	Decreases Expression	[85]
Insulin-like growth factor-binding protein 2 (IGFBP2)	OTG1P60E	IBP2_HUMAN	Decreases Expression	[85]
3',5'-cyclic-AMP phosphodiesterase 4A (PDE4A)	OTMUUZLF	PDE4A_HUMAN	Decreases Expression	[85]
Cytokine receptor common subunit beta (CSF2RB)	OTGEZR0L	IL3RB_HUMAN	Increases Expression	[85]
Neutrophil defensin 1 (DEFA1)	OT5N1B9B	DEF1_HUMAN	Increases Expression	[85]
Fanconi anemia group C protein (FANCC)	OTTIDM3P	FANCC_HUMAN	Increases Expression	[85]
Galectin-10 (CLC)	OTYMYR85	LEG10_HUMAN	Increases Expression	[85]
Potassium voltage-gated channel subfamily H member 2 (KCNH2)	OTZX881H	KCNH2_HUMAN	Increases Expression	[85]
Fascin (FSCN1)	OTTGIHTM	FSCN1_HUMAN	Decreases Expression	[85]
GRAM domain-containing protein 2B (GRAMD2B)	OTGT3E98	GRM2B_HUMAN	Increases Expression	[85]
Carbohydrate sulfotransferase 6 (CHST6)	OTXD2IWK	CHST6_HUMAN	Increases Expression	[85]
Cytokine-like protein 1 (CYTL1)	OTLYUPUY	CYTL1_HUMAN	Decreases Expression	[85]
Sialidase-3 (NEU3)	OTQ5PQOW	NEUR3_HUMAN	Increases Expression	[85]
Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B)	OTO7O3CU	DYR1B_HUMAN	Increases Expression	[85]
LHFPL tetraspan subfamily member 6 protein (LHFPL6)	OTY6LHJY	LHPL6_HUMAN	Decreases Expression	[85]
Integral membrane protein 2A (ITM2A)	OT590V63	ITM2A_HUMAN	Decreases Expression	[28]
Tripartite motif-containing protein 16 (TRIM16)	OTLRXYOZ	TRI16_HUMAN	Increases Expression	[28]
NADH-cytochrome b5 reductase 3 (CYB5R3)	OTUGT3G8	NB5R3_HUMAN	Increases Expression	[28]
Cystatin-C (CST3)	OTNZ6AO4	CYTC_HUMAN	Decreases Expression	[28]
HLA class I histocompatibility antigen, B alpha chain (HLA-B)	OTNXFWY2	HLAB_HUMAN	Decreases Expression	[28]
HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA)	OT7KZMP2	DRA_HUMAN	Decreases Expression	[28]
Protein kinase C beta type (PRKCB)	OTYQ0656	KPCB_HUMAN	Decreases Expression	[28]
Heme oxygenase 1 (HMOX1)	OTC1W6UX	HMOX1_HUMAN	Increases Expression	[28]
Fructose-bisphosphate aldolase C (ALDOC)	OTEC13I5	ALDOC_HUMAN	Decreases Expression	[28]
Metallothionein 1H-like protein 1 (MT1HL1)	OTTB2N9F	M1BL1_HUMAN	Increases Expression	[28]
Myb-related protein A (MYBL1)	OTBJMC2P	MYBA_HUMAN	Decreases Expression	[28]
HLA class I histocompatibility antigen, C alpha chain (HLA-C)	OTV38BUJ	HLAC_HUMAN	Decreases Expression	[28]
Lysosomal protective protein (CTSA)	OT167UBM	PPGB_HUMAN	Increases Expression	[28]
5-aminolevulinate synthase, non-specific, mitochondrial (ALAS1)	OTQY6ZSF	HEM1_HUMAN	Increases Expression	[28]
Metallothionein-1G (MT1G)	OTAV1OCR	MT1G_HUMAN	Increases Expression	[28]
Prolyl 4-hydroxylase subunit alpha-1 (P4HA1)	OTV04QE5	P4HA1_HUMAN	Decreases Expression	[28]
HLA class I histocompatibility antigen, alpha chain G (HLA-G)	OTMLK1KN	HLAG_HUMAN	Decreases Expression	[28]
Proteasome subunit beta type-8 (PSMB8)	OTW5XGMF	PSB8_HUMAN	Decreases Expression	[28]
Flavin reductase (BLVRB)	OTHCFN2C	BLVRB_HUMAN	Increases Expression	[28]
HLA class I histocompatibility antigen, alpha chain F (HLA-F)	OT76CM19	HLAF_HUMAN	Decreases Expression	[28]
NADP-dependent malic enzyme (ME1)	OTSVEUQE	MAOX_HUMAN	Increases Expression	[28]
Glutamate--cysteine ligase regulatory subunit (GCLM)	OT6CP234	GSH0_HUMAN	Increases Expression	[28]
Cysteine and glycine-rich protein 3 (CSRP3)	OTECBJMV	CSRP3_HUMAN	Decreases Expression	[28]
Caveolin-2 (CAV2)	OT1FGRQX	CAV2_HUMAN	Decreases Expression	[28]
ADP-ribosylation factor-like protein 4C (ARL4C)	OTQ3QNNU	ARL4C_HUMAN	Decreases Expression	[28]
Metallothionein-1H (MT1H)	OT0MVBM6	MT1H_HUMAN	Increases Expression	[28]
Large ribosomal subunit protein eL20 (RPL18A)	OTKBMVCX	RL18A_HUMAN	Decreases Expression	[28]
Caveolin-1 (CAV1)	OTEZUR1L	CAV1_HUMAN	Decreases Expression	[28]
Transcription factor SOX-4 (SOX4)	OTSS40SS	SOX4_HUMAN	Decreases Expression	[28]
Dual specificity protein phosphatase 4 (DUSP4)	OT6WAO12	DUS4_HUMAN	Decreases Expression	[28]
BMP and activin membrane-bound inhibitor homolog (BAMBI)	OTCEJ8W5	BAMBI_HUMAN	Decreases Expression	[28]
SERTA domain-containing protein 2 (SERTAD2)	OTYIG6TP	SRTD2_HUMAN	Decreases Expression	[28]
Cytoplasmic dynein 1 heavy chain 1 (DYNC1H1)	OTD1KRKO	DYHC1_HUMAN	Increases Expression	[28]
Insulin-like growth factor-binding protein 7 (IGFBP7)	OT1D416P	IBP7_HUMAN	Decreases Expression	[28]
Neuronal regeneration-related protein (NREP)	OT2AZPKK	NREP_HUMAN	Decreases Expression	[28]
Terminal nucleotidyltransferase 5C (TENT5C)	OTOWVQ4O	TET5C_HUMAN	Decreases Expression	[28]
Heme transporter HRG1 (SLC48A1)	OTPFHZLO	HRG1_HUMAN	Increases Expression	[28]
Membrane progestin receptor delta (PAQR6)	OTEX44Z2	PAQR6_HUMAN	Decreases Expression	[28]
Extracellular sulfatase Sulf-1 (SULF1)	OTJCNCO0	SULF1_HUMAN	Decreases Expression	[28]
Solute carrier family 22 member 18 (SLC22A18)	OT9C3KR4	S22AI_HUMAN	Decreases Expression	[28]
Legumain (LGMN)	OTB323OZ	LGMN_HUMAN	Decreases Expression	[28]
Cbp/p300-interacting transactivator 2 (CITED2)	OT812TV7	CITE2_HUMAN	Decreases Expression	[28]
BTB/POZ domain-containing protein 2 (BTBD2)	OTAZ4DWD	BTBD2_HUMAN	Decreases Expression	[28]
C-type lectin domain family 7 member A (CLEC7A)	OTRTBH27	CLC7A_HUMAN	Decreases Expression	[28]
Transcription regulator protein BACH2 (BACH2)	OT17GS18	BACH2_HUMAN	Decreases Expression	[28]
Retinoid-inducible serine carboxypeptidase (SCPEP1)	OT43LYEZ	RISC_HUMAN	Increases Expression	[28]
tRNA (TRMT1)	OTV0WBHX	TRM1_HUMAN	Increases Expression	[28]
G-protein coupled receptor family C group 5 member D (GPRC5D)	OT7NYWCI	GPC5D_HUMAN	Decreases Expression	[28]
Cysteine-rich motor neuron 1 protein (CRIM1)	OTTZNV6Y	CRIM1_HUMAN	Increases Expression	[28]
Ena/VASP-like protein (EVL)	OTZ8ZDNY	EVL_HUMAN	Decreases Expression	[28]
F-box/LRR-repeat protein 7 (FBXL7)	OTNUK1DJ	FBXL7_HUMAN	Decreases Expression	[28]
BTB/POZ domain-containing protein 3 (BTBD3)	OTZ607YT	BTBD3_HUMAN	Decreases Expression	[28]
Methionine-R-sulfoxide reductase B2, mitochondrial (MSRB2)	OTURGRA8	MSRB2_HUMAN	Decreases Expression	[28]
Hypoxia-inducible lipid droplet-associated protein (HILPDA)	OTEID3ZM	HLPDA_HUMAN	Decreases Expression	[28]
Roundabout homolog 1 (ROBO1)	OT52UFVS	ROBO1_HUMAN	Decreases Expression	[28]
Galectin-9 (LGALS9)	OT7MF91K	LEG9_HUMAN	Increases Expression	[29]
Ras-related protein Rab-27B (RAB27B)	OTPF9D0K	RB27B_HUMAN	Decreases Expression	[29]
Pirin (PIR)	OT8ALXHU	PIR_HUMAN	Increases Expression	[29]
Class E basic helix-loop-helix protein 40 (BHLHE40)	OTITX14U	BHE40_HUMAN	Increases Expression	[29]
Tumor protein p53-inducible protein 11 (TP53I11)	OTFPDYZU	P5I11_HUMAN	Decreases Expression	[29]
Krueppel-like factor 11 (KLF11)	OTKVQDJD	KLF11_HUMAN	Decreases Expression	[29]
Synapsin-3 (SYN3)	OTSGYNA5	SYN3_HUMAN	Decreases Expression	[29]
PDZ domain-containing protein 2 (PDZD2)	OTPPVRGY	PDZD2_HUMAN	Decreases Expression	[29]
ERC protein 2 (ERC2)	OTFEDI56	ERC2_HUMAN	Increases Expression	[29]
FYN-binding protein 1 (FYB1)	OT6345CH	FYB1_HUMAN	Increases Expression	[29]
Band 4.1-like protein 2 (EPB41L2)	OT6UABPM	E41L2_HUMAN	Decreases Expression	[29]
Linker for activation of T-cells family member 1 (LAT)	OTZC1XZ1	LAT_HUMAN	Increases Expression	[29]
Orexin/Hypocretin receptor type 1 (HCRTR1)	OTB8UEWR	OX1R_HUMAN	Decreases Expression	[29]
Sialic acid-binding Ig-like lectin 6 (SIGLEC6)	OTO4F5C9	SIGL6_HUMAN	Increases Expression	[29]
Maleylacetoacetate isomerase (GSTZ1)	OTQ43JCE	MAAI_HUMAN	Increases Expression	[29]
E3 ubiquitin ligase TRAF3IP2 (TRAF3IP2)	OTLLZERL	CIKS_HUMAN	Increases Expression	[29]
Origin recognition complex subunit 4 (ORC4)	OT3ACTST	ORC4_HUMAN	Decreases Expression	[29]
Sushi domain-containing protein 5 (SUSD5)	OTIMJGDH	SUSD5_HUMAN	Increases Expression	[29]
BMP/retinoic acid-inducible neural-specific protein 1 (BRINP1)	OTEUVSCP	BRNP1_HUMAN	Increases Expression	[29]
Plexin-C1 (PLXNC1)	OTJ5XKYY	PLXC1_HUMAN	Increases Expression	[29]
Adenylate cyclase type 9 (ADCY9)	OT1IZT5K	ADCY9_HUMAN	Decreases Expression	[29]
Musculin (MSC)	OTBRPZL5	MUSC_HUMAN	Decreases Expression	[29]
Kinesin-like protein KIF21B (KIF21B)	OTFXFIU3	KI21B_HUMAN	Increases Expression	[29]
NEDD4-binding protein 1 (N4BP1)	OTN2TL6N	N4BP1_HUMAN	Increases Expression	[29]
Obscurin-like protein 1 (OBSL1)	OT6M8M3J	OBSL1_HUMAN	Increases Expression	[29]
Tumor necrosis factor ligand superfamily member 13 (TNFSF13)	OT90OWIO	TNF13_HUMAN	Increases Expression	[29]
Gamma-aminobutyric acid type B receptor subunit 2 (GABBR2)	OT67RIFY	GABR2_HUMAN	Decreases Expression	[29]
Ribosomal L1 domain-containing protein 1 (RSL1D1)	OT3CL4R3	RL1D1_HUMAN	Decreases Expression	[29]
Transcription factor SOX-30 (SOX30)	OTGT38E3	SOX30_HUMAN	Increases Expression	[29]
Statherin (STATH)	OTQHBHM9	STAT_HUMAN	Decreases Expression	[29]
Interstitial collagenase (MMP1)	OTI4I2V1	MMP1_HUMAN	Decreases Expression	[29]
Lysosomal acid glucosylceramidase (GBA1)	OT0XMD63	GBA1_HUMAN	Increases Expression	[29]
Sodium/potassium-transporting ATPase subunit beta-1 (ATP1B1)	OTTO6ZP4	AT1B1_HUMAN	Decreases Expression	[29]
Secretogranin-1 (CHGB)	OT7SAQT2	SCG1_HUMAN	Increases Expression	[29]
Protein S100-A9 (S100A9)	OTOARHCS	S10A9_HUMAN	Increases Expression	[29]
Corticoliberin (CRH)	OT2MOC4T	CRF_HUMAN	Decreases Expression	[29]
Serine protease 1 (PRSS1)	OTA425AX	TRY1_HUMAN	Increases Expression	[29]
Chymotrypsin-like elastase family member 2A (CELA2A)	OTY8QG2J	CEL2A_HUMAN	Increases Expression	[29]
Integrin alpha-IIb (ITGA2B)	OT4Y17PY	ITA2B_HUMAN	Increases Expression	[29]
Pro-cathepsin H (CTSH)	OTLFL0DG	CATH_HUMAN	Decreases Expression	[29]
Secretin (SCT)	OTV3MLOO	SECR_HUMAN	Decreases Expression	[29]
Tyrosine-protein kinase Fgr (FGR)	OTCUYU9F	FGR_HUMAN	Increases Expression	[29]
Chorionic somatomammotropin hormone 1 (CSH1)	OT33HTRR	CSH1_HUMAN	Decreases Expression	[29]
Fibroblast growth factor receptor 1 (FGFR1)	OT4GLCXW	FGFR1_HUMAN	Decreases Expression	[29]
C-C motif chemokine 2 (CCL2)	OTAD2HEL	CCL2_HUMAN	Increases Expression	[29]
Hepatocyte growth factor (HGF)	OTGHUA23	HGF_HUMAN	Decreases Expression	[29]
Antigen-presenting glycoprotein CD1d (CD1D)	OT3ROU4J	CD1D_HUMAN	Decreases Expression	[29]
Transcription factor 4 (TCF4)	OTB9ASTK	ITF2_HUMAN	Increases Expression	[29]
Bactericidal permeability-increasing protein (BPI)	OTNN9LJ5	BPI_HUMAN	Increases Expression	[29]
Transcription factor JunD (JUND)	OTNKACJD	JUND_HUMAN	Increases Expression	[29]
Hexokinase-1 (HK1)	OTMPHE8O	HXK1_HUMAN	Increases Expression	[29]
Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B)	OTDS2EAR	TNR1B_HUMAN	Decreases Expression	[29]
Amine oxidase A (MAOA)	OT8NIWMQ	AOFA_HUMAN	Increases Expression	[29]
Kit ligand (KITLG)	OTB9AVQ4	SCF_HUMAN	Decreases Expression	[29]
Fibroblast growth factor receptor 2 (FGFR2)	OTLOPACK	FGFR2_HUMAN	Decreases Expression	[29]
Iduronate 2-sulfatase (IDS)	OTZO94EO	IDS_HUMAN	Increases Expression	[29]
C-X-C chemokine receptor type 2 (CXCR2)	OTISGW7L	CXCR2_HUMAN	Increases Expression	[29]
Integrin beta-7 (ITGB7)	OT33UUKU	ITB7_HUMAN	Increases Expression	[29]
Leukocyte elastase inhibitor (SERPINB1)	OT5RDUFO	ILEU_HUMAN	Increases Expression	[29]
Syndecan-4 (SDC4)	OTKUVUGZ	SDC4_HUMAN	Decreases Expression	[29]
Type II inositol 1,4,5-trisphosphate 5-phosphatase (INPP5B)	OT0SC8W5	I5P2_HUMAN	Increases Expression	[29]
G-protein coupled receptor 183 (GPR183)	OTRILX7G	GP183_HUMAN	Increases Expression	[29]
G protein-coupled receptor kinase 4 (GRK4)	OTUU8V2S	GRK4_HUMAN	Increases Expression	[29]
Intercellular adhesion molecule 3 (ICAM3)	OTTZ5A5D	ICAM3_HUMAN	Increases Expression	[29]
CD70 antigen (CD70)	OTHB2AL1	CD70_HUMAN	Decreases Expression	[29]
Tumor necrosis factor ligand superfamily member 8 (TNFSF8)	OTDYGDJ3	TNFL8_HUMAN	Increases Expression	[29]
Lymphocyte-specific protein 1 (LSP1)	OTSPSIFO	LSP1_HUMAN	Increases Expression	[29]
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (MAN1A1)	OT6LIGJP	MA1A1_HUMAN	Increases Expression	[29]
Tyrosine-protein kinase RYK (RYK)	OTZ3WWZH	RYK_HUMAN	Decreases Expression	[29]
Catenin alpha-1 (CTNNA1)	OTFC725Z	CTNA1_HUMAN	Decreases Expression	[29]
Transcription factor SOX-18 (SOX18)	OTPUMHWA	SOX18_HUMAN	Decreases Expression	[29]
Guanine nucleotide-binding protein G(olf) subunit alpha (GNAL)	OTESDTEU	GNAL_HUMAN	Increases Expression	[29]
Thrombopoietin receptor (MPL)	OTZEN192	TPOR_HUMAN	Decreases Expression	[29]
T-lymphocyte activation antigen CD86 (CD86)	OTJCSBPC	CD86_HUMAN	Decreases Expression	[29]
Tyrosine-protein kinase FRK (FRK)	OTEKV1SC	FRK_HUMAN	Decreases Expression	[29]
3-ketoacyl-CoA thiolase, mitochondrial (ACAA2)	OTGLVWOP	THIM_HUMAN	Increases Expression	[29]
Solute carrier family 15 member 1 (SLC15A1)	OT1P16B5	S15A1_HUMAN	Decreases Expression	[29]
E3 ubiquitin-protein ligase RNF144A (RNF144A)	OTCG27CT	R144A_HUMAN	Increases Expression	[29]
Neuronal membrane glycoprotein M6-a (GPM6A)	OT8G13EG	GPM6A_HUMAN	Increases Expression	[29]
Homeobox protein PKNOX1 (PKNOX1)	OTUDMNHX	PKNX1_HUMAN	Decreases Expression	[29]
C-C motif chemokine 23 (CCL23)	OTE2DU0A	CCL23_HUMAN	Increases Expression	[29]
Peroxisomal biogenesis factor 3 (PEX3)	OTGZ7ME2	PEX3_HUMAN	Increases Expression	[29]
Cyclin-A1 (CCNA1)	OTX4HD45	CCNA1_HUMAN	Decreases Expression	[29]
Insulinoma-associated protein 1 (INSM1)	OTG8RV8E	INSM1_HUMAN	Increases Expression	[29]
DNA-binding protein inhibitor ID-2 (ID2)	OT0U1D53	ID2_HUMAN	Decreases Expression	[29]
Cyclic AMP-responsive element-binding protein 5 (CREB5)	OTJDUJPI	CREB5_HUMAN	Increases Expression	[29]
Urokinase plasminogen activator surface receptor (PLAUR)	OTIRKKEQ	UPAR_HUMAN	Decreases Expression	[29]
3',5'-cyclic-AMP phosphodiesterase 4B (PDE4B)	OTOA8WU2	PDE4B_HUMAN	Decreases Expression	[29]
Ankyrin-3 (ANK3)	OTJ3IRBP	ANK3_HUMAN	Decreases Expression	[29]
Mammaglobin-A (SCGB2A2)	OTXBFHK8	SG2A2_HUMAN	Increases Expression	[29]
Transformer-2 protein homolog alpha (TRA2A)	OT5NHOO3	TRA2A_HUMAN	Decreases Expression	[29]
Krueppel-like factor 5 (KLF5)	OT1ABI9N	KLF5_HUMAN	Increases Expression	[29]
ARF GTPase-activating protein GIT2 (GIT2)	OTQ2EQJ1	GIT2_HUMAN	Increases Expression	[29]
Ensconsin (MAP7)	OTVSSJ33	MAP7_HUMAN	Increases Expression	[29]
NGFI-A-binding protein 2 (NAB2)	OTG4BDF3	NAB2_HUMAN	Decreases Expression	[29]
Mothers against decapentaplegic homolog 1 (SMAD1)	OTQSHR25	SMAD1_HUMAN	Decreases Expression	[29]
Urea transporter 2 (SLC14A2)	OTYI6SX1	UT2_HUMAN	Increases Expression	[29]
C-C motif chemokine 15 (CCL15)	OTOGZ85M	CCL15_HUMAN	Increases Expression	[29]
Gamma-interferon-inducible protein 16 (IFI16)	OT4SPU0U	IF16_HUMAN	Decreases Expression	[29]
Kynureninase (KYNU)	OTINL2RE	KYNU_HUMAN	Increases Expression	[29]
Sodium-coupled monocarboxylate transporter 2 (SLC5A12)	OTKY9NAL	SC5AC_HUMAN	Increases Expression	[29]
Centrosome and spindle pole-associated protein 1 (CSPP1)	OTNX7GD4	CSPP1_HUMAN	Decreases Expression	[29]
Pleckstrin homology-like domain family A member 2 (PHLDA2)	OTMV9DPP	PHLA2_HUMAN	Decreases Expression	[29]
Pleckstrin homology domain-containing family O member 1 (PLEKHO1)	OTMVUQ9W	PKHO1_HUMAN	Decreases Expression	[29]
Cordon-bleu protein-like 1 (COBLL1)	OTQFN1TC	COBL1_HUMAN	Increases Expression	[29]
Plasma membrane ascorbate-dependent reductase CYBRD1 (CYBRD1)	OTUTVBES	CYBR1_HUMAN	Increases Expression	[29]
Tetratricopeptide repeat protein 38 (TTC38)	OTKE53HT	TTC38_HUMAN	Increases Expression	[29]
Formin-binding protein 1-like (FNBP1L)	OTH1S2P2	FBP1L_HUMAN	Decreases Expression	[29]
NEDD4-binding protein 2-like 1 (N4BP2L1)	OTEGV3GO	N42L1_HUMAN	Decreases Expression	[29]
Serine/threonine-protein kinase MRCK alpha (CDC42BPA)	OTCPFOSA	MRCKA_HUMAN	Increases Expression	[29]
Myomegalin (PDE4DIP)	OTS15WNF	MYOME_HUMAN	Increases Expression	[29]
Coiled-coil domain-containing protein 102B (CCDC102B)	OTVDZVD0	C102B_HUMAN	Increases Expression	[29]
Parafibromin (CDC73)	OT6JASZ1	CDC73_HUMAN	Increases Expression	[29]
MTOR-associated protein MEAK7 (MEAK7)	OT9A8JSO	MEAK7_HUMAN	Increases Expression	[29]
GTPase IMAP family member 6 (GIMAP6)	OTDKV8V8	GIMA6_HUMAN	Increases Expression	[29]
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (PAOX)	OT7HVXRL	PAOX_HUMAN	Increases Expression	[29]
Ankyrin repeat domain-containing protein 12 (ANKRD12)	OTK16BL9	ANR12_HUMAN	Increases Expression	[29]
8-oxo-dGDP phosphatase NUDT18 (NUDT18)	OT03IQA5	NUD18_HUMAN	Increases Expression	[29]
LisH domain-containing protein ARMC9 (ARMC9)	OT0MZER2	ARMC9_HUMAN	Decreases Expression	[29]
Deleted in azoospermia protein 4 (DAZ4)	OTWY1A9V	DAZ4_HUMAN	Increases Expression	[29]
IQ domain-containing protein H (IQCH)	OTEYWCIW	IQCH_HUMAN	Increases Expression	[29]
Neuron navigator 3 (NAV3)	OT97M1TR	NAV3_HUMAN	Decreases Expression	[29]
FAD-dependent oxidoreductase domain-containing protein 2 (FOXRED2)	OTSJOZ3O	FXRD2_HUMAN	Increases Expression	[29]
CKLF-like MARVEL transmembrane domain-containing protein 8 (CMTM8)	OTG28GH2	CKLF8_HUMAN	Decreases Expression	[29]
Spindle and centriole-associated protein 1 (SPICE1)	OTQ5I44M	SPICE_HUMAN	Increases Expression	[29]
Actin filament-associated protein 1 (AFAP1)	OTR473H8	AFAP1_HUMAN	Increases Expression	[29]
Ras association domain-containing protein 8 (RASSF8)	OTXKGIB3	RASF8_HUMAN	Increases Expression	[29]
Secretory carrier-associated membrane protein 5 (SCAMP5)	OT9MXA2J	SCAM5_HUMAN	Decreases Expression	[29]
Protein FAM110B (FAM110B)	OTLYN2T1	F110B_HUMAN	Increases Expression	[29]
GPI ethanolamine phosphate transferase 3 (PIGO)	OTGDOBO1	PIGO_HUMAN	Increases Expression	[29]
Choline transporter-like protein 1 (SLC44A1)	OT46R03O	CTL1_HUMAN	Decreases Expression	[29]
DnaJ homolog subfamily C member 9 (DNAJC9)	OTDBQBNZ	DNJC9_HUMAN	Increases Expression	[29]
Histone acetyltransferase KAT6B (KAT6B)	OTMUDTAH	KAT6B_HUMAN	Decreases Expression	[29]
Transmembrane protein 158 (TMEM158)	OT0KUBBI	TM158_HUMAN	Decreases Expression	[29]
Rap guanine nucleotide exchange factor 4 (RAPGEF4)	OT59PSSE	RPGF4_HUMAN	Increases Expression	[29]
AP-3 complex subunit sigma-1 (AP3S1)	OTI5UTF6	AP3S1_HUMAN	Decreases Expression	[29]
Peroxidasin homolog (PXDN)	OTFGGM9R	PXDN_HUMAN	Decreases Expression	[29]
Transcription factor AP-2 gamma (TFAP2C)	OTUDIW05	AP2C_HUMAN	Decreases Expression	[29]
Proprotein convertase subtilisin/kexin type 5 (PCSK5)	OTP0RJ4Y	PCSK5_HUMAN	Increases Expression	[29]
Tumor necrosis factor receptor superfamily member 25 (TNFRSF25)	OTVZ7I3A	TNR25_HUMAN	Decreases Expression	[29]
BTB/POZ domain-containing protein KCTD12 (KCTD12)	OTPYKT4Z	KCD12_HUMAN	Decreases Expression	[29]
RUS family member 1 (RUSF1)	OTRIIY6J	RUSF1_HUMAN	Increases Expression	[29]
Platelet-activating factor acetylhydrolase 2, cytoplasmic (PAFAH2)	OTSHD5M5	PAFA2_HUMAN	Increases Expression	[29]
Interleukin-12 receptor subunit beta-2 (IL12RB2)	OTDLV8H8	I12R2_HUMAN	Increases Expression	[29]
Neuronal PAS domain-containing protein 1 (NPAS1)	OTZKO6ZN	NPAS1_HUMAN	Increases Expression	[29]
Histone H2B type 1-M (H2BC14)	OTSDZZZY	H2B1M_HUMAN	Decreases Expression	[29]
Endophilin-A1 (SH3GL2)	OTOE443G	SH3G2_HUMAN	Increases Expression	[29]
Oxidoreductase HTATIP2 (HTATIP2)	OT9MZ4QO	HTAI2_HUMAN	Increases Expression	[29]
Interferon-induced helicase C domain-containing protein 1 (IFIH1)	OTZA2AHA	IFIH1_HUMAN	Decreases Expression	[29]
Matrix metalloproteinase-28 (MMP28)	OTHQZXM1	MMP28_HUMAN	Decreases Expression	[29]
Golgin-45 (BLZF1)	OT5QD8FG	GO45_HUMAN	Increases Expression	[29]
Beta,beta-carotene 15,15'-dioxygenase (BCO1)	OTZKQTCL	BCDO1_HUMAN	Decreases Expression	[29]
Cytochrome P450 3A43 (CYP3A43)	OTMXADGA	CP343_HUMAN	Increases Expression	[29]
Calpain-10 (CAPN10)	OTS9LJW4	CAN10_HUMAN	Increases Expression	[29]
Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (ALG13)	OTOH9PMY	ALG13_HUMAN	Increases Expression	[29]
Ubiquitin carboxyl-terminal hydrolase CYLD (CYLD)	OT37FKH0	CYLD_HUMAN	Decreases Expression	[29]
Transcriptional and immune response regulator (TCIM)	OTARUXQF	TCIM_HUMAN	Increases Expression	[29]
PDZ and LIM domain protein 7 (PDLIM7)	OTAZVODU	PDLI7_HUMAN	Increases Expression	[29]
Factor associated with metabolism and energy (CCDC198)	OTP0QSL3	FAME_HUMAN	Increases Expression	[29]
Stabilin-1 (STAB1)	OTW2HMCE	STAB1_HUMAN	Decreases Expression	[29]
Voltage-dependent calcium channel subunit alpha-2/delta-2 (CACNA2D2)	OTFJXVQQ	CA2D2_HUMAN	Increases Expression	[29]
24-hydroxycholesterol 7-alpha-hydroxylase (CYP39A1)	OTBAJT4I	CP39A_HUMAN	Decreases Expression	[29]
CCR4-NOT transcription complex subunit 2 (CNOT2)	OT98OJ42	CNOT2_HUMAN	Decreases Expression	[29]
E3 ubiquitin-protein ligase MARCHF2 (MARCHF2)	OTADQ0OA	MARH2_HUMAN	Increases Expression	[29]
Ribosome-binding protein 1 (RRBP1)	OT4ZTPTM	RRBP1_HUMAN	Increases Expression	[29]
Arginine-glutamic acid dipeptide repeats protein (RERE)	OT3G4GBZ	RERE_HUMAN	Increases Expression	[29]
Fibulin-5 (FBLN5)	OTLVNZ8U	FBLN5_HUMAN	Increases Expression	[29]
DnaJ homolog subfamily B member 4 (DNAJB4)	OTUD01BK	DNJB4_HUMAN	Increases Expression	[29]
Solute carrier organic anion transporter family member 3A1 (SLCO3A1)	OTME93NY	SO3A1_HUMAN	Increases Expression	[29]
Purine-rich element-binding protein gamma (PURG)	OTXPQDWN	PURG_HUMAN	Increases Expression	[29]
Signal-transducing adaptor protein 1 (STAP1)	OTUTZH0W	STAP1_HUMAN	Increases Expression	[29]
LIM/homeobox protein Lhx6 (LHX6)	OT47UQZ5	LHX6_HUMAN	Decreases Expression	[29]
DNA-binding protein SATB2 (SATB2)	OT2W80XC	SATB2_HUMAN	Decreases Expression	[29]
RING finger protein 24 (RNF24)	OTUZI597	RNF24_HUMAN	Increases Expression	[29]
E3 ubiquitin-protein ligase RNF6 (RNF6)	OTNAXM6D	RNF6_HUMAN	Increases Expression	[29]
Nuclease EXOG, mitochondrial (EXOG)	OTZAI8L7	EXOG_HUMAN	Increases Expression	[29]
Phospholipid-transporting ATPase IA (ATP8A1)	OT2B7XBT	AT8A1_HUMAN	Increases Expression	[29]
Proteoglycan 3 (PRG3)	OTZ40GRN	PRG3_HUMAN	Increases Expression	[29]
Sodium- and chloride-dependent glycine transporter 2 (SLC6A5)	OTKYC433	SC6A5_HUMAN	Increases Expression	[29]
Prostaglandin D2 receptor 2 (PTGDR2)	OTCSMVF1	PD2R2_HUMAN	Increases Expression	[29]
Collectin-10 (COLEC10)	OTMBADGZ	COL10_HUMAN	Decreases Expression	[29]
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (CYP24A1)	OTG2T749	CP24A_HUMAN	Decreases Expression	[86]
26S proteasome non-ATPase regulatory subunit 11 (PSMD11)	OT8KO67V	PSD11_HUMAN	Increases Expression	[30]
Insulin-induced gene 1 protein (INSIG1)	OTZF5X1D	INSI1_HUMAN	Decreases Expression	[30]
Protein ecdysoneless homolog (ECD)	OT3L3PCU	ECD_HUMAN	Decreases Expression	[30]
Fructose-bisphosphate aldolase A (ALDOA)	OTWRFTIB	ALDOA_HUMAN	Decreases Expression	[30]
Microtubule-associated protein 2 (MAP2)	OT6UYT3X	MTAP2_HUMAN	Decreases Expression	[30]
Glutamine synthetase (GLUL)	OTYGTCGF	GLNA_HUMAN	Increases Expression	[30]
Elongation factor 1-gamma (EEF1G)	OTW7DH2F	EF1G_HUMAN	Decreases Expression	[30]
Cleavage stimulation factor subunit 2 (CSTF2)	OTR6G4II	CSTF2_HUMAN	Increases Expression	[30]
Fibrillin-2 (FBN2)	OT3KYJQL	FBN2_HUMAN	Decreases Expression	[30]
Ras-related protein Rab-7a (RAB7A)	OTBSPWMQ	RAB7A_HUMAN	Decreases Expression	[30]
Myomesin-1 (MYOM1)	OTWALWGY	MYOM1_HUMAN	Decreases Expression	[30]
Actin, gamma-enteric smooth muscle (ACTG2)	OTRDWUO0	ACTH_HUMAN	Increases Expression	[30]
Elongation factor 1-alpha 1 (EEF1A1)	OT00THXS	EF1A1_HUMAN	Decreases Expression	[30]
Serine/arginine-rich splicing factor 4 (SRSF4)	OTLI7CU1	SRSF4_HUMAN	Decreases Expression	[30]
Cytoplasmic dynein 1 intermediate chain 2 (DYNC1I2)	OTS0UOL5	DC1I2_HUMAN	Decreases Expression	[30]
Unconventional myosin-IXb (MYO9B)	OTQ94R5K	MYO9B_HUMAN	Decreases Expression	[30]
Lysosomal-associated transmembrane protein 5 (LAPTM5)	OT2XI2JG	LAPM5_HUMAN	Increases Expression	[30]
Kelch-like ECH-associated protein 1 (KEAP1)	OTFHOD0C	KEAP1_HUMAN	Increases Expression	[30]
Ryanodine receptor 3 (RYR3)	OT4EHIP4	RYR3_HUMAN	Increases Expression	[30]
Methylsterol monooxygenase 1 (MSMO1)	OTKV62RZ	MSMO1_HUMAN	Decreases Expression	[30]
Neuroblastoma breakpoint family member 12 (NBPF12)	OT8UDVNV	NBPFC_HUMAN	Decreases Expression	[30]
N6-adenosine-methyltransferase catalytic subunit (METTL3)	OTSXP1M3	MTA70_HUMAN	Decreases Expression	[30]
X-linked retinitis pigmentosa GTPase regulator (RPGR)	OTJ7O69I	RPGR_HUMAN	Decreases Expression	[30]
StAR-related lipid transfer protein 4 (STARD4)	OTPQ0BFY	STAR4_HUMAN	Decreases Expression	[30]
Methionine synthase (MTR)	OTF2K2TA	METH_HUMAN	Decreases Expression	[30]
Ras GTPase-activating protein-binding protein 2 (G3BP2)	OTAWW3KI	G3BP2_HUMAN	Decreases Expression	[30]
Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (MACF1)	OTVIHD77	MACF1_HUMAN	Decreases Expression	[30]
ATP synthase subunit a (ATP6)	OTPHOGLX	ATP6_HUMAN	Decreases Expression	[87]
Keratin, type II cytoskeletal 6A (KRT6A)	OT392M5T	K2C6A_HUMAN	Increases Expression	[87]
Translationally-controlled tumor protein (TPT1)	OTHMTRJU	TCTP_HUMAN	Decreases Expression	[87]
Aminopeptidase N (ANPEP)	OTP3WYFD	AMPN_HUMAN	Decreases Expression	[87]
ATP synthase subunit alpha, mitochondrial (ATP5F1A)	OT3FZDLX	ATPA_HUMAN	Decreases Expression	[87]
Protein S100-A10 (S100A10)	OTI71243	S10AA_HUMAN	Increases Expression	[87]
Glutathione S-transferase P (GSTP1)	OTLP0A0Y	GSTP1_HUMAN	Increases Expression	[88]
DNA cytosine-5)-methyltransferase 1 (DNMT1)	OTM2DGTK	DNMT1_HUMAN	Decreases Expression	[88]
Glutathione peroxidase 1 (GPX1)	OTE2O72Q	GPX1_HUMAN	Decreases Activity	[89]
Polypyrimidine tract-binding protein 3 (PTBP3)	OTVVYKIF	PTBP3_HUMAN	Increases Expression	[90]
Glutathione reductase, mitochondrial (GSR)	OTM2TUYM	GSHR_HUMAN	Increases Expression	[90]
Fibronectin (FN1)	OTB5ZN4Q	FINC_HUMAN	Increases Expression	[90]
Clathrin light chain B (CLTB)	OTPW9VRE	CLCB_HUMAN	Increases Expression	[90]
Mitogen-activated protein kinase 1 (MAPK1)	OTH85PI5	MK01_HUMAN	Increases Expression	[90]
AP-1 complex subunit sigma-1A (AP1S1)	OTQ2H8DN	AP1S1_HUMAN	Increases Expression	[90]
Four and a half LIM domains protein 1 (FHL1)	OTN535SU	FHL1_HUMAN	Increases Expression	[90]
Septin-6 (SEPTIN6)	OTIV9RTK	SEPT6_HUMAN	Increases Expression	[90]
Septin-11 (SEPTIN11)	OTX2O0ZX	SEP11_HUMAN	Increases Expression	[90]
Protein CDV3 homolog (CDV3)	OTUA175T	CDV3_HUMAN	Increases Expression	[90]
Unconventional myosin-VI (MYO6)	OTJQYRC7	MYO6_HUMAN	Increases Expression	[90]
Chloride intracellular channel protein 4 (CLIC4)	OT6KTPKD	CLIC4_HUMAN	Increases Expression	[90]
DNA fragmentation factor subunit alpha (DFFA)	OTFPFMT8	DFFA_HUMAN	Increases Expression	[31]
Tumor necrosis factor receptor superfamily member 11B (TNFRSF11B)	OTQ4W7MT	TR11B_HUMAN	Increases Expression	[31]
Cell division cycle 7-related protein kinase (CDC7)	OT5133XY	CDC7_HUMAN	Increases Expression	[31]
TNF receptor-associated factor 5 (TRAF5)	OTSBTLO0	TRAF5_HUMAN	Increases Expression	[31]
Tumor necrosis factor ligand superfamily member 11 (TNFSF11)	OTJEPKEQ	TNF11_HUMAN	Decreases Expression	[31]
Bcl-2-like protein 11 (BCL2L11)	OTNQQWFJ	B2L11_HUMAN	Increases Expression	[31]
Lipid transferase CIDEA (CIDEA)	OTDUTSOV	CIDEA_HUMAN	Increases Expression	[31]
Nibrin (NBN)	OT73B5MD	NBN_HUMAN	Increases Expression	[31]
Tumor necrosis factor receptor superfamily member 21 (TNFRSF21)	OT3EDGXO	TNR21_HUMAN	Affects Expression	[31]
Cytochrome P450 7B1 (CYP7B1)	OTIKFYP6	CP7B1_HUMAN	Increases Expression	[31]
DNA fragmentation factor subunit beta (DFFB)	OTPBW5N5	DFFB_HUMAN	Increases Expression	[31]
Tumor necrosis factor ligand superfamily member 15 (TNFSF15)	OTNGA2BW	TNF15_HUMAN	Increases Expression	[31]
BAG family molecular chaperone regulator 3 (BAG3)	OTVXYUDQ	BAG3_HUMAN	Affects Expression	[31]
B-cell lymphoma/leukemia 10 (BCL10)	OT47MCLI	BCL10_HUMAN	Increases Expression	[31]
Interleukin-1 alpha (IL1A)	OTPSGILV	IL1A_HUMAN	Decreases Expression	[31]
Plasminogen activator inhibitor 1 (SERPINE1)	OTT0MPQ3	PAI1_HUMAN	Decreases Expression	[31]
Cytochrome P450 2E1 (CYP2E1)	OTHQ17JG	CP2E1_HUMAN	Affects Expression	[31]
Interleukin-8 (CXCL8)	OTS7T5VH	IL8_HUMAN	Decreases Expression	[31]
Cyclin-dependent kinase 4 (CDK4)	OT7EP05T	CDK4_HUMAN	Increases Expression	[31]
G2/mitotic-specific cyclin-B1 (CCNB1)	OT19S7E5	CCNB1_HUMAN	Decreases Expression	[31]
G1/S-specific cyclin-D1 (CCND1)	OT8HPTKJ	CCND1_HUMAN	Decreases Expression	[31]
CD27 antigen (CD27)	OTH7NA58	CD27_HUMAN	Increases Expression	[31]
Bifunctional epoxide hydrolase 2 (EPHX2)	OTPTRCNW	HYES_HUMAN	Increases Expression	[31]
Replication protein A 14 kDa subunit (RPA3)	OT8JAQGL	RFA3_HUMAN	Decreases Expression	[31]
Metalloproteinase inhibitor 3 (TIMP3)	OTDGQAD1	TIMP3_HUMAN	Increases Expression	[31]
Tumor necrosis factor ligand superfamily member 9 (TNFSF9)	OTV9L89D	TNFL9_HUMAN	Increases Expression	[31]
Caspase-2 (CASP2)	OTUDYSPP	CASP2_HUMAN	Increases Expression	[31]
Tumor necrosis factor receptor superfamily member 4 (TNFRSF4)	OTDK74C0	TNR4_HUMAN	Increases Expression	[31]
DNA replication licensing factor MCM2 (MCM2)	OTGGORIQ	MCM2_HUMAN	Increases Expression	[31]
Tumor necrosis factor ligand superfamily member 10 (TNFSF10)	OT4PXBTA	TNF10_HUMAN	Decreases Expression	[31]
Small ubiquitin-related modifier 1 (SUMO1)	OTJFD4P5	SUMO1_HUMAN	Decreases Expression	[31]
Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	OT1YFEP1	TNR17_HUMAN	Decreases Expression	[31]
TNF receptor-associated factor 2 (TRAF2)	OT1MEZZN	TRAF2_HUMAN	Decreases Expression	[31]
TNF receptor-associated factor 3 (TRAF3)	OT5TQBGV	TRAF3_HUMAN	Increases Expression	[31]
Transcription factor Dp-1 (TFDP1)	OT6RZ7VT	TFDP1_HUMAN	Decreases Expression	[31]
Transcription factor E2F2 (E2F2)	OTO75RM7	E2F2_HUMAN	Increases Expression	[31]
Transcription factor E2F5 (E2F5)	OT1XWING	E2F5_HUMAN	Decreases Expression	[31]
Hsp90 co-chaperone Cdc37 (CDC37)	OTYDT4A7	CDC37_HUMAN	Increases Expression	[31]
Ubiquitin carboxyl-terminal hydrolase BAP1 (BAP1)	OTS8G0EN	BAP1_HUMAN	Affects Expression	[31]
Heat shock protein 105 kDa (HSPH1)	OTVRR73T	HS105_HUMAN	Increases Expression	[31]
DNA repair protein RAD50 (RAD50)	OTYMU9G1	RAD50_HUMAN	Increases Expression	[31]
DNA repair endonuclease XPF (ERCC4)	OTFIOPG1	XPF_HUMAN	Increases Expression	[31]
Bcl2-associated agonist of cell death (BAD)	OT63ERYM	BAD_HUMAN	Increases Expression	[31]
Tumor necrosis factor receptor superfamily member 14 (TNFRSF14)	OTB82PFO	TNR14_HUMAN	Decreases Expression	[31]
Cullin-5 (CUL5)	OTMTZD47	CUL5_HUMAN	Increases Expression	[31]
Myeloid differentiation primary response protein MyD88 (MYD88)	OTB4D6FL	MYD88_HUMAN	Increases Expression	[31]
BAG family molecular chaperone regulator 1 (BAG1)	OTRQNIA4	BAG1_HUMAN	Decreases Expression	[31]
TNF receptor-associated factor 4 (TRAF4)	OTJLRVMC	TRAF4_HUMAN	Increases Expression	[31]
Tumor necrosis factor receptor superfamily member 10D (TNFRSF10D)	OTOSRDJT	TR10D_HUMAN	Increases Expression	[31]
Tumor necrosis factor ligand superfamily member 18 (TNFSF18)	OT3ANRX1	TNF18_HUMAN	Increases Expression	[31]
Tumor necrosis factor ligand superfamily member 13B (TNFSF13B)	OTND26XR	TN13B_HUMAN	Affects Expression	[31]
TNF receptor-associated factor 6 (TRAF6)	OTA5GO5K	TRAF6_HUMAN	Increases Expression	[31]
Tumor necrosis factor receptor superfamily member 18 (TNFRSF18)	OTCW8HT6	TNR18_HUMAN	Decreases Expression	[31]
Interferon-related developmental regulator 1 (IFRD1)	OT4SQMLQ	IFRD1_HUMAN	Decreases Expression	[32]
Calmegin (CLGN)	OTEWVFQV	CLGN_HUMAN	Decreases Expression	[32]
Peptidyl-prolyl cis-trans isomerase H (PPIH)	OTB3HCLB	PPIH_HUMAN	Increases Expression	[32]
Ribonuclease H2 subunit A (RNASEH2A)	OT8G3G7K	RNH2A_HUMAN	Increases Expression	[32]
Dickkopf-related protein 1 (DKK1)	OTRDLUSP	DKK1_HUMAN	Increases Expression	[32]
G2/mitotic-specific cyclin-B2 (CCNB2)	OTIEXTDK	CCNB2_HUMAN	Increases Expression	[32]
Tumor necrosis factor alpha-induced protein 8 (TNFAIP8)	OT1G9297	TFIP8_HUMAN	Increases Expression	[32]
Securin (PTTG1)	OTIMYS4W	PTTG1_HUMAN	Increases Expression	[32]
Complement factor B (CFB)	OTZITNEJ	CFAB_HUMAN	Decreases Expression	[32]
Non-histone chromosomal protein HMG-17 (HMGN2)	OTN20MEF	HMGN2_HUMAN	Increases Expression	[32]
Alpha-galactosidase A (GLA)	OTBSR6DT	AGAL_HUMAN	Increases Expression	[32]
Epoxide hydrolase 1 (EPHX1)	OTBKWQER	HYEP_HUMAN	Decreases Expression	[32]
Asparagine synthetase (ASNS)	OT8R922G	ASNS_HUMAN	Decreases Expression	[32]
Aldo-keto reductase family 1 member B1 (AKR1B1)	OTRX72TH	ALDR_HUMAN	Decreases Expression	[32]
High mobility group protein HMG-I/HMG-Y (HMGA1)	OTQUSHPX	HMGA1_HUMAN	Increases Expression	[32]
Gastricsin (PGC)	OTQRITKI	PEPC_HUMAN	Decreases Expression	[32]
Tumor necrosis factor alpha-induced protein 3 (TNFAIP3)	OTVLI4DD	TNAP3_HUMAN	Increases Expression	[32]
Zinc-alpha-2-glycoprotein (AZGP1)	OTPD9TDR	ZA2G_HUMAN	Decreases Expression	[32]
Replication factor C subunit 2 (RFC2)	OTJ9N6BD	RFC2_HUMAN	Increases Expression	[32]
17-beta-hydroxysteroid dehydrogenase type 2 (HSD17B2)	OT3K7HY5	DHB2_HUMAN	Decreases Expression	[32]
Excitatory amino acid transporter 2 (SLC1A2)	OTEP3QGN	EAA2_HUMAN	Decreases Expression	[32]
Placenta growth factor (PGF)	OT5MF5DJ	PLGF_HUMAN	Decreases Expression	[32]
Nuclear pore complex protein Nup107 (NUP107)	OTG4RDYS	NU107_HUMAN	Increases Expression	[32]
Fractalkine (CX3CL1)	OTPLGI0E	X3CL1_HUMAN	Decreases Expression	[32]
Nucleobindin-2 (NUCB2)	OTHO6JWN	NUCB2_HUMAN	Decreases Expression	[32]
Matrix-remodeling-associated protein 7 (MXRA7)	OTVQLYIY	MXRA7_HUMAN	Increases Expression	[32]
Methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase , mitochondrial (ALDH6A1)	OT8LCZCT	MMSA_HUMAN	Decreases Expression	[32]
A-kinase anchor protein 12 (AKAP12)	OTCVRDDX	AKA12_HUMAN	Increases Expression	[32]
Centromere protein R (ITGB3BP)	OT6Q7GR3	CENPR_HUMAN	Increases Expression	[32]
Protein OS-9 (OS9)	OTB5B2TY	OS9_HUMAN	Decreases Expression	[32]
Pachytene checkpoint protein 2 homolog (TRIP13)	OTFM3TI9	PCH2_HUMAN	Increases Expression	[32]
Cyclin-dependent kinase inhibitor 3 (CDKN3)	OTBE3H07	CDKN3_HUMAN	Increases Expression	[32]
G-protein coupled estrogen receptor 1 (GPER1)	OTUK0TDC	GPER1_HUMAN	Decreases Expression	[32]
Rac GTPase-activating protein 1 (RACGAP1)	OTQE8IEH	RGAP1_HUMAN	Increases Expression	[32]
Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase (ST6GALNAC4)	OTJCJQI7	SIA7D_HUMAN	Decreases Expression	[32]
Structural maintenance of chromosomes protein 4 (SMC4)	OTEJE6AG	SMC4_HUMAN	Increases Expression	[32]
Lipid transferase CIDEB (CIDEB)	OT873IYM	CIDEB_HUMAN	Decreases Expression	[32]
Leukocyte cell-derived chemotaxin 1 (CNMD)	OTHND8EL	CNMD_HUMAN	Decreases Expression	[91]
C-X-C motif chemokine 9 (CXCL9)	OTMFVZKZ	CXCL9_HUMAN	Decreases Expression	[91]
Amyloid beta precursor protein binding family B member 1 (APBB1)	OTZPVSSC	APBB1_HUMAN	Decreases Expression	[33]
Sulfhydryl oxidase 1 (QSOX1)	OT4ZPK4P	QSOX1_HUMAN	Decreases Expression	[33]
Podocalyxin (PODXL)	OTPNQXF3	PODXL_HUMAN	Decreases Expression	[33]
C-C motif chemokine 22 (CCL22)	OTT3QJC2	CCL22_HUMAN	Decreases Expression	[33]
Phospholipid phosphatase 3 (PLPP3)	OTSSF7BK	PLPP3_HUMAN	Increases Expression	[33]
Tumor necrosis factor ligand superfamily member 14 (TNFSF14)	OT5QRF09	TNF14_HUMAN	Decreases Expression	[33]
Synaptogyrin-1 (SYNGR1)	OT0MBUK5	SNG1_HUMAN	Decreases Expression	[33]
Nuclear protein 1 (NUPR1)	OT4FU8C0	NUPR1_HUMAN	Increases Expression	[33]
Gremlin-1 (GREM1)	OTCK4IGV	GREM1_HUMAN	Decreases Expression	[33]
Protein diaphanous homolog 1 (DIAPH1)	OTZBYPLH	DIAP1_HUMAN	Decreases Expression	[33]
Hematopoietic prostaglandin D synthase (HPGDS)	OTU8FWHU	HPGDS_HUMAN	Decreases Expression	[33]
Cell division control protein 45 homolog (CDC45)	OT6NNLOD	CDC45_HUMAN	Decreases Expression	[33]
Glypican-4 (GPC4)	OTUJ14DW	GPC4_HUMAN	Decreases Expression	[33]
Claudin-14 (CLDN14)	OTS7GKOI	CLD14_HUMAN	Decreases Expression	[33]
Immunoglobulin superfamily member 6 (IGSF6)	OT5TUH02	IGSF6_HUMAN	Decreases Expression	[33]
Purine nucleoside phosphorylase (PNP)	OTO5NIJ2	PNPH_HUMAN	Decreases Expression	[33]
Complement C1q subcomponent subunit B (C1QB)	OT2G1IOX	C1QB_HUMAN	Increases Expression	[33]
Platelet basic protein (PPBP)	OT1FHGQS	CXCL7_HUMAN	Increases Expression	[33]
HLA class I histocompatibility antigen, A alpha chain (HLA-A)	OTAH14LU	HLAA_HUMAN	Decreases Expression	[33]
Protein S100-A8 (S100A8)	OTVMOB3F	S10A8_HUMAN	Decreases Expression	[33]
Galectin-2 (LGALS2)	OTY08TMQ	LEG2_HUMAN	Decreases Expression	[33]
Lipoprotein lipase (LPL)	OTTW0267	LIPL_HUMAN	Decreases Expression	[33]
Matrilysin (MMP7)	OTVT3SEJ	MMP7_HUMAN	Decreases Expression	[33]
Fructose-1,6-bisphosphatase 1 (FBP1)	OTQBANEP	F16P1_HUMAN	Decreases Expression	[33]
Tumor-associated calcium signal transducer 2 (TACSTD2)	OTLSZR00	TACD2_HUMAN	Decreases Expression	[33]
C-C motif chemokine 3 (CCL3)	OTW2H3ND	CCL3_HUMAN	Decreases Expression	[33]
E3 SUMO-protein ligase EGR2 (EGR2)	OTAVQ78J	EGR2_HUMAN	Decreases Expression	[33]
HLA class I histocompatibility antigen, alpha chain E (HLA-E)	OTX1CTFB	HLAE_HUMAN	Decreases Expression	[33]
Ras-related C3 botulinum toxin substrate 2 (RAC2)	OTAOHFNH	RAC2_HUMAN	Decreases Expression	[33]
15-hydroxyprostaglandin dehydrogenase (HPGD)	OTYZI6JB	PGDH_HUMAN	Decreases Expression	[33]
Carboxypeptidase E (CPE)	OTXNTV79	CBPE_HUMAN	Decreases Expression	[33]
Alpha-2B adrenergic receptor (ADRA2B)	OTLJKGSE	ADA2B_HUMAN	Decreases Expression	[33]
Interleukin-1 receptor antagonist protein (IL1RN)	OT308CBE	IL1RA_HUMAN	Decreases Expression	[33]
Syndecan-1 (SDC1)	OTWKRVZC	SDC1_HUMAN	Decreases Expression	[33]
C-X-C motif chemokine 2 (CXCL2)	OTEJCYMY	CXCL2_HUMAN	Increases Expression	[33]
Arachidonate 5-lipoxygenase-activating protein (ALOX5AP)	OT0DH40W	AL5AP_HUMAN	Decreases Expression	[33]
Collagen alpha-2(VIII) chain (COL8A2)	OTASWJ69	CO8A2_HUMAN	Decreases Expression	[33]
Rhombotin-2 (LMO2)	OTCC370G	RBTN2_HUMAN	Decreases Expression	[33]
CAMPATH-1 antigen (CD52)	OT02LDQN	CD52_HUMAN	Decreases Expression	[33]
Chitinase-3-like protein 1 (CHI3L1)	OT2Z7VJH	CH3L1_HUMAN	Decreases Expression	[33]
Macrophage metalloelastase (MMP12)	OT9Z7LHM	MMP12_HUMAN	Decreases Expression	[33]
Isoleucine--tRNA ligase, cytoplasmic (IARS1)	OT9WXH5N	SYIC_HUMAN	Decreases Expression	[33]
Aldo-keto reductase family 1 member C3 (AKR1C3)	OTU2SXBA	AK1C3_HUMAN	Increases Expression	[33]
Megakaryocyte-associated tyrosine-protein kinase (MATK)	OTVOJJLJ	MATK_HUMAN	Decreases Expression	[33]
Glioma pathogenesis-related protein 1 (GLIPR1)	OT0FGQK7	GLIP1_HUMAN	Decreases Expression	[33]
Sodium- and chloride-dependent betaine transporter (SLC6A12)	OTKOR4F2	S6A12_HUMAN	Decreases Expression	[33]
Adhesion G protein-coupled receptor E5 (ADGRE5)	OTTSB84Q	AGRE5_HUMAN	Decreases Expression	[33]
Protein numb homolog (NUMB)	OTMB586Q	NUMB_HUMAN	Decreases Expression	[33]
Cathelicidin antimicrobial peptide (CAMP)	OT3Y8011	CAMP_HUMAN	Decreases Expression	[33]
Hexokinase-3 (HK3)	OTZKONGB	HXK3_HUMAN	Decreases Expression	[33]
Allograft inflammatory factor 1 (AIF1)	OTGES18F	AIF1_HUMAN	Decreases Expression	[33]
Phospholipid transfer protein (PLTP)	OTVJJO5Z	PLTP_HUMAN	Decreases Expression	[33]
C-C motif chemokine 18 (CCL18)	OT7JYSK9	CCL18_HUMAN	Increases Expression	[33]
Oxidized low-density lipoprotein receptor 1 (OLR1)	OTS44RIC	OLR1_HUMAN	Decreases Expression	[33]
Serine protease HTRA3 (HTRA3)	OTXJ0H4X	HTRA3_HUMAN	Increases Expression	[33]
Tumor necrosis factor-inducible gene 6 protein (TNFAIP6)	OT1SLUZH	TSG6_HUMAN	Decreases Expression	[33]
Myocyte-specific enhancer factor 2B (MEF2B)	OT880SE6	MEF2B_HUMAN	Decreases Expression	[33]
Antigen peptide transporter 1 (TAP1)	OTJL27PW	TAP1_HUMAN	Decreases Expression	[33]
Sialomucin core protein 24 (CD164)	OTZ7FIU8	MUC24_HUMAN	Decreases Expression	[33]
Chitotriosidase-1 (CHIT1)	OTPQR0A6	CHIT1_HUMAN	Decreases Expression	[33]
Krueppel-like factor 9 (KLF9)	OTBFEJRQ	KLF9_HUMAN	Decreases Expression	[33]
Fibroleukin (FGL2)	OT8M3H72	FGL2_HUMAN	Decreases Expression	[33]
Condensin complex subunit 2 (NCAPH)	OTXOS97C	CND2_HUMAN	Decreases Expression	[33]
Cysteine and glycine-rich protein 2 (CSRP2)	OT4SW0HI	CSRP2_HUMAN	Decreases Expression	[33]
Bcl-2-related protein A1 (BCL2A1)	OTWRYSNA	B2LA1_HUMAN	Decreases Expression	[33]
Drebrin (DBN1)	OTZVKG8A	DREB_HUMAN	Decreases Expression	[33]
Interleukin-27 receptor subunit alpha (IL27RA)	OTSQBAKI	I27RA_HUMAN	Decreases Expression	[33]
Fatty acid 2-hydroxylase (FA2H)	OT8HA13U	FA2H_HUMAN	Decreases Expression	[33]
Protein TAMALIN (TAMALIN)	OTK75X47	GRASP_HUMAN	Decreases Expression	[33]
Polypeptide N-acetylgalactosaminyltransferase 12 (GALNT12)	OTVIBUST	GLT12_HUMAN	Decreases Expression	[33]
Osteoclast-associated immunoglobulin-like receptor (OSCAR)	OT0ALXSL	OSCAR_HUMAN	Decreases Expression	[33]
Metallothionein-1M (MT1M)	OTVT8PLU	MT1M_HUMAN	Increases Expression	[33]
E3 ubiquitin-protein ligase RNF128 (RNF128)	OTJO86CJ	RN128_HUMAN	Decreases Expression	[33]
E3 ubiquitin-protein ligase TRIM41 (TRIM41)	OTU3ADNG	TRI41_HUMAN	Decreases Expression	[33]
Brain and acute leukemia cytoplasmic protein (BAALC)	OTUZSRVF	BAALC_HUMAN	Decreases Expression	[33]
Ras-like protein family member 10A (RASL10A)	OTEXTN6I	RSLAA_HUMAN	Decreases Expression	[33]
Protein naked cuticle homolog 2 (NKD2)	OTCYT3I6	NKD2_HUMAN	Increases Expression	[33]
Zinc transporter ZIP13 (SLC39A13)	OTF36U59	S39AD_HUMAN	Decreases Expression	[33]
Spondin-2 (SPON2)	OTE7JLNM	SPON2_HUMAN	Decreases Expression	[33]
Acetyl-CoA acetyltransferase, cytosolic (ACAT2)	OTZ092ZJ	THIC_HUMAN	Decreases Expression	[33]
Normal mucosa of esophagus-specific gene 1 protein (C15ORF48)	OT85J32K	NMES1_HUMAN	Decreases Expression	[33]
Linker for activation of T-cells family member 2 (LAT2)	OTWJDKIH	NTAL_HUMAN	Decreases Expression	[33]
Solute carrier family 28 member 3 (SLC28A3)	OT5TLTYU	S28A3_HUMAN	Decreases Expression	[33]
Solute carrier family 40 member 1 (SLC40A1)	OT8RV2VY	S40A1_HUMAN	Increases Expression	[33]
Tumor necrosis factor receptor superfamily member 12A (TNFRSF12A)	OT5V52LN	TNR12_HUMAN	Decreases Expression	[33]
PH and SEC7 domain-containing protein 3 (PSD3)	OTTN9B9O	PSD3_HUMAN	Decreases Expression	[33]
Very long chain fatty acid elongase 5 (ELOVL5)	OT375W1Z	ELOV5_HUMAN	Decreases Expression	[33]
Ral guanine nucleotide dissociation stimulator-like 1 (RGL1)	OTY6ZHVA	RGL1_HUMAN	Increases Expression	[33]
Myoferlin (MYOF)	OTRFC3IJ	MYOF_HUMAN	Decreases Expression	[33]
Polycystin-2-like protein 1 (PKD2L1)	OT1KJDAT	PK2L1_HUMAN	Decreases Expression	[33]
Hematopoietic cell signal transducer (HCST)	OTILCB4K	HCST_HUMAN	Decreases Expression	[33]
Cystine/glutamate transporter (SLC7A11)	OTKJ6PXW	XCT_HUMAN	Increases Expression	[33]
Phosphoserine aminotransferase (PSAT1)	OTVV1YV9	SERC_HUMAN	Decreases Expression	[33]
Prostaglandin G/H synthase 2 (PTGS2)	OT75U9M4	PGH2_HUMAN	Decreases Expression	[92]
Small ribosomal subunit protein uS12m (MRPS12)	OTGY4GIX	RT12_HUMAN	Decreases Expression	[34]
Acyl-protein thioesterase 1 (LYPLA1)	OTENU47T	LYPA1_HUMAN	Decreases Expression	[34]
Eukaryotic translation initiation factor 3 subunit G (EIF3G)	OT5L1SRY	EIF3G_HUMAN	Decreases Expression	[34]
Glutamate dehydrogenase 1, mitochondrial (GLUD1)	OTXKOCUH	DHE3_HUMAN	Decreases Expression	[34]
Cystatin-B (CSTB)	OT3U0JF8	CYTB_HUMAN	Decreases Expression	[34]
Ubiquitin-like protein ISG15 (ISG15)	OT53QQ7N	ISG15_HUMAN	Decreases Expression	[34]
Tropomyosin alpha-3 chain (TPM3)	OT5RU5G6	TPM3_HUMAN	Decreases Expression	[34]
L-lactate dehydrogenase B chain (LDHB)	OT9B1CT3	LDHB_HUMAN	Decreases Expression	[34]
Heat shock cognate 71 kDa protein (HSPA8)	OTJI2RCI	HSP7C_HUMAN	Increases Expression	[34]
Elongation factor 2 (EEF2)	OTZ7SZ39	EF2_HUMAN	Decreases Expression	[34]
Macrophage migration inhibitory factor (MIF)	OTUCMVCX	MIF_HUMAN	Decreases Expression	[34]
Interferon-induced GTP-binding protein Mx1 (MX1)	OT6X8G5T	MX1_HUMAN	Increases Expression	[34]
Cofilin-1 (CFL1)	OTT6D5MH	COF1_HUMAN	Decreases Expression	[34]
Proteasome subunit alpha type-5 (PSMA5)	OT38E6Y1	PSA5_HUMAN	Decreases Expression	[34]
Cytosol aminopeptidase (LAP3)	OT658KRM	AMPL_HUMAN	Decreases Expression	[34]
Enoyl-CoA hydratase, mitochondrial (ECHS1)	OTS0593S	ECHM_HUMAN	Increases Expression	[34]
Protein disulfide-isomerase A3 (PDIA3)	OTHPQ0Q3	PDIA3_HUMAN	Decreases Expression	[34]
Adenylosuccinate synthetase isozyme 2 (ADSS2)	OTW26XXB	PURA2_HUMAN	Decreases Expression	[34]
Coronin-1A (CORO1A)	OTVAZOHC	COR1A_HUMAN	Increases Expression	[34]
26S proteasome regulatory subunit 7 (PSMC2)	OTJ4V337	PRS7_HUMAN	Decreases Expression	[34]
Eukaryotic initiation factor 4A-III (EIF4A3)	OTYYFE7K	IF4A3_HUMAN	Increases Expression	[34]
T-complex protein 1 subunit zeta (CCT6A)	OTCYWL5F	TCPZ_HUMAN	Increases Expression	[34]
T-complex protein 1 subunit gamma (CCT3)	OTL6EOS1	TCPG_HUMAN	Increases Expression	[34]
Alanine--tRNA ligase, cytoplasmic (AARS1)	OTW8D813	SYAC_HUMAN	Decreases Expression	[34]
GMP synthase (GMPS)	OTDC90IS	GUAA_HUMAN	Decreases Expression	[34]
Galactokinase (GALK1)	OTB2W7DW	GALK1_HUMAN	Increases Expression	[34]
Proteasome activator complex subunit 3 (PSME3)	OTSTC4YY	PSME3_HUMAN	Decreases Expression	[34]
T-complex protein 1 subunit beta (CCT2)	OTW1VV4E	TCPB_HUMAN	Increases Expression	[34]
Aminoacylase-1 (ACY1)	OT9WU7X3	ACY1_HUMAN	Decreases Expression	[34]
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (ECH1)	OTA0UNHM	ECH1_HUMAN	Increases Expression	[34]
Peroxiredoxin-4 (PRDX4)	OTT4OR8G	PRDX4_HUMAN	Increases Expression	[34]
Eukaryotic translation initiation factor 3 subunit I (EIF3I)	OTE07WND	EIF3I_HUMAN	Decreases Expression	[34]
UDP-glucose 4-epimerase (GALE)	OTVFS16E	GALE_HUMAN	Increases Expression	[34]
DNA replication licensing factor MCM6 (MCM6)	OTKLIAWT	MCM6_HUMAN	Increases Expression	[34]
Neutral alpha-glucosidase AB (GANAB)	OTYLXY4M	GANAB_HUMAN	Increases Expression	[34]
NEDD8 (NEDD8)	OT8C37XH	NEDD8_HUMAN	Decreases Expression	[34]
Phosphoenolpyruvate carboxykinase , mitochondrial (PCK2)	OTJ8LX4N	PCKGM_HUMAN	Decreases Expression	[34]
Paraspeckle component 1 (PSPC1)	OTYS6WQ8	PSPC1_HUMAN	Decreases Expression	[34]
Far upstream element-binding protein 1 (FUBP1)	OT77SC9N	FUBP1_HUMAN	Decreases Expression	[34]
Aconitate hydratase, mitochondrial (ACO2)	OTF2UVNV	ACON_HUMAN	Decreases Expression	[34]
Queuine tRNA-ribosyltransferase catalytic subunit 1 (QTRT1)	OTC33MCV	TGT_HUMAN	Decreases Expression	[34]
Sialic acid synthase (NANS)	OTMQ2FUH	SIAS_HUMAN	Decreases Expression	[34]
RuvB-like 1 (RUVBL1)	OTWV19L7	RUVB1_HUMAN	Increases Expression	[34]
DnaJ homolog subfamily B member 6 (DNAJB6)	OTMHIIAN	DNJB6_HUMAN	Increases Expression	[80]
60 kDa heat shock protein, mitochondrial (HSPD1)	OTTO1Y11	CH60_HUMAN	Increases Expression	[80]
NAD(P)H dehydrogenase 1 (NQO1)	OTZGGIVK	NQO1_HUMAN	Increases Expression	[80]
DnaJ homolog subfamily B member 2 (DNAJB2)	OTZHPV5M	DNJB2_HUMAN	Increases Expression	[80]
DnaJ homolog subfamily A member 1 (DNAJA1)	OT38BZQQ	DNJA1_HUMAN	Increases Expression	[80]
Cystathionine gamma-lyase (CTH)	OTC90LA0	CGL_HUMAN	Increases Expression	[80]
Serine hydroxymethyltransferase, cytosolic (SHMT1)	OTIINA3J	GLYC_HUMAN	Increases Expression	[80]
Glutamate--cysteine ligase catalytic subunit (GCLC)	OTESDI4D	GSH1_HUMAN	Increases Expression	[80]
Bcl-2-modifying factor (BMF)	OT90NSLI	BMF_HUMAN	Increases Expression	[80]
Insulin-like growth factor 1 receptor (IGF1R)	OTXJIF13	IGF1R_HUMAN	Decreases Expression	[93]
Hepatocyte growth factor receptor (MET)	OT7K55MU	MET_HUMAN	Decreases Expression	[93]
Androgen receptor (AR)	OTUBKAZZ	ANDR_HUMAN	Decreases Expression	[93]
3-oxo-5-alpha-steroid 4-dehydrogenase 1 (SRD5A1)	OTQRET2B	S5A1_HUMAN	Decreases Expression	[93]
Retinoic acid receptor RXR-alpha (RXRA)	OTP1TBDM	RXRA_HUMAN	Increases Expression	[93]
Cyclin-dependent kinase 4 inhibitor D (CDKN2D)	OT2TTZPZ	CDN2D_HUMAN	Increases Expression	[93]
Receptor tyrosine-protein kinase erbB-4 (ERBB4)	OT9L6C41	ERBB4_HUMAN	Increases Expression	[93]
Hypoxia-inducible factor 1-alpha (HIF1A)	OTADSC03	HIF1A_HUMAN	Decreases Expression	[93]
Tumor necrosis factor receptor superfamily member 11A (TNFRSF11A)	OT1FISGN	TNR11_HUMAN	Decreases Expression	[93]
Shootin-1 (SHTN1)	OTB07MOG	SHOT1_HUMAN	Increases Expression	[35]
Protein tyrosine phosphatase domain-containing protein 1 (PTPDC1)	OTTM4N1J	PTPC1_HUMAN	Decreases Expression	[35]
Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMCHD1)	OTBV52DR	SMHD1_HUMAN	Increases Expression	[35]
Galectin-8 (LGALS8)	OT71LJ8T	LEG8_HUMAN	Increases Expression	[35]
Eukaryotic translation initiation factor 3 subunit F (EIF3F)	OTU20K6L	EIF3F_HUMAN	Increases Expression	[35]
cGMP-dependent 3',5'-cyclic phosphodiesterase (PDE2A)	OTZESF4H	PDE2A_HUMAN	Decreases Expression	[35]
Phosphatidylinositol 3-kinase regulatory subunit beta (PIK3R2)	OTZSUQK5	P85B_HUMAN	Decreases Expression	[35]
Cytochrome c oxidase subunit NDUFA4 (NDUFA4)	OTDVH3QG	NDUA4_HUMAN	Increases Expression	[35]
Syntenin-1 (SDCBP)	OTS3NCC5	SDCB1_HUMAN	Increases Expression	[35]
CCN family member 1 (CCN1)	OTKJBEMD	CCN1_HUMAN	Decreases Expression	[35]
Serine/threonine-protein phosphatase 6 catalytic subunit (PPP6C)	OTR1STMJ	PPP6_HUMAN	Increases Expression	[35]
Eukaryotic translation initiation factor 1A, Y-chromosomal (EIF1AY)	OTWVDOJU	IF1AY_HUMAN	Increases Expression	[35]
Actin-binding LIM protein 1 (ABLIM1)	OTHXEK3E	ABLM1_HUMAN	Increases Expression	[35]
Transmembrane gamma-carboxyglutamic acid protein 1 (PRRG1)	OTMH6OWG	TMG1_HUMAN	Increases Expression	[35]
Programmed cell death protein 5 (PDCD5)	OT6T2DDL	PDCD5_HUMAN	Increases Expression	[35]
Tripeptidyl-peptidase 1 (TPP1)	OT2LQ771	TPP1_HUMAN	Increases Expression	[35]
Kinetochore protein NDC80 homolog (NDC80)	OTS7D306	NDC80_HUMAN	Increases Expression	[35]
Tetraspanin-4 (TSPAN4)	OTKFK57F	TSN4_HUMAN	Decreases Expression	[35]
Peripheral plasma membrane protein CASK (CASK)	OT8EF7ZF	CSKP_HUMAN	Increases Expression	[35]
Cyclin-G-associated kinase (GAK)	OTLM5H4P	GAK_HUMAN	Increases Expression	[35]
Period circadian protein homolog 2 (PER2)	OTU2B1DJ	PER2_HUMAN	Decreases Expression	[35]
Angiopoietin-2 (ANGPT2)	OTEQK65P	ANGP2_HUMAN	Increases Expression	[35]
Protein Mdm4 (MDM4)	OTU10BSF	MDM4_HUMAN	Decreases Expression	[35]
Phospholipid scramblase 1 (PLSCR1)	OTGY9B5T	PLS1_HUMAN	Increases Expression	[35]
ADAM DEC1 (ADAMDEC1)	OTMT7ZMG	ADEC1_HUMAN	Increases Expression	[35]
Serine palmitoyltransferase 2 (SPTLC2)	OTBTMH1Z	SPTC2_HUMAN	Increases Expression	[35]
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (INPPL1)	OTCDAVBQ	SHIP2_HUMAN	Increases Expression	[35]
Fanconi anemia group A protein (FANCA)	OTPEFJD4	FANCA_HUMAN	Increases Expression	[35]
ATP-binding cassette sub-family C member 5 (ABCC5)	OT34G4US	MRP5_HUMAN	Increases Expression	[35]
Toll-like receptor 3 (TLR3)	OT8QPYXZ	TLR3_HUMAN	Increases Expression	[35]
N-glycosylase/DNA lyase (OGG1)	OTJ97TF3	OGG1_HUMAN	Decreases Expression	[35]
Kunitz-type protease inhibitor 2 (SPINT2)	OTQV7BKQ	SPIT2_HUMAN	Increases Expression	[35]
Heterogeneous nuclear ribonucleoprotein R (HNRNPR)	OT3FITK2	HNRPR_HUMAN	Increases Expression	[35]
Tumor protein D54 (TPD52L2)	OTTOG0NK	TPD54_HUMAN	Increases Expression	[35]
Trans-Golgi network integral membrane protein 2 (TGOLN2)	OTM647IV	TGON2_HUMAN	Decreases Expression	[35]
Ragulator complex protein LAMTOR5 (LAMTOR5)	OTER0U8L	LTOR5_HUMAN	Increases Expression	[35]
Mothers against decapentaplegic homolog 6 (SMAD6)	OTUZZWUD	SMAD6_HUMAN	Decreases Expression	[35]
Progonadoliberin-2 (GNRH2)	OTORRM53	GON2_HUMAN	Decreases Expression	[35]
E3 ubiquitin-protein ligase RNF13 (RNF13)	OT7HNYF4	RNF13_HUMAN	Increases Expression	[35]
Neuronal migration protein doublecortin (DCX)	OTISR7K3	DCX_HUMAN	Increases Expression	[35]
Protein regulator of cytokinesis 1 (PRC1)	OTHD0XS0	PRC1_HUMAN	Increases Expression	[35]
U3 small nucleolar RNA-interacting protein 2 (RRP9)	OT97EAV4	U3IP2_HUMAN	Decreases Expression	[35]
Kalirin (KALRN)	OT8WRCBH	KALRN_HUMAN	Increases Expression	[35]
NUAK family SNF1-like kinase 1 (NUAK1)	OTLLHJJQ	NUAK1_HUMAN	Decreases Expression	[35]
Voltage-dependent calcium channel gamma-3 subunit (CACNG3)	OTWMBPIX	CCG3_HUMAN	Increases Expression	[35]
HMG box-containing protein 1 (HBP1)	OTDPGGDV	HBP1_HUMAN	Increases Expression	[35]
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (MAN1A2)	OTITCN3Q	MA1A2_HUMAN	Increases Expression	[35]
Homeobox protein DLX-3 (DLX3)	OTARP5SQ	DLX3_HUMAN	Decreases Expression	[35]
Heterogeneous nuclear ribonucleoprotein Q (SYNCRIP)	OTRNDZXB	HNRPQ_HUMAN	Increases Expression	[35]
Glycylpeptide N-tetradecanoyltransferase 2 (NMT2)	OTLNA39Z	NMT2_HUMAN	Increases Expression	[35]
Tetraspanin-3 (TSPAN3)	OT7WS6ZI	TSN3_HUMAN	Increases Expression	[35]
Receptor activity-modifying protein 2 (RAMP2)	OTGQXLH5	RAMP2_HUMAN	Decreases Expression	[35]
F-box-like/WD repeat-containing protein TBL1X (TBL1X)	OTXQ51E0	TBL1X_HUMAN	Increases Expression	[35]
Low-density lipoprotein receptor-related protein 4 (LRP4)	OTO4M459	LRP4_HUMAN	Increases Expression	[35]
TSC22 domain family protein 2 (TSC22D2)	OTFXF349	T22D2_HUMAN	Increases Expression	[35]
Semaphorin-7A (SEMA7A)	OT0ZJK64	SEM7A_HUMAN	Decreases Expression	[35]
V-type proton ATPase subunit G 1 (ATP6V1G1)	OTBT1O58	VATG1_HUMAN	Increases Expression	[35]
Advillin (AVIL)	OTUK67IT	AVIL_HUMAN	Increases Expression	[35]
Transforming acidic coiled-coil-containing protein 1 (TACC1)	OTGX20TE	TACC1_HUMAN	Increases Expression	[35]
E3 ubiquitin-protein ligase MYCBP2 (MYCBP2)	OTHODA1F	MYCB2_HUMAN	Increases Expression	[35]
Transcription elongation factor A protein 3 (TCEA3)	OTLTRSK4	TCEA3_HUMAN	Increases Expression	[35]
DNA repair protein RAD51 homolog 4 (RAD51D)	OTKOU5XN	RA51D_HUMAN	Increases Expression	[35]
Diacylglycerol kinase iota (DGKI)	OTDZ602D	DGKI_HUMAN	Increases Expression	[35]
Cell cycle checkpoint protein RAD17 (RAD17)	OT1I93DT	RAD17_HUMAN	Increases Expression	[35]
A-kinase anchor protein 3 (AKAP3)	OT42QOFG	AKAP3_HUMAN	Increases Expression	[35]
snRNA-activating protein complex subunit 5 (SNAPC5)	OTNCB038	SNPC5_HUMAN	Decreases Expression	[35]
Glutaredoxin-3 (GLRX3)	OTUPAU1N	GLRX3_HUMAN	Increases Expression	[35]
Actin-like protein 6B (ACTL6B)	OTO7EJIS	ACL6B_HUMAN	Increases Expression	[35]
Serine/threonine-protein kinase D3 (PRKD3)	OT987HJI	KPCD3_HUMAN	Increases Expression	[35]
Regulator of G-protein signaling 11 (RGS11)	OTIAZ36F	RGS11_HUMAN	Increases Expression	[35]
SAM and SH3 domain-containing protein 1 (SASH1)	OTQA8BD4	SASH1_HUMAN	Increases Expression	[35]
Pre-mRNA cleavage complex 2 protein Pcf11 (PCF11)	OT54GCY6	PCF11_HUMAN	Increases Expression	[35]
Glutaminase kidney isoform, mitochondrial (GLS)	OTGOZG2M	GLSK_HUMAN	Increases Expression	[35]
Fibrinogen silencer-binding protein (RAD54B)	OTMWB2P2	FSBP_HUMAN	Increases Expression	[35]
Snurportin-1 (SNUPN)	OTD068EO	SPN1_HUMAN	Decreases Expression	[35]
Methyl-CpG-binding domain protein 4 (MBD4)	OTWR9YXE	MBD4_HUMAN	Increases Expression	[35]
CCN family member 4 (CCN4)	OT69BER9	CCN4_HUMAN	Decreases Expression	[35]
A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAMTS2)	OTTK22NO	ATS2_HUMAN	Decreases Expression	[35]
Claudin-9 (CLDN9)	OTCKI2IZ	CLD9_HUMAN	Decreases Expression	[35]
Acidic leucine-rich nuclear phosphoprotein 32 family member D (ANP32D)	OTAGQSQ6	AN32D_HUMAN	Increases Expression	[35]
Secretoglobin family 1D member 2 (SCGB1D2)	OTSYWZAQ	SG1D2_HUMAN	Increases Expression	[35]
Histone-lysine N-methyltransferase NSD2 (NSD2)	OTQ6SW4R	NSD2_HUMAN	Increases Expression	[35]
L-lactate dehydrogenase A chain (LDHA)	OTN7K4XB	LDHA_HUMAN	Increases Expression	[35]
Superoxide dismutase (SOD1)	OT39TA1L	SODC_HUMAN	Increases Expression	[35]
Ceruloplasmin (CP)	OTM8JE4Y	CERU_HUMAN	Decreases Expression	[35]
Coagulation factor XIII A chain (F13A1)	OTO8O184	F13A_HUMAN	Increases Expression	[35]
Aspartate aminotransferase, mitochondrial (GOT2)	OT6XBWN0	AATM_HUMAN	Increases Expression	[35]
Tyrosine-protein kinase ABL1 (ABL1)	OT09YVXH	ABL1_HUMAN	Decreases Expression	[35]
Complement C1r subcomponent (C1R)	OTA0ZNIU	C1R_HUMAN	Increases Expression	[35]
Tissue-type plasminogen activator (PLAT)	OTQPDNAB	TPA_HUMAN	Decreases Expression	[35]
Cystatin-A (CSTA)	OT1K68KE	CYTA_HUMAN	Increases Expression	[35]
Glycoprotein hormones alpha chain (CGA)	OT00U3Y3	GLHA_HUMAN	Increases Expression	[35]
Lymphotoxin-alpha (LTA)	OTUC3S76	TNFB_HUMAN	Increases Expression	[35]
Ferritin light chain (FTL)	OTYQA8A6	FRIL_HUMAN	Increases Expression	[35]
RAF proto-oncogene serine/threonine-protein kinase (RAF1)	OT51LSFO	RAF1_HUMAN	Increases Expression	[35]
Phospholipase A2 (PLA2G1B)	OT1GG9FK	PA21B_HUMAN	Increases Expression	[35]
Tissue alpha-L-fucosidase (FUCA1)	OTW71IK4	FUCO_HUMAN	Increases Expression	[35]
Platelet-derived growth factor subunit A (PDGFA)	OTCMZ0W8	PDGFA_HUMAN	Decreases Expression	[35]
HLA class II histocompatibility antigen gamma chain (CD74)	OTO16X4Q	HG2A_HUMAN	Increases Expression	[35]
Protein S100-B (S100B)	OTHHDS33	S100B_HUMAN	Increases Expression	[35]
Argininosuccinate lyase (ASL)	OTI2NGQR	ARLY_HUMAN	Increases Expression	[35]
Cytochrome b-245 heavy chain (CYBB)	OTGSG868	CY24B_HUMAN	Decreases Expression	[35]
Insulin-like growth factor I (IGF1)	OTIIZR61	IGF1_HUMAN	Decreases Expression	[35]
Amyloid-beta precursor protein (APP)	OTKFD7R4	A4_HUMAN	Increases Expression	[35]
Integrin beta-2 (ITGB2)	OTEKPEPR	ITB2_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein uL10 (RPLP0)	OT3XKD6Y	RLA0_HUMAN	Decreases Expression	[35]
Cholinesterase (BCHE)	OTOH3WQ9	CHLE_HUMAN	Increases Expression	[35]
Creatine kinase M-type (CKM)	OTME0KO7	KCRM_HUMAN	Increases Expression	[35]
Glycogen phosphorylase, liver form (PYGL)	OTS1YFGR	PYGL_HUMAN	Increases Expression	[35]
Nucleophosmin (NPM1)	OTTBYYT0	NPM_HUMAN	Increases Expression	[35]
Protein disulfide-isomerase (P4HB)	OTTYNYPF	PDIA1_HUMAN	Increases Expression	[35]
Alcohol dehydrogenase 1A (ADH1A)	OTTS983E	ADH1A_HUMAN	Increases Expression	[35]
Gastrin-releasing peptide (GRP)	OT8JDFNI	GRP_HUMAN	Decreases Expression	[35]
Collagen alpha-2(I) chain (COL1A2)	OTY7G382	CO1A2_HUMAN	Decreases Expression	[35]
Corticosteroid-binding globulin (SERPINA6)	OTOIBEW7	CBG_HUMAN	Increases Expression	[35]
Heat shock protein HSP 90-beta (HSP90AB1)	OTR69EG7	HS90B_HUMAN	Increases Expression	[35]
Inhibin beta A chain (INHBA)	OTSP64PQ	INHBA_HUMAN	Decreases Expression	[35]
Low affinity immunoglobulin gamma Fc region receptor III-A (FCGR3A)	OTOWXCF3	FCG3A_HUMAN	Increases Expression	[35]
Cytochrome P450 3A4 (CYP3A4)	OTQGYY83	CP3A4_HUMAN	Increases Expression	[35]
Galectin-1 (LGALS1)	OT8LDFWR	LEG1_HUMAN	Decreases Expression	[35]
Glutathione S-transferase Mu 1 (GSTM1)	OTSBF2MO	GSTM1_HUMAN	Increases Expression	[35]
Clathrin light chain A (CLTA)	OTLHOXMQ	CLCA_HUMAN	Increases Expression	[35]
Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1)	OTIRPN6B	ROA1_HUMAN	Increases Expression	[35]
Ras-related protein R-Ras (RRAS)	OTBBF28C	RRAS_HUMAN	Increases Expression	[35]
Nuclear receptor subfamily 2 group F member 6 (NR2F6)	OTNVO2B6	NR2F6_HUMAN	Decreases Expression	[35]
S-formylglutathione hydrolase (ESD)	OTUSIBPS	ESTD_HUMAN	Increases Expression	[35]
Interferon regulatory factor 1 (IRF1)	OT43DI6J	IRF1_HUMAN	Decreases Expression	[35]
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1)	OTA675TJ	GTR1_HUMAN	Increases Expression	[35]
Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (DBT)	OT4KZ5R9	ODB2_HUMAN	Increases Expression	[35]
Ras-related protein Ral-A (RALA)	OT734R7X	RALA_HUMAN	Increases Expression	[35]
Breakpoint cluster region protein (BCR)	OTCN76C1	BCR_HUMAN	Decreases Expression	[35]
Spectrin beta chain, erythrocytic (SPTB)	OT1Q9ABM	SPTB1_HUMAN	Increases Expression	[35]
Serine/threonine-protein kinase pim-1 (PIM1)	OTWEKXTU	PIM1_HUMAN	Increases Expression	[35]
C-1-tetrahydrofolate synthase, cytoplasmic (MTHFD1)	OTMKHVWC	C1TC_HUMAN	Decreases Expression	[35]
Serum response factor (SRF)	OTW18FQN	SRF_HUMAN	Decreases Expression	[35]
Collagen alpha-3(VI) chain (COL6A3)	OTAS6R6I	CO6A3_HUMAN	Decreases Expression	[35]
Coagulation factor V (F5)	OTDMZ3LT	FA5_HUMAN	Increases Expression	[35]
Myosin light chain 4 (MYL4)	OTURFCSE	MYL4_HUMAN	Increases Expression	[35]
Proto-oncogene tyrosine-protein kinase Src (SRC)	OTETYX40	SRC_HUMAN	Decreases Expression	[35]
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (COX4I1)	OTU0FC24	COX41_HUMAN	Increases Expression	[35]
Myosin-6 (MYH6)	OT3YNCH1	MYH6_HUMAN	Increases Expression	[35]
Endoplasmin (HSP90B1)	OT02XLBR	ENPL_HUMAN	Decreases Expression	[35]
POU domain, class 2, transcription factor 1 (POU2F1)	OTK7ELJ0	PO2F1_HUMAN	Increases Expression	[35]
Gamma-aminobutyric acid receptor subunit alpha-1 (GABRA1)	OTC2W96H	GBRA1_HUMAN	Increases Expression	[35]
Protein C-ets-1 (ETS1)	OT4LVGDN	ETS1_HUMAN	Decreases Expression	[35]
Protein C-ets-2 (ETS2)	OTPVHOZ7	ETS2_HUMAN	Increases Expression	[35]
Histatin-3 (HTN3)	OTEUXA81	HIS3_HUMAN	Increases Expression	[35]
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHKG2)	OTL0KLRP	PHKG2_HUMAN	Increases Expression	[35]
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2)	OTPGAU0U	AT2A2_HUMAN	Decreases Expression	[35]
Rho-related GTP-binding protein RhoQ (RHOQ)	OTUBTU57	RHOQ_HUMAN	Increases Expression	[35]
Aspartate aminotransferase, cytoplasmic (GOT1)	OTZLM5UB	AATC_HUMAN	Increases Expression	[35]
Transcription factor JunB (JUNB)	OTG2JXV5	JUNB_HUMAN	Decreases Expression	[35]
Tyrosine aminotransferase (TAT)	OT2CJ91O	ATTY_HUMAN	Increases Expression	[35]
Endoglin (ENG)	OTL2LSMI	EGLN_HUMAN	Decreases Expression	[35]
Galectin-3 (LGALS3)	OTYQT0ZI	LEG3_HUMAN	Increases Expression	[35]
T-complex protein 1 subunit alpha (TCP1)	OT1MGUX9	TCPA_HUMAN	Increases Expression	[35]
Early growth response protein 1 (EGR1)	OTCP6XGZ	EGR1_HUMAN	Decreases Expression	[35]
Cyclic AMP-dependent transcription factor ATF-3 (ATF3)	OTC1UOHP	ATF3_HUMAN	Decreases Expression	[35]
Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A)	OT2D9DOV	TNR1A_HUMAN	Increases Expression	[35]
Sodium/hydrogen exchanger 1 (SLC9A1)	OT6HNHFV	SL9A1_HUMAN	Decreases Expression	[35]
Inter-alpha-trypsin inhibitor heavy chain H1 (ITIH1)	OTSXJGQF	ITIH1_HUMAN	Increases Expression	[35]
Nuclear factor NF-kappa-B p105 subunit (NFKB1)	OTNRRD8I	NFKB1_HUMAN	Decreases Expression	[35]
HLA class II histocompatibility antigen, DP alpha 1 chain (HLA-DPA1)	OT7OG7Y2	DPA1_HUMAN	Increases Expression	[35]
Cyclin-A2 (CCNA2)	OTPHHYZJ	CCNA2_HUMAN	Decreases Expression	[35]
B-cell receptor CD22 (CD22)	OTXDJR9T	CD22_HUMAN	Increases Expression	[35]
Transcription factor BTF3 (BTF3)	OT5ZZFJL	BTF3_HUMAN	Increases Expression	[35]
Ras-related protein Rab-5A (RAB5A)	OTFR2KM4	RAB5A_HUMAN	Increases Expression	[35]
Ephrin-A1 (EFNA1)	OTU2NUA2	EFNA1_HUMAN	Increases Expression	[35]
Cytoplasmic aconitate hydratase (ACO1)	OT2VUR7L	ACOHC_HUMAN	Increases Expression	[35]
Macrophage scavenger receptor types I and II (MSR1)	OTHANJ7A	MSRE_HUMAN	Decreases Expression	[35]
Fibroblast growth factor 7 (FGF7)	OTGK6ANL	FGF7_HUMAN	Decreases Expression	[35]
Cartilage matrix protein (MATN1)	OTBRTCTQ	MATN1_HUMAN	Increases Expression	[35]
Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS)	OTMZN747	PUR6_HUMAN	Increases Expression	[35]
5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS2)	OTJXOUCL	HEM0_HUMAN	Increases Expression	[35]
Nuclear receptor subfamily 4immunitygroup A member 1 (NR4A1)	OTGP6GA4	NR4A1_HUMAN	Decreases Expression	[35]
Splicing factor, proline- and glutamine-rich (SFPQ)	OTLCIAPJ	SFPQ_HUMAN	Increases Expression	[35]
COUP transcription factor 2 (NR2F2)	OTJFS67N	COT2_HUMAN	Decreases Expression	[35]
Protein kinase C eta type (PRKCH)	OTC498N5	KPCL_HUMAN	Increases Expression	[35]
DNA-directed RNA polymerase II subunit RPB1 (POLR2A)	OTHJQ1DZ	RPB1_HUMAN	Increases Expression	[35]
Cyclin-dependent kinase 2 (CDK2)	OTB5DYYZ	CDK2_HUMAN	Decreases Expression	[35]
Proteasome subunit alpha type-1 (PSMA1)	OTNBVM2U	PSA1_HUMAN	Increases Expression	[35]
Rab proteins geranylgeranyltransferase component A 2 (CHML)	OTW3VW8D	RAE2_HUMAN	Increases Expression	[35]
Mitogen-activated protein kinase 3 (MAPK3)	OTCYKGKO	MK03_HUMAN	Decreases Expression	[35]
Multifunctional protein CAD (CAD)	OTNCUYYE	PYR1_HUMAN	Decreases Expression	[35]
Calreticulin (CALR)	OTYD2TR1	CALR_HUMAN	Decreases Expression	[35]
Calnexin (CANX)	OTYP1F6J	CALX_HUMAN	Increases Expression	[35]
Proteasome subunit beta type-4 (PSMB4)	OTOJ9OHA	PSB4_HUMAN	Increases Expression	[35]
Protein ITPRID2 (ITPRID2)	OTO3JDX5	ITPI2_HUMAN	Increases Expression	[35]
Nitric oxide synthase 3 (NOS3)	OTLDT7NR	NOS3_HUMAN	Increases Expression	[35]
Leiomodin-1 (LMOD1)	OTZ2MEMG	LMOD1_HUMAN	Increases Expression	[35]
G1/S-specific cyclin-D3 (CCND3)	OTNKPQ22	CCND3_HUMAN	Decreases Expression	[35]
Transmembrane 4 L6 family member 1 (TM4SF1)	OTY0ECQN	T4S1_HUMAN	Decreases Expression	[35]
Glycylpeptide N-tetradecanoyltransferase 1 (NMT1)	OT42GQ3D	NMT1_HUMAN	Increases Expression	[35]
Heme oxygenase 2 (HMOX2)	OTG40XBT	HMOX2_HUMAN	Increases Expression	[35]
Glutathione S-transferase theta-1 (GSTT1)	OTRFMWBK	GSTT1_HUMAN	Decreases Expression	[35]
High affinity cationic amino acid transporter 1 (SLC7A1)	OTR2ZVA8	CTR1_HUMAN	Increases Expression	[35]
RAC-alpha serine/threonine-protein kinase (AKT1)	OT8H2YY7	AKT1_HUMAN	Decreases Expression	[35]
Heterogeneous nuclear ribonucleoprotein H (HNRNPH1)	OTFRWOLM	HNRH1_HUMAN	Increases Expression	[35]
Protein S100-A11 (S100A11)	OTI57KDN	S10AB_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein uL6 (RPL9)	OTKE01O8	RL9_HUMAN	Decreases Expression	[35]
MHC class II transactivator (CIITA)	OTRJNZFO	C2TA_HUMAN	Decreases Expression	[35]
DNA replication licensing factor MCM4 (MCM4)	OT19PNNG	MCM4_HUMAN	Increases Expression	[35]
Insulin receptor substrate 1 (IRS1)	OTNO82CU	IRS1_HUMAN	Decreases Expression	[35]
Choline kinase alpha (CHKA)	OT7FVO3Z	CHKA_HUMAN	Increases Expression	[35]
Protein phosphatase 1A (PPM1A)	OT1U770U	PPM1A_HUMAN	Decreases Expression	[35]
Phosphoglucomutase-1 (PGM1)	OT3VM4JX	PGM1_HUMAN	Increases Expression	[35]
Phospholipid hydroperoxide glutathione peroxidase GPX4 (GPX4)	OTRAFFX2	GPX4_HUMAN	Increases Expression	[35]
Hippocalcin-like protein 1 (HPCAL1)	OTOBBFRD	HPCL1_HUMAN	Increases Expression	[35]
Transaldolase (TALDO1)	OTDKV2S2	TALDO_HUMAN	Increases Expression	[35]
Alpha-synuclein (SNCA)	OTPWC1MR	SYUA_HUMAN	Decreases Expression	[35]
Breast cancer type 1 susceptibility protein (BRCA1)	OT5BN6VH	BRCA1_HUMAN	Increases Expression	[35]
V-type proton ATPase catalytic subunit A (ATP6V1A)	OTYZ2S9E	VATA_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein uL3 (RPL3)	OTX6VXLB	RL3_HUMAN	Increases Expression	[35]
Glial cell line-derived neurotrophic factor (GDNF)	OT8ICC4Z	GDNF_HUMAN	Increases Expression	[35]
Interleukin-15 (IL15)	OTQSYWQS	IL15_HUMAN	Decreases Expression	[35]
Glycine--tRNA ligase (GARS1)	OT5B6R9Y	GARS_HUMAN	Increases Expression	[35]
Exosome RNA helicase MTR4 (MTREX)	OTSQY30V	MTREX_HUMAN	Increases Expression	[35]
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PIK3CA)	OTTOMI8J	PK3CA_HUMAN	Decreases Expression	[35]
Prostaglandin E2 receptor EP2 subtype (PTGER2)	OT1AUZAA	PE2R2_HUMAN	Decreases Expression	[35]
ETS translocation variant 4 (ETV4)	OT8C98UZ	ETV4_HUMAN	Decreases Expression	[35]
Tyrosine-protein kinase SYK (SYK)	OTQID87L	KSYK_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein eL21 (RPL21)	OT74GE74	RL21_HUMAN	Increases Expression	[35]
Microtubule-associated protein 1B (MAP1B)	OTVXW089	MAP1B_HUMAN	Increases Expression	[35]
F-actin-capping protein subunit alpha-2 (CAPZA2)	OTHAO4V2	CAZA2_HUMAN	Increases Expression	[35]
Sodium- and chloride-dependent creatine transporter 1 (SLC6A8)	OT88C8JA	SC6A8_HUMAN	Increases Expression	[35]
Gap junction alpha-8 protein (GJA8)	OTZCPRKD	CXA8_HUMAN	Increases Expression	[35]
Transmembrane 4 L6 family member 4 (TM4SF4)	OTRI8EHN	T4S4_HUMAN	Decreases Expression	[35]
Lithostathine-1-beta (REG1B)	OTSC2133	REG1B_HUMAN	Increases Expression	[35]
26S proteasome non-ATPase regulatory subunit 8 (PSMD8)	OTY6X27P	PSMD8_HUMAN	Increases Expression	[35]
Casein kinase I isoform delta (CSNK1D)	OTNF4S77	KC1D_HUMAN	Increases Expression	[35]
MAP kinase-activated protein kinase 2 (MAPKAPK2)	OT460SBO	MAPK2_HUMAN	Decreases Expression	[35]
Deoxyribonuclease-1-like 1 (DNASE1L1)	OT9ZOFN9	DNSL1_HUMAN	Increases Expression	[35]
Natural resistance-associated macrophage protein 1 (SLC11A1)	OTCN8N8B	NRAM1_HUMAN	Increases Expression	[35]
Ubiquitin-conjugating enzyme E2 R1 (CDC34)	OTNBK390	UB2R1_HUMAN	Decreases Expression	[35]
Steroidogenic acute regulatory protein, mitochondrial (STAR)	OTFEZ5AI	STAR_HUMAN	Increases Expression	[35]
G-protein coupled receptor 15 (GPR15)	OTK8674M	GPR15_HUMAN	Increases Expression	[35]
Dual specificity protein kinase CLK1 (CLK1)	OTG1LACW	CLK1_HUMAN	Increases Expression	[35]
Dual specificity protein kinase CLK3 (CLK3)	OT74DJ3J	CLK3_HUMAN	Increases Expression	[35]
Selenoprotein P (SELENOP)	OT02B8IR	SEPP1_HUMAN	Decreases Expression	[35]
Hsc70-interacting protein (ST13)	OTNML6UP	F10A1_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein eL14 (RPL14)	OTZZW7TK	RL14_HUMAN	Increases Expression	[35]
T-complex protein 1 subunit theta (CCT8)	OTA7GQN9	TCPQ_HUMAN	Increases Expression	[35]
Ras-related protein Rab-13 (RAB13)	OTIQ484I	RAB13_HUMAN	Increases Expression	[35]
RNA-binding protein Nova-1 (NOVA1)	OT6A9KHY	NOVA1_HUMAN	Decreases Expression	[35]
Probable global transcription activator SNF2L2 (SMARCA2)	OTSGJ8SV	SMCA2_HUMAN	Increases Expression	[35]
Transcription activator BRG1 (SMARCA4)	OT68WOPQ	SMCA4_HUMAN	Increases Expression	[35]
Aldehyde dehydrogenase family 3 member A2 (ALDH3A2)	OT714BUO	AL3A2_HUMAN	Increases Expression	[35]
Prolargin (PRELP)	OT9EEBUJ	PRELP_HUMAN	Decreases Expression	[35]
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 (FUT6)	OTBZUQ7F	FUT6_HUMAN	Increases Expression	[35]
6-phosphogluconate dehydrogenase, decarboxylating (PGD)	OTVG296F	6PGD_HUMAN	Increases Expression	[35]
Rho GDP-dissociation inhibitor 2 (ARHGDIB)	OT9PD6CS	GDIR2_HUMAN	Increases Expression	[35]
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (NDST1)	OT9E10W2	NDST1_HUMAN	Increases Expression	[35]
Arfaptin-1 (ARFIP1)	OTXHWO6M	ARFP1_HUMAN	Increases Expression	[35]
Geranylgeranyl transferase type-1 subunit beta (PGGT1B)	OTNGYUXE	PGTB1_HUMAN	Decreases Expression	[35]
Coatomer subunit beta (COPB1)	OT50CV12	COPB_HUMAN	Increases Expression	[35]
Activated RNA polymerase II transcriptional coactivator p15 (SUB1)	OTK71JYU	TCP4_HUMAN	Increases Expression	[35]
Voltage-dependent calcium channel subunit alpha-2/delta-1 (CACNA2D1)	OT5YLZIH	CA2D1_HUMAN	Increases Expression	[35]
Epithelial membrane protein 3 (EMP3)	OTODMJ1D	EMP3_HUMAN	Decreases Expression	[35]
Eukaryotic translation initiation factor 5 (EIF5)	OT79PQUN	IF5_HUMAN	Increases Expression	[35]
Mesencephalic astrocyte-derived neurotrophic factor (MANF)	OT2AH8VJ	MANF_HUMAN	Decreases Expression	[35]
Protein AF-10 (MLLT10)	OTURMDV7	AF10_HUMAN	Increases Expression	[35]
Nucleosome assembly protein 1-like 1 (NAP1L1)	OTI7WBZV	NP1L1_HUMAN	Increases Expression	[35]
Double-stranded RNA-specific adenosine deaminase (ADAR)	OTQNOHR8	DSRAD_HUMAN	Increases Expression	[35]
Tumor protein D52 (TPD52)	OTPKSK43	TPD52_HUMAN	Increases Expression	[35]
Heterogeneous nuclear ribonucleoprotein H2 (HNRNPH2)	OTMGP4J7	HNRH2_HUMAN	Increases Expression	[35]
ATP synthase subunit e, mitochondrial (ATP5ME)	OTADVEE2	ATP5I_HUMAN	Increases Expression	[35]
Pro-neuregulin-3, membrane-bound isoform (NRG3)	OTIFZ5CT	NRG3_HUMAN	Increases Expression	[35]
Krueppel-like factor 3 (KLF3)	OTIIAC18	KLF3_HUMAN	Increases Expression	[35]
Gamma-aminobutyric acid receptor-associated protein-like 2 (GABARAPL2)	OTS7YVHF	GBRL2_HUMAN	Increases Expression	[35]
Actin, cytoplasmic 1 (ACTB)	OT1MCP2F	ACTB_HUMAN	Decreases Expression	[35]
Ribose-phosphate pyrophosphokinase 1 (PRPS1)	OTN3A6CN	PRPS1_HUMAN	Increases Expression	[35]
Proteasome subunit alpha type-6 (PSMA6)	OTJ6RPX5	PSA6_HUMAN	Increases Expression	[35]
Cell division control protein 42 homolog (CDC42)	OT5QBC5M	CDC42_HUMAN	Increases Expression	[35]
Ras-related protein Rap-1b (RAP1B)	OTHEIIMM	RAP1B_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein uL24 (RPL26)	OTFNRC27	RL26_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein eL37 (RPL37)	OTB6SDZ1	RL37_HUMAN	Increases Expression	[35]
Small ubiquitin-related modifier 2 (SUMO2)	OT1Y5IKN	SUMO2_HUMAN	Increases Expression	[35]
Small nuclear ribonucleoprotein E (SNRPE)	OT18J6E8	RUXE_HUMAN	Increases Expression	[35]
Small nuclear ribonucleoprotein F (SNRPF)	OTZE5W6G	RUXF_HUMAN	Increases Expression	[35]
Estrogen-related receptor gamma (ESRRG)	OTC3A0KU	ERR3_HUMAN	Increases Expression	[35]
CCHC-type zinc finger nucleic acid binding protein (CNBP)	OTTGM9NK	CNBP_HUMAN	Decreases Expression	[35]
Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PPP2CB)	OT24GMCM	PP2AB_HUMAN	Increases Expression	[35]
Ras-related protein Rab-1A (RAB1A)	OTKPHRD0	RAB1A_HUMAN	Increases Expression	[35]
Small ribosomal subunit protein eS25 (RPS25)	OTKLWED2	RS25_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein uL1 (RPL10A)	OTDLCJ53	RL10A_HUMAN	Increases Expression	[35]
Peptidyl-prolyl cis-trans isomerase A (PPIA)	OTHJMWQQ	PPIA_HUMAN	Increases Expression	[35]
Ubiquitin-ribosomal protein eS31 fusion protein (RPS27A)	OTIIGGZ2	RS27A_HUMAN	Increases Expression	[35]
Growth factor receptor-bound protein 2 (GRB2)	OTOP7LTE	GRB2_HUMAN	Increases Expression	[35]
Actin, cytoplasmic 2 (ACTG1)	OTH4V7VQ	ACTG_HUMAN	Decreases Expression	[35]
Tropomyosin alpha-4 chain (TPM4)	OTN4YLYR	TPM4_HUMAN	Increases Expression	[35]
Hemoglobin subunit beta (HBB)	OT514IKQ	HBB_HUMAN	Affects Expression	[35]
Homeobox protein Nkx-3.2 (NKX3-2)	OTH4NRH7	NKX32_HUMAN	Decreases Expression	[35]
Protein BTG2 (BTG2)	OTZF6K1H	BTG2_HUMAN	Increases Expression	[35]
Brain acid soluble protein 1 (BASP1)	OTF4VS5G	BASP1_HUMAN	Increases Expression	[35]
U7 snRNA-associated Sm-like protein LSm11 (LSM11)	OTN9M7QG	LSM11_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein eL42 (RPL36A)	OT1LYV85	RL36A_HUMAN	Increases Expression	[35]
Neuron-specific calcium-binding protein hippocalcin (HPCA)	OTERUPP6	HPCA_HUMAN	Decreases Expression	[35]
ADP-ribosylation factor 1 (ARF1)	OT5C4C3L	ARF1_HUMAN	Increases Expression	[35]
Clathrin heavy chain 1 (CLTC)	OTBFASMA	CLH1_HUMAN	Decreases Expression	[35]
E3 ubiquitin-protein ligase Mdm2 (MDM2)	OTOVXARF	MDM2_HUMAN	Decreases Expression	[35]
Protein SET (SET)	OTGYYQJO	SET_HUMAN	Increases Expression	[35]
Transcription factor RelB (RELB)	OTU3QYEF	RELB_HUMAN	Decreases Expression	[35]
Interferon-induced transmembrane protein 3 (IFITM3)	OT2QP8D3	IFM3_HUMAN	Increases Expression	[35]
Adrenocorticotropic hormone receptor (MC2R)	OT6V19Y9	ACTHR_HUMAN	Increases Expression	[35]
Melanocyte-stimulating hormone receptor (MC1R)	OTB95LIK	MSHR_HUMAN	Increases Expression	[35]
POU domain, class 4, transcription factor 1 (POU4F1)	OTMHYGWQ	PO4F1_HUMAN	Increases Expression	[35]
Transcription factor Spi-B (SPIB)	OTO4YKYI	SPIB_HUMAN	Decreases Expression	[35]
Paired box protein Pax-5 (PAX5)	OTYBJJWX	PAX5_HUMAN	Increases Expression	[35]
cAMP-responsive element modulator (CREM)	OTJIJ5AL	CREM_HUMAN	Increases Expression	[35]
Histone-lysine N-methyltransferase MECOM (MECOM)	OTP983W8	MECOM_HUMAN	Decreases Expression	[35]
Centromere protein C (CENPC)	OTVJ6VE9	CENPC_HUMAN	Increases Expression	[35]
CCAAT/enhancer-binding protein zeta (CEBPZ)	OT11BATG	CEBPZ_HUMAN	Increases Expression	[35]
Lactoylglutathione lyase (GLO1)	OTXFS5B3	LGUL_HUMAN	Increases Expression	[35]
Single-stranded DNA-binding protein, mitochondrial (SSBP1)	OTH2PZWH	SSBP_HUMAN	Increases Expression	[35]
Collagen alpha-1(XIV) chain (COL14A1)	OTLNJ13O	COEA1_HUMAN	Increases Expression	[35]
Dual specificity protein phosphatase 2 (DUSP2)	OTH54FMR	DUS2_HUMAN	Decreases Expression	[35]
Peroxiredoxin-1 (PRDX1)	OTZ3BEC4	PRDX1_HUMAN	Increases Expression	[35]
Collagen alpha-1(XVI) chain (COL16A1)	OTOWKUO2	COGA1_HUMAN	Increases Expression	[35]
Alpha-actinin-3 (ACTN3)	OT9DZ7JQ	ACTN3_HUMAN	Decreases Expression	[35]
Voltage-dependent L-type calcium channel subunit beta-2 (CACNB2)	OT53K8W2	CACB2_HUMAN	Increases Expression	[35]
Golgin subfamily A member 2 (GOLGA2)	OT5S9KYM	GOGA2_HUMAN	Increases Expression	[35]
Histone-binding protein RBBP4 (RBBP4)	OTG3BT3M	RBBP4_HUMAN	Decreases Expression	[35]
Histone acetyltransferase p300 (EP300)	OTL8QJDX	EP300_HUMAN	Increases Expression	[35]
Alpha-(1,3)-fucosyltransferase 7 (FUT7)	OTJF6BSN	FUT7_HUMAN	Increases Expression	[35]
Calcium-activated potassium channel subunit alpha-1 (KCNMA1)	OTNYXOZO	KCMA1_HUMAN	Increases Expression	[35]
Hyaluronidase-1 (HYAL1)	OT2SJN0X	HYAL1_HUMAN	Increases Expression	[35]
Proline-rich nuclear receptor coactivator 1 (PNRC1)	OTQMLEE1	PNRC1_HUMAN	Increases Expression	[35]
A-kinase anchor protein 13 (AKAP13)	OTOZAR14	AKP13_HUMAN	Increases Expression	[35]
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1)	OT2LP7LJ	SNF5_HUMAN	Increases Expression	[35]
Tyrosine-protein kinase Mer (MERTK)	OTWBRAJ6	MERTK_HUMAN	Decreases Expression	[35]
Tripartite motif-containing protein 26 (TRIM26)	OTS0DJIP	TRI26_HUMAN	Increases Expression	[35]
Rho GTPase-activating protein 5 (ARHGAP5)	OTOQELUN	RHG05_HUMAN	Increases Expression	[35]
Striatin-3 (STRN3)	OT44KXPY	STRN3_HUMAN	Increases Expression	[35]
TNF receptor-associated factor 1 (TRAF1)	OTTLM5RU	TRAF1_HUMAN	Increases Expression	[35]
Protein Red (IK)	OTWSSXX0	RED_HUMAN	Increases Expression	[35]
RE1-silencing transcription factor (REST)	OTLL92LQ	REST_HUMAN	Increases Expression	[35]
Dual specificity protein phosphatase 8 (DUSP8)	OTPLMPG9	DUS8_HUMAN	Increases Expression	[35]
Growth factor receptor-bound protein 10 (GRB10)	OTCKXGRC	GRB10_HUMAN	Increases Expression	[35]
Peptidyl-prolyl cis-trans isomerase G (PPIG)	OTZ8BTTM	PPIG_HUMAN	Increases Expression	[35]
Metaxin-1 (MTX1)	OTLSDNZO	MTX1_HUMAN	Decreases Expression	[35]
Acid ceramidase (ASAH1)	OT1DNGXL	ASAH1_HUMAN	Increases Expression	[35]
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)	OTHD9KJG	KCC2G_HUMAN	Increases Expression	[35]
Myotubularin-related protein 2 (MTMR2)	OTNCYGBP	MTMR2_HUMAN	Decreases Expression	[35]
Cullin-2 (CUL2)	OTPF83PG	CUL2_HUMAN	Increases Expression	[35]
Nascent polypeptide-associated complex subunit alpha (NACA)	OTLP1KR3	NACA_HUMAN	Increases Expression	[35]
Nuclear receptor coactivator 4 (NCOA4)	OTRVU0UA	NCOA4_HUMAN	Increases Expression	[35]
Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)	OTXEE550	APR_HUMAN	Decreases Expression	[35]
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2)	OTTUU92F	ENPP2_HUMAN	Increases Expression	[35]
Bone morphogenetic protein receptor type-2 (BMPR2)	OTM9W547	BMPR2_HUMAN	Increases Expression	[35]
Runt-related transcription factor 2 (RUNX2)	OT97RQQM	RUNX2_HUMAN	Decreases Expression	[35]
Ras-related protein Rab-33A (RAB33A)	OTHHU6WA	RB33A_HUMAN	Increases Expression	[35]
Ribosome biogenesis protein BOP1 (BOP1)	OTMZMQDO	BOP1_HUMAN	Decreases Expression	[35]
Glutathione hydrolase light chain 2 (GGTLC2)	OT003Y7X	GGTL2_HUMAN	Decreases Expression	[35]
Polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3)	OT7M67WT	GALT3_HUMAN	Increases Expression	[35]
Transcription factor HES-1 (HES1)	OT8P19W2	HES1_HUMAN	Decreases Expression	[35]
E3 ubiquitin-protein ligase TRIP12 (TRIP12)	OT2ORYIH	TRIPC_HUMAN	Increases Expression	[35]
Prostaglandin reductase 1 (PTGR1)	OTMAR351	PTGR1_HUMAN	Increases Expression	[35]
Nucleolar and coiled-body phosphoprotein 1 (NOLC1)	OTKDZU0D	NOLC1_HUMAN	Decreases Expression	[35]
Opioid-binding protein/cell adhesion molecule (OPCML)	OT93PQ6Y	OPCM_HUMAN	Increases Expression	[35]
DAZ-associated protein 2 (DAZAP2)	OTNURO9F	DAZP2_HUMAN	Increases Expression	[35]
DNA polymerase delta subunit 3 (POLD3)	OTEQEFQ2	DPOD3_HUMAN	Increases Expression	[35]
Platelet-activating factor acetylhydrolase IB subunit alpha1 (PAFAH1B3)	OT6A9JT8	PA1B3_HUMAN	Increases Expression	[35]
Procollagen C-endopeptidase enhancer 1 (PCOLCE)	OTJXOAN4	PCOC1_HUMAN	Decreases Expression	[35]
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PPP2R5A)	OTZBCRGI	2A5A_HUMAN	Decreases Expression	[35]
Prostaglandin E synthase 3 (PTGES3)	OTPPQWI0	TEBP_HUMAN	Increases Expression	[35]
Poly(rC)-binding protein 2 (PCBP2)	OTXCN9CG	PCBP2_HUMAN	Increases Expression	[35]
Angiopoietin-1 (ANGPT1)	OTVZ1NG3	ANGP1_HUMAN	Decreases Expression	[35]
Monocyte to macrophage differentiation factor (MMD)	OTB5I4OC	PAQRB_HUMAN	Increases Expression	[35]
Rho-related GTP-binding protein RhoH (RHOH)	OT1J9SEB	RHOH_HUMAN	Increases Expression	[35]
Microtubule-associated protein RP/EB family member 1 (MAPRE1)	OTCVQD60	MARE1_HUMAN	Increases Expression	[35]
TSC22 domain family protein 1 (TSC22D1)	OTN4GFWD	T22D1_HUMAN	Decreases Expression	[35]
Probable E3 ubiquitin-protein ligase HERC1 (HERC1)	OT73FVYZ	HERC1_HUMAN	Increases Expression	[35]
Glutamate receptor ionotropic, kainate 4 (GRIK4)	OTL5EIPA	GRIK4_HUMAN	Increases Expression	[35]
Septin-7 (SEPTIN7)	OTJI08YX	SEPT7_HUMAN	Increases Expression	[35]
Ecto-NOX disulfide-thiol exchanger 2 (ENOX2)	OTMDA97Z	ENOX2_HUMAN	Increases Expression	[35]
Transcription factor E2F4 (E2F4)	OTB3JFH4	E2F4_HUMAN	Increases Expression	[35]
Programmed cell death protein 2 (PDCD2)	OTUOGSDJ	PDCD2_HUMAN	Increases Expression	[35]
Dihydropyrimidinase-related protein 2 (DPYSL2)	OTWNQ74H	DPYL2_HUMAN	Increases Expression	[35]
Atypical chemokine receptor 1 (ACKR1)	OT9M11LX	ACKR1_HUMAN	Decreases Expression	[35]
Cyclin-G2 (CCNG2)	OTII38K2	CCNG2_HUMAN	Increases Expression	[35]
Extracellular matrix protein 1 (ECM1)	OT1K65VW	ECM1_HUMAN	Increases Expression	[35]
Glutathione S-transferase A3 (GSTA3)	OTJ3REE3	GSTA3_HUMAN	Increases Expression	[35]
Laminin subunit alpha-3 (LAMA3)	OTFME7HT	LAMA3_HUMAN	Increases Expression	[35]
Meprin A subunit alpha (MEP1A)	OTY2Z48T	MEP1A_HUMAN	Increases Expression	[35]
Dual specificity protein phosphatase 7 (DUSP7)	OT6Z5AHP	DUS7_HUMAN	Decreases Expression	[35]
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (ST3GAL2)	OT8WM21E	SIA4B_HUMAN	Decreases Expression	[35]
Leukotriene C4 synthase (LTC4S)	OT3XNFJZ	LTC4S_HUMAN	Decreases Expression	[35]
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)	OTCQMOIX	LRRK1_HUMAN	Increases Expression	[35]
Protein PTHB1 (BBS9)	OT23V9YF	PTHB1_HUMAN	Increases Expression	[35]
Cryptochrome-2 (CRY2)	OTERZ93T	CRY2_HUMAN	Increases Expression	[35]
B-cell CLL/lymphoma 7 protein family member A (BCL7A)	OTYFUJTP	BCL7A_HUMAN	Increases Expression	[35]
Tigger transposable element-derived protein 2 (TIGD2)	OTRXGZ1X	TIGD2_HUMAN	Decreases Expression	[35]
Programmed cell death protein 4 (PDCD4)	OTZ6NXUX	PDCD4_HUMAN	Increases Expression	[35]
Seizure protein 6 homolog (SEZ6)	OTCD8K5D	SEZ6_HUMAN	Increases Expression	[35]
Centrosomal protein of 55 kDa (CEP55)	OTGSG2PA	CEP55_HUMAN	Increases Expression	[35]
Sigma intracellular receptor 2 (TMEM97)	OTH76ZWK	SGMR2_HUMAN	Increases Expression	[35]
Ras-specific guanine nucleotide-releasing factor RalGPS1 (RALGPS1)	OTEQN0MA	RGPS1_HUMAN	Increases Expression	[35]
Synaptosomal-associated protein 47 (SNAP47)	OT1DE2QT	SNP47_HUMAN	Decreases Expression	[35]
Rho GTPase-activating protein 21 (ARHGAP21)	OT6XY8Y9	RHG21_HUMAN	Increases Expression	[35]
Immediate early response gene 5-like protein (IER5L)	OT6IG629	IER5L_HUMAN	Decreases Expression	[35]
Sodium-dependent glucose transporter 1 (MFSD4B)	OTHHKWRT	MFS4B_HUMAN	Increases Expression	[35]
GTPase-activating Rap/Ran-GAP domain-like protein 3 (GARNL3)	OTYK950M	GARL3_HUMAN	Increases Expression	[35]
Proteasome adapter and scaffold protein ECM29 (ECPAS)	OT1C0KOI	ECM29_HUMAN	Increases Expression	[35]
Olfactomedin-like protein 2A (OLFML2A)	OT416MJA	OLM2A_HUMAN	Increases Expression	[35]
CWF19-like protein 1 (CWF19L1)	OTAMYTOW	C19L1_HUMAN	Decreases Expression	[35]
NADH-cytochrome b5 reductase 2 (CYB5R2)	OTTLM7XN	NB5R2_HUMAN	Decreases Expression	[35]
Ral GTPase-activating protein subunit alpha-1 (RALGAPA1)	OTHT5DW0	RGPA1_HUMAN	Increases Expression	[35]
Protein FAM117B (FAM117B)	OT11P91V	F117B_HUMAN	Increases Expression	[35]
Kinesin light chain 3 (KLC3)	OT38HGDY	KLC3_HUMAN	Increases Expression	[35]
Polypeptide N-acetylgalactosaminyltransferase 18 (GALNT18)	OTKIIELC	GLT18_HUMAN	Increases Expression	[35]
Volume-regulated anion channel subunit LRRC8B (LRRC8B)	OTH2LMJ4	LRC8B_HUMAN	Decreases Expression	[35]
Gap junction beta-7 protein (GJB7)	OTV4FUEA	CXB7_HUMAN	Decreases Expression	[35]
Neutral cholesterol ester hydrolase 1 (NCEH1)	OTZ66CKX	NCEH1_HUMAN	Increases Expression	[35]
Poly(A) RNA polymerase GLD2 (TENT2)	OTB7J28X	GLD2_HUMAN	Increases Expression	[35]
NAD(+) hydrolase SARM1 (SARM1)	OTEP4I5O	SARM1_HUMAN	Increases Expression	[35]
Kelch-like protein 24 (KLHL24)	OTWZSX5C	KLH24_HUMAN	Increases Expression	[35]
Aftiphilin (AFTPH)	OTDUYPRS	AFTIN_HUMAN	Increases Expression	[35]
Protein TEX261 (TEX261)	OTNLKLNA	TX261_HUMAN	Increases Expression	[35]
GRB10-interacting GYF protein 2 (GIGYF2)	OTFNVEJ4	GGYF2_HUMAN	Increases Expression	[35]
Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (B3GNT6)	OTAX8BNJ	B3GN6_HUMAN	Decreases Expression	[35]
Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1)	OTMQXW7S	RAPH1_HUMAN	Increases Expression	[35]
Putative Polycomb group protein ASXL2 (ASXL2)	OTNG4E2M	ASXL2_HUMAN	Increases Expression	[35]
BTB/POZ domain-containing protein KCTD9 (KCTD9)	OTBN6ZUC	KCTD9_HUMAN	Increases Expression	[35]
Eukaryotic translation initiation factor 3 subunit M (EIF3M)	OTVWEV60	EIF3M_HUMAN	Increases Expression	[35]
Cation channel sperm-associated protein 4 (CATSPER4)	OTXJ4E8J	CTSR4_HUMAN	Increases Expression	[35]
Protein mono-ADP-ribosyltransferase TIPARP (TIPARP)	OTZ4BG4B	PARPT_HUMAN	Increases Expression	[35]
Chemokine-like protein TAFA-5 (TAFA5)	OT2SWBT6	TAFA5_HUMAN	Increases Expression	[35]
Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1IP)	OTN02KUV	AB1IP_HUMAN	Increases Expression	[35]
N-terminal EF-hand calcium-binding protein 2 (NECAB2)	OT6PITM9	NECA2_HUMAN	Decreases Expression	[35]
E3 ubiquitin-protein ligase HUWE1 (HUWE1)	OTFH6BJS	HUWE1_HUMAN	Increases Expression	[35]
PX domain-containing protein kinase-like protein (PXK)	OTSP1WLK	PXK_HUMAN	Increases Expression	[35]
Filamin-A-interacting protein 1 (FILIP1)	OTMZD6D4	FLIP1_HUMAN	Increases Expression	[35]
Desmoglein-4 (DSG4)	OTWIQDC4	DSG4_HUMAN	Increases Expression	[35]
Pleckstrin homology-like domain family B member 2 (PHLDB2)	OTDKMB2G	PHLB2_HUMAN	Increases Expression	[35]
Trafficking protein particle complex subunit 6B (TRAPPC6B)	OTDSWXHT	TPC6B_HUMAN	Increases Expression	[35]
Tetratricopeptide repeat protein 7B (TTC7B)	OTUE51B3	TTC7B_HUMAN	Increases Expression	[35]
Probable RNA-binding protein 23 (RBM23)	OTDNGLHY	RBM23_HUMAN	Decreases Expression	[35]
E3 ubiquitin-protein ligase MARCHF3 (MARCHF3)	OT89V4N5	MARH3_HUMAN	Decreases Expression	[35]
Homeodomain-interacting protein kinase 1 (HIPK1)	OTSEA8RS	HIPK1_HUMAN	Increases Expression	[35]
ATP-binding cassette sub-family A member 9 (ABCA9)	OTD0EDYM	ABCA9_HUMAN	Increases Expression	[35]
ELKS/Rab6-interacting/CAST family member 1 (ERC1)	OTYBGGNO	RB6I2_HUMAN	Decreases Expression	[35]
Armadillo repeat-containing protein 8 (ARMC8)	OTNAXGM7	ARMC8_HUMAN	Increases Expression	[35]
Mitogen-activated protein kinase kinase kinase kinase 3 (MAP4K3)	OTNJX38T	M4K3_HUMAN	Increases Expression	[35]
Mitochondrial Rho GTPase 1 (RHOT1)	OTBIRR8Q	MIRO1_HUMAN	Increases Expression	[35]
Patatin-like phospholipase domain-containing protein 6 (PNPLA6)	OTT5T45Q	PLPL6_HUMAN	Increases Expression	[35]
Structural maintenance of chromosomes protein 5 (SMC5)	OT91M6N4	SMC5_HUMAN	Increases Expression	[35]
Dedicator of cytokinesis protein 3 (DOCK3)	OTF3YS2W	DOCK3_HUMAN	Increases Expression	[35]
Abnormal spindle-like microcephaly-associated protein (ASPM)	OTKXQMNA	ASPM_HUMAN	Increases Expression	[35]
T-cell activation Rho GTPase-activating protein (TAGAP)	OTHJNNO2	TAGAP_HUMAN	Increases Expression	[35]
Leucine-rich repeat LGI family member 3 (LGI3)	OT0CZ85H	LGI3_HUMAN	Decreases Expression	[35]
Protein PALS1 (PALS1)	OTUCGL9L	PALS1_HUMAN	Increases Expression	[35]
Formin-binding protein 4 (FNBP4)	OTV1UBCS	FNBP4_HUMAN	Increases Expression	[35]
Ferritin, mitochondrial (FTMT)	OTIUX6XG	FTMT_HUMAN	Increases Expression	[35]
Homeobox protein ESX1 (ESX1)	OTZUPU2C	ESX1_HUMAN	Increases Expression	[35]
Ankyrin repeat domain-containing protein 29 (ANKRD29)	OTUPUEAP	ANR29_HUMAN	Decreases Expression	[35]
Methyltransferase-like protein 27 (METTL27)	OTOF0GTU	MET27_HUMAN	Increases Expression	[35]
CD177 antigen (CD177)	OTS79FNF	CD177_HUMAN	Increases Expression	[35]
Kelch domain-containing protein 1 (KLHDC1)	OTMX4YTM	KLDC1_HUMAN	Increases Expression	[35]
SERPINE1 mRNA-binding protein 1 (SERBP1)	OTZVSU0X	SERB1_HUMAN	Increases Expression	[35]
BTB/POZ domain-containing protein KCTD6 (KCTD6)	OTC22GE4	KCTD6_HUMAN	Increases Expression	[35]
Paraneoplastic antigen Ma1 (PNMA1)	OTEUG8RL	PNMA1_HUMAN	Increases Expression	[35]
Kelch domain-containing protein 9 (KLHDC9)	OTMZQMGW	KLDC9_HUMAN	Increases Expression	[35]
Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (LFNG)	OTPSUBN2	LFNG_HUMAN	Decreases Expression	[35]
AT-rich interactive domain-containing protein 1B (ARID1B)	OTILK3Q7	ARI1B_HUMAN	Decreases Expression	[35]
Centrosomal protein of 70 kDa (CEP70)	OTMY5KAE	CEP70_HUMAN	Increases Expression	[35]
Tudor domain-containing protein 7 (TDRD7)	OTK639ET	TDRD7_HUMAN	Increases Expression	[35]
Protein NEDD1 (NEDD1)	OTBD6X77	NEDD1_HUMAN	Increases Expression	[35]
Protocadherin-19 (PCDH19)	OTSOW3MV	PCD19_HUMAN	Decreases Expression	[35]
Solute carrier family 7 member 14 (SLC7A14)	OT07YJW4	S7A14_HUMAN	Increases Expression	[35]
TBC1 domain family member 15 (TBC1D15)	OTIT3Y14	TBC15_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein uL30m (MRPL30)	OT26OPYV	RM30_HUMAN	Increases Expression	[35]
Signal peptide peptidase-like 2A (SPPL2A)	OTCVF6MM	SPP2A_HUMAN	Increases Expression	[35]
Mucolipin-3 (MCOLN3)	OTCRPRVS	MCLN3_HUMAN	Increases Expression	[35]
Hepatitis A virus cellular receptor 2 (HAVCR2)	OTOL603T	HAVR2_HUMAN	Increases Expression	[35]
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CSGALNACT1)	OTBML9D9	CGAT1_HUMAN	Increases Expression	[35]
LIM homeobox transcription factor 1-alpha (LMX1A)	OTEEYD5L	LMX1A_HUMAN	Increases Expression	[35]
Fas-binding factor 1 (FBF1)	OTKA7EZI	FBF1_HUMAN	Increases Expression	[35]
Serine/threonine/tyrosine-interacting protein (STYX)	OT8W6Y1J	STYX_HUMAN	Increases Expression	[35]
Pleckstrin homology-like domain family A member 1 (PHLDA1)	OTFTWMIQ	PHLA1_HUMAN	Decreases Expression	[35]
Ankyrin repeat and SOCS box protein 5 (ASB5)	OT42QMSY	ASB5_HUMAN	Decreases Expression	[35]
Caskin-2 (CASKIN2)	OTCIT4EF	CSKI2_HUMAN	Increases Expression	[35]
Dynein axonemal heavy chain 7 (DNAH7)	OTTI8FRY	DYH7_HUMAN	Increases Expression	[35]
Inhibitor of growth protein 5 (ING5)	OTRNNSFM	ING5_HUMAN	Increases Expression	[35]
Tribbles homolog 2 (TRIB2)	OTHSX3MX	TRIB2_HUMAN	Decreases Expression	[35]
Engulfment and cell motility protein 1 (ELMO1)	OTY2ORXK	ELMO1_HUMAN	Increases Expression	[35]
Mastermind-like protein 1 (MAML1)	OTQA4DDN	MAML1_HUMAN	Increases Expression	[35]
Dual specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2)	OTMDVWPS	DYRK2_HUMAN	Increases Expression	[35]
Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B)	OT3SQMLU	AN32B_HUMAN	Increases Expression	[35]
Histone acetyltransferase KAT2B (KAT2B)	OTWQITWK	KAT2B_HUMAN	Increases Expression	[35]
Proteoglycan 4 (PRG4)	OT34NR3N	PRG4_HUMAN	Increases Expression	[35]
RNA-binding protein with multiple splicing (RBPMS)	OT1RDKR9	RBPMS_HUMAN	Increases Expression	[35]
Secretory carrier-associated membrane protein 4 (SCAMP4)	OTSCZTJ5	SCAM4_HUMAN	Increases Expression	[35]
BLOC-2 complex member HPS3 (HPS3)	OTAKROK7	HPS3_HUMAN	Increases Expression	[35]
E3 ubiquitin-protein ligase RNF34 (RNF34)	OTQY58LU	RNF34_HUMAN	Increases Expression	[35]
Ras-related protein Rab-24 (RAB24)	OTOFNAJK	RAB24_HUMAN	Increases Expression	[35]
PAT complex subunit CCDC47 (CCDC47)	OTUIN61P	CCD47_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein uL24m (MRPL24)	OTEIQZ5G	RM24_HUMAN	Increases Expression	[35]
Mitoferrin-2 (SLC25A28)	OT6H32AI	MFRN2_HUMAN	Decreases Expression	[35]
Arrestin domain-containing protein 3 (ARRDC3)	OTAKW7R9	ARRD3_HUMAN	Increases Expression	[35]
PHD finger protein 21A (PHF21A)	OTU3FFG4	PF21A_HUMAN	Increases Expression	[35]
Transcription termination factor 3, mitochondrial (MTERF3)	OTVE8W7X	MTEF3_HUMAN	Increases Expression	[35]
PAK4-inhibitor INKA1 (INKA1)	OTT98BIB	INKA1_HUMAN	Decreases Expression	[35]
Molybdenum cofactor sulfurase (MOCOS)	OT0TL3Q5	MOCOS_HUMAN	Increases Expression	[35]
DAZ-associated protein 1 (DAZAP1)	OTWLY0UE	DAZP1_HUMAN	Increases Expression	[35]
tRNA (TRMT61A)	OTMIXQQ6	TRM61_HUMAN	Decreases Expression	[35]
Cilia- and flagella-associated protein 36 (CFAP36)	OTXR1FWX	CFA36_HUMAN	Increases Expression	[35]
Scavenger receptor class F member 2 (SCARF2)	OT0X0ZLC	SREC2_HUMAN	Decreases Expression	[35]
Solute carrier family 41 member 3 (SLC41A3)	OTCABXH9	S41A3_HUMAN	Decreases Expression	[35]
PDZ and LIM domain protein 5 (PDLIM5)	OTLQVV22	PDLI5_HUMAN	Decreases Expression	[35]
Splicing factor 45 (RBM17)	OT9ROJCL	SPF45_HUMAN	Increases Expression	[35]
Epithelial-stromal interaction protein 1 (EPSTI1)	OT75I1UH	ESIP1_HUMAN	Increases Expression	[35]
CCR4-NOT transcription complex subunit 6-like (CNOT6L)	OTLBRR6Q	CNO6L_HUMAN	Increases Expression	[35]
Sphingomyelin synthase-related protein 1 (SAMD8)	OTGJTVEN	SAMD8_HUMAN	Increases Expression	[35]
Spermatogenesis-associated protein 13 (SPATA13)	OTQ8NPAW	SPT13_HUMAN	Increases Expression	[35]
Dachshund homolog 2 (DACH2)	OT33KEUZ	DACH2_HUMAN	Increases Expression	[35]
Opalin (OPALIN)	OTUA3WE3	OPALI_HUMAN	Increases Expression	[35]
Transcriptional-regulating factor 1 (TRERF1)	OTA7UQF1	TREF1_HUMAN	Increases Expression	[35]
KH domain-containing RNA-binding protein QKI (QKI)	OTTAUGLB	QKI_HUMAN	Increases Expression	[35]
E3 ubiquitin ligase RNF157 (RNF157)	OTOEA0T5	RN157_HUMAN	Increases Expression	[35]
Gasdermin-A (GSDMA)	OT912R2E	GSDMA_HUMAN	Increases Expression	[35]
Pannexin-2 (PANX2)	OTAQ2S8R	PANX2_HUMAN	Decreases Expression	[35]
Fc receptor-like protein 5 (FCRL5)	OTA7VHNE	FCRL5_HUMAN	Increases Expression	[35]
Ran-binding protein 9 (RANBP9)	OTM8COM5	RANB9_HUMAN	Increases Expression	[35]
Protein artemis (DCLRE1C)	OTW3KB1I	DCR1C_HUMAN	Increases Expression	[35]
Protein ABHD1 (ABHD1)	OTY56U02	ABHD1_HUMAN	Increases Expression	[35]
Spermatid perinuclear RNA-binding protein (STRBP)	OTU7XLZL	STRBP_HUMAN	Increases Expression	[35]
26S proteasome non-ATPase regulatory subunit 1 (PSMD1)	OTW258OV	PSMD1_HUMAN	Increases Expression	[35]
Perilipin-2 (PLIN2)	OTRXJ9UN	PLIN2_HUMAN	Increases Expression	[35]
Max-binding protein MNT (MNT)	OTPC4ANL	MNT_HUMAN	Decreases Expression	[35]
Eukaryotic translation initiation factor 3 subunit C (EIF3C)	OTR8RF9X	EIF3C_HUMAN	Increases Expression	[35]
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (PKMYT1)	OTYRXD2T	PMYT1_HUMAN	Decreases Expression	[35]
Phospholipid-transporting ATPase ABCA3 (ABCA3)	OTH6MSKQ	ABCA3_HUMAN	Increases Expression	[35]
Protein arginine N-methyltransferase 1 (PRMT1)	OTN8GTXW	ANM1_HUMAN	Decreases Expression	[35]
A-kinase anchor protein 9 (AKAP9)	OT7Z2YRP	AKAP9_HUMAN	Increases Expression	[35]
Zinc phosphodiesterase ELAC protein 2 (ELAC2)	OTY3BOF6	RNZ2_HUMAN	Decreases Expression	[35]
Large ribosomal subunit protein mL63 (MRPL57)	OTRB659E	RT63_HUMAN	Increases Expression	[35]
Junctophilin-2 (JPH2)	OTL9YH7V	JPH2_HUMAN	Increases Expression	[35]
Deubiquitinase DESI2 (DESI2)	OTHUOKOC	DESI2_HUMAN	Increases Expression	[35]
Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 (CHCHD7)	OTHHROAQ	CHCH7_HUMAN	Decreases Expression	[35]
Arginine/serine-rich protein 1 (RSRP1)	OTOAZLCL	RSRP1_HUMAN	Increases Expression	[35]
Replication initiator 1 (REPIN1)	OTVTPXNX	REPI1_HUMAN	Increases Expression	[35]
Nucleolar and spindle-associated protein 1 (NUSAP1)	OT85HIJ5	NUSAP_HUMAN	Increases Expression	[35]
Dual specificity protein phosphatase 16 (DUSP16)	OTK7S078	DUS16_HUMAN	Decreases Expression	[35]
Cytoplasmic polyadenylation element-binding protein 1 (CPEB1)	OTLCXC6H	CPEB1_HUMAN	Increases Expression	[35]
Oxysterol-binding protein-related protein 8 (OSBPL8)	OTD50E5Y	OSBL8_HUMAN	Increases Expression	[35]
Oxysterol-binding protein-related protein 6 (OSBPL6)	OT0NCUUA	OSBL6_HUMAN	Increases Expression	[35]
Acidic mammalian chitinase (CHIA)	OT1SAVEW	CHIA_HUMAN	Increases Expression	[35]
Apoptosis facilitator Bcl-2-like protein 14 (BCL2L14)	OT87E7HW	B2L14_HUMAN	Increases Expression	[35]
cAMP-dependent protein kinase inhibitor beta (PKIB)	OT7C8GFN	IPKB_HUMAN	Decreases Expression	[35]
DNA-directed RNA polymerase II subunit RPB11-b1 (POLR2J3)	OTXTSHH8	RPB1B_HUMAN	Increases Expression	[35]
Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 (SLC6A16)	OT1MJ5BD	S6A16_HUMAN	Increases Expression	[35]
E3 ubiquitin-protein ligase makorin-2 (MKRN2)	OTDD1V3O	MKRN2_HUMAN	Increases Expression	[35]
NUAK family SNF1-like kinase 2 (NUAK2)	OTUEZLO8	NUAK2_HUMAN	Increases Expression	[35]
Cystatin-like 1 (CSTL1)	OTX1I8H9	CSTL1_HUMAN	Increases Expression	[35]
Homeobox protein aristaless-like 4 (ALX4)	OTNS9A29	ALX4_HUMAN	Increases Expression	[35]
Olfactory receptor 10A5 (OR10A5)	OTWL3XZ4	O10A5_HUMAN	Increases Expression	[35]
Cadherin-23 (CDH23)	OTOJGQ7S	CAD23_HUMAN	Increases Expression	[35]
Spectrin beta chain, non-erythrocytic 4 (SPTBN4)	OTAJAVP9	SPTN4_HUMAN	Decreases Expression	[35]
SH3 domain-binding glutamic acid-rich-like protein 3 (SH3BGRL3)	OTKMW34I	SH3L3_HUMAN	Decreases Expression	[35]
Membrane-spanning 4-domains subfamily A member 6A (MS4A6A)	OTK4BXQS	M4A6A_HUMAN	Increases Expression	[35]
Polyadenylate-binding protein 3 (PABPC3)	OTTR9DPT	PABP3_HUMAN	Increases Expression	[35]
tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (OSGEPL1)	OTT32BWT	OSGL1_HUMAN	Increases Expression	[35]
Protein salvador homolog 1 (SAV1)	OTSAEV92	SAV1_HUMAN	Increases Expression	[35]
PDZ domain-containing protein 7 (PDZD7)	OTX3VAOB	PDZD7_HUMAN	Increases Expression	[35]
Coiled-coil domain-containing protein 86 (CCDC86)	OT5YQ0R0	CCD86_HUMAN	Decreases Expression	[35]
Src-like-adapter 2 (SLA2)	OTNVE666	SLAP2_HUMAN	Increases Expression	[35]
Nucleolar protein 6 (NOL6)	OT6OIF2Q	NOL6_HUMAN	Increases Expression	[35]
E3 ubiquitin-protein ligase RNF167 (RNF167)	OTNNKBYS	RN167_HUMAN	Increases Expression	[35]
Tetratricopeptide repeat protein 12 (TTC12)	OTDB24YV	TTC12_HUMAN	Increases Expression	[35]
Metal transporter CNNM2 (CNNM2)	OTZHO8WU	CNNM2_HUMAN	Increases Expression	[35]
Sialate O-acetylesterase (SIAE)	OTDQUESH	SIAE_HUMAN	Increases Expression	[35]
Dual specificity protein kinase CLK4 (CLK4)	OTD38YJI	CLK4_HUMAN	Increases Expression	[35]
Potassium channel subfamily K member 12 (KCNK12)	OTFP82TK	KCNKC_HUMAN	Increases Expression	[35]
Cytochrome P450 4F11 (CYP4F11)	OTHZ2GG2	CP4FB_HUMAN	Decreases Expression	[35]
Popeye domain-containing protein 2 (POPDC2)	OTDAZSY5	POPD2_HUMAN	Increases Expression	[35]
Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2)	OTAQD3YV	ARNT2_HUMAN	Increases Expression	[35]
Sodium/potassium/calcium exchanger 3 (SLC24A3)	OTEJN38N	NCKX3_HUMAN	Increases Expression	[35]
Protein TANC2 (TANC2)	OTDXY7PX	TANC2_HUMAN	Increases Expression	[35]
Transient receptor potential cation channel subfamily M member 3 (TRPM3)	OTE4CDOQ	TRPM3_HUMAN	Increases Expression	[35]
p53-regulated apoptosis-inducing protein 1 (TP53AIP1)	OT1XVNDP	TPIP1_HUMAN	Increases Expression	[35]
Stromal cell-derived factor 2-like protein 1 (SDF2L1)	OTE7JIO2	SDF2L_HUMAN	Decreases Expression	[35]
Podocin (NPHS2)	OTLCNUII	PODO_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein mL65 (MRPS30)	OTDXIAGG	RT30_HUMAN	Increases Expression	[35]
Neugrin (NGRN)	OTP51NME	NGRN_HUMAN	Increases Expression	[35]
Nuclear receptor-interacting protein 3 (NRIP3)	OTU15GMK	NRIP3_HUMAN	Increases Expression	[35]
Transcription factor 7-like 2 (TCF7L2)	OTVWPZ8B	TF7L2_HUMAN	Increases Expression	[35]
Reticulon-4 (RTN4)	OTIH85O3	RTN4_HUMAN	Increases Expression	[35]
Ras-related GTP-binding protein D (RRAGD)	OTXLVWAH	RRAGD_HUMAN	Increases Expression	[35]
Kinesin-like protein KIF13B (KIF13B)	OTAFS1YV	KI13B_HUMAN	Increases Expression	[35]
DNA polymerase epsilon subunit 4 (POLE4)	OTCMWUT6	DPOE4_HUMAN	Increases Expression	[35]
Peroxisomal membrane protein 2 (PXMP2)	OTYHX5MI	PXMP2_HUMAN	Increases Expression	[35]
Dual oxidase 2 (DUOX2)	OTU14HCN	DUOX2_HUMAN	Increases Expression	[35]
Serine/threonine-protein kinase LATS2 (LATS2)	OT6XO8JP	LATS2_HUMAN	Increases Expression	[35]
Olfactomedin-like protein 3 (OLFML3)	OTDN45FN	OLFL3_HUMAN	Decreases Expression	[35]
Oligosaccharyltransferase complex subunit OSTC (OSTC)	OTT0823Y	OSTC_HUMAN	Decreases Expression	[35]
Serine incorporator 1 (SERINC1)	OTF3UASX	SERC1_HUMAN	Decreases Expression	[35]
Protein diaphanous homolog 3 (DIAPH3)	OTPOT23F	DIAP3_HUMAN	Increases Expression	[35]
Teneurin-2 (TENM2)	OTPLUYEF	TEN2_HUMAN	Increases Expression	[35]
PI-PLC X domain-containing protein 1 (PLCXD1)	OTU7KCQL	PLCX1_HUMAN	Decreases Expression	[35]
Protein lin-7 homolog C (LIN7C)	OTB3015O	LIN7C_HUMAN	Decreases Expression	[35]
Trimethyllysine dioxygenase, mitochondrial (TMLHE)	OTH4ZLJP	TMLH_HUMAN	Increases Expression	[35]
FGFR1 oncogene partner 2 (FGFR1OP2)	OTAHO1ZC	FGOP2_HUMAN	Increases Expression	[35]
CKLF-like MARVEL transmembrane domain-containing protein 6 (CMTM6)	OT70T27A	CKLF6_HUMAN	Increases Expression	[35]
Sphingomyelin phosphodiesterase 3 (SMPD3)	OTHQBETH	NSMA2_HUMAN	Increases Expression	[35]
Telomeric repeat-binding factor 2-interacting protein 1 (TERF2IP)	OT3M5P3G	TE2IP_HUMAN	Increases Expression	[35]
Peptidyl-prolyl cis-trans isomerase FKBP11 (FKBP11)	OTY2GC67	FKB11_HUMAN	Increases Expression	[35]
Cadherin EGF LAG seven-pass G-type receptor 1 (CELSR1)	OT7PS8O1	CELR1_HUMAN	Increases Expression	[35]
Formin-2 (FMN2)	OTUY7BSV	FMN2_HUMAN	Increases Expression	[35]
Glycolipid transfer protein (GLTP)	OTM78ZFI	GLTP_HUMAN	Decreases Expression	[35]
Sacsin (SACS)	OTZGXQ8A	SACS_HUMAN	Increases Expression	[35]
Bifunctional apoptosis regulator (BFAR)	OTTBG0V7	BFAR_HUMAN	Increases Expression	[35]
Thymocyte nuclear protein 1 (THYN1)	OTMRKMPD	THYN1_HUMAN	Increases Expression	[35]
Docking protein 5 (DOK5)	OT2XWUPN	DOK5_HUMAN	Increases Expression	[35]
NHS-like protein 3 (NHSL3)	OT48AES1	NHSL3_HUMAN	Increases Expression	[35]
E3 ubiquitin-protein ligase MARCHF4 (MARCHF4)	OTK43VNA	MARH4_HUMAN	Increases Expression	[35]
Ankyrin repeat and IBR domain-containing protein 1 (ANKIB1)	OTGKB7Y2	AKIB1_HUMAN	Increases Expression	[35]
Headcase protein homolog (HECA)	OTWG3P6C	HDC_HUMAN	Increases Expression	[35]
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A)	OTHCDQ22	PRGC1_HUMAN	Increases Expression	[35]
Dickkopf-related protein 3 (DKK3)	OTDU94EY	DKK3_HUMAN	Increases Expression	[35]
Voltage-dependent calcium channel gamma-5 subunit (CACNG5)	OTN4PGI5	CCG5_HUMAN	Increases Expression	[35]
Poly polymerase 2 (PARP2)	OTYL81ZI	PARP2_HUMAN	Increases Expression	[35]
AF4/FMR2 family member 4 (AFF4)	OTTL5Y8R	AFF4_HUMAN	Decreases Expression	[35]
Interleukin-19 (IL19)	OT9VGDIP	IL19_HUMAN	Increases Expression	[35]
Large neutral amino acids transporter small subunit 2 (SLC7A8)	OT8XXVO8	LAT2_HUMAN	Increases Expression	[35]
Transcription elongation factor A protein-like 9 (TCEAL9)	OT4UHDB5	TCAL9_HUMAN	Increases Expression	[35]
GPN-loop GTPase 3 (GPN3)	OTZ4584O	GPN3_HUMAN	Decreases Expression	[35]
Poly(U)-binding-splicing factor PUF60 (PUF60)	OTG90DYF	PUF60_HUMAN	Increases Expression	[35]
ATPase inhibitor, mitochondrial (ATP5IF1)	OTQFD73H	ATIF1_HUMAN	Increases Expression	[35]
Potassium voltage-gated channel subfamily G member 1 (KCNG1)	OTZ9ZRG8	KCNG1_HUMAN	Increases Expression	[35]
ERBB receptor feedback inhibitor 1 (ERRFI1)	OT7VZ2IZ	ERRFI_HUMAN	Decreases Expression	[35]
F-box/LRR-repeat protein 4 (FBXL4)	OTZECCIQ	FBXL4_HUMAN	Increases Expression	[35]
Disintegrin and metalloproteinase domain-containing protein 29 (ADAM29)	OTGLTTKU	ADA29_HUMAN	Increases Expression	[35]
Integrator complex subunit 6 (INTS6)	OT6GDV46	INT6_HUMAN	Increases Expression	[35]
Ras-related protein Rab-21 (RAB21)	OTH3WGLG	RAB21_HUMAN	Increases Expression	[35]
Myelin transcription factor 1-like protein (MYT1L)	OTV45MAS	MYT1L_HUMAN	Decreases Expression	[35]
Malignant T-cell-amplified sequence 1 (MCTS1)	OT7SAOJP	MCTS1_HUMAN	Increases Expression	[35]
Pleckstrin homology domain-containing family G member 1 (PLEKHG1)	OTDVYW2F	PKHG1_HUMAN	Decreases Expression	[35]
A-kinase anchor protein 8-like (AKAP8L)	OTM3ZHGU	AKP8L_HUMAN	Increases Expression	[35]
TP53-target gene 3 protein (TP53TG3)	OTWS7OY4	T53G3_HUMAN	Increases Expression	[35]
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide (DAPP1)	OTZTE1PG	DAPP1_HUMAN	Increases Expression	[35]
Protein timeless homolog (TIMELESS)	OTD8DCBJ	TIM_HUMAN	Decreases Expression	[35]
Frizzled-1 (FZD1)	OTZATHVS	FZD1_HUMAN	Decreases Expression	[35]
Conserved oligomeric Golgi complex subunit 5 (COG5)	OTZEG7K0	COG5_HUMAN	Increases Expression	[35]
Zinc finger protein PLAGL2 (PLAGL2)	OT6AP4V2	PLAL2_HUMAN	Increases Expression	[35]
C-type lectin domain family 11 member A (CLEC11A)	OT9KBH7C	CLC11_HUMAN	Decreases Expression	[35]
HIG1 domain family member 1A, mitochondrial (HIGD1A)	OTS351DV	HIG1A_HUMAN	Increases Expression	[35]
Sialic acid-binding Ig-like lectin 7 (SIGLEC7)	OTNDLURR	SIGL7_HUMAN	Increases Expression	[35]
Integral membrane protein 2B (ITM2B)	OTMXEPXB	ITM2B_HUMAN	Increases Expression	[35]
Sodium-dependent multivitamin transporter (SLC5A6)	OT77CX29	SC5A6_HUMAN	Increases Expression	[35]
Nck-associated protein 1 (NCKAP1)	OTEZQXXJ	NCKP1_HUMAN	Increases Expression	[35]
PALM2-AKAP2 fusion protein (PALM2AKAP2)	OTI618VF	PLAK2_HUMAN	Decreases Expression	[35]
Serine/threonine-protein kinase 38-like (STK38L)	OTI00JVW	ST38L_HUMAN	Increases Expression	[35]
Lysine-specific demethylase 2A (KDM2A)	OTNNSM9P	KDM2A_HUMAN	Increases Expression	[35]
Polymerase delta-interacting protein 2 (POLDIP2)	OT8SZSJ6	PDIP2_HUMAN	Increases Expression	[35]
Krueppel-like factor 13 (KLF13)	OTMIKHZ4	KLF13_HUMAN	Decreases Expression	[35]
Protein SGT1 homolog (SUGT1)	OTPBEOEB	SGT1_HUMAN	Decreases Expression	[35]
Ras-related protein Rap-2c (RAP2C)	OT4HBPHE	RAP2C_HUMAN	Increases Expression	[35]
Kinesin-like protein KIF3A (KIF3A)	OTMUBSSK	KIF3A_HUMAN	Increases Expression	[35]
Lysine-specific demethylase 3A (KDM3A)	OTZYJ8VN	KDM3A_HUMAN	Increases Expression	[35]
G-protein-signaling modulator 3 (GPSM3)	OT2MO458	GPSM3_HUMAN	Decreases Expression	[35]
Protein phosphatase methylesterase 1 (PPME1)	OTBSUOL8	PPME1_HUMAN	Increases Expression	[35]
FH1/FH2 domain-containing protein 1 (FHOD1)	OTROM7N3	FHOD1_HUMAN	Decreases Expression	[35]
Protein O-mannosyl-transferase 1 (POMT1)	OTGQSHL5	POMT1_HUMAN	Decreases Expression	[35]
EP300-interacting inhibitor of differentiation 1 (EID1)	OT3OI5H4	EID1_HUMAN	Increases Expression	[35]
Serine/threonine-protein kinase 24 (STK24)	OTGUHOIL	STK24_HUMAN	Increases Expression	[35]
Large ribosomal subunit protein mL42 (MRPL42)	OTD5RXDI	RM42_HUMAN	Decreases Expression	[35]
Calcineurin-binding protein cabin-1 (CABIN1)	OT4G5CIK	CABIN_HUMAN	Decreases Expression	[35]
Catalase (CAT)	OTHEBX9R	CATA_HUMAN	Decreases Expression	[94]
Target of Myb1 membrane trafficking protein (TOM1)	OT30QA56	TOM1_HUMAN	Decreases Expression	[37]
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (GCNT3)	OTQ9ALTR	GCNT3_HUMAN	Decreases Expression	[37]
Fibroblast growth factor 1 (FGF1)	OT8I64X8	FGF1_HUMAN	Decreases Expression	[37]
Ribosyldihydronicotinamide dehydrogenase (NQO2)	OTGDAJRZ	NQO2_HUMAN	Increases Expression	[37]
Homeobox protein Hox-A5 (HOXA5)	OTLWGPQD	HXA5_HUMAN	Decreases Expression	[37]
Serine/threonine-protein kinase MAK (MAK)	OTEU2G41	MAK_HUMAN	Decreases Expression	[37]
Cysteine and glycine-rich protein 1 (CSRP1)	OTUS7RM2	CSRP1_HUMAN	Decreases Expression	[37]
Interleukin-1 receptor type 2 (IL1R2)	OT0G7E35	IL1R2_HUMAN	Increases Expression	[37]
Neuroendocrine convertase 1 (PCSK1)	OTPBRJ54	NEC1_HUMAN	Increases Expression	[37]
cAMP-dependent protein kinase type I-beta regulatory subunit (PRKAR1B)	OT777OHS	KAP1_HUMAN	Decreases Expression	[37]
Nuclear pore complex protein Nup153 (NUP153)	OTCAS0AR	NU153_HUMAN	Decreases Expression	[37]
Aldo-keto reductase family 1 member C2 (AKR1C2)	OTQ2XMO3	AK1C2_HUMAN	Increases Expression	[37]
Uncharacterized protein C22orf42 (C22ORF42)	OTBT0463	CV042_HUMAN	Increases Expression	[37]
Insulin growth factor-like family member 1 (IGFL1)	OT0QQU8C	IGFL1_HUMAN	Increases Expression	[37]
Putative glycosyltransferase 6 domain-containing protein 1 (GLT6D1)	OT4PFC15	GL6D1_HUMAN	Increases Expression	[37]
Signal peptide peptidase-like 2C (SPPL2C)	OTUTY2ED	SPP2C_HUMAN	Decreases Expression	[37]
Kelch domain-containing protein 8A (KLHDC8A)	OTIZA3AM	KLD8A_HUMAN	Increases Expression	[37]
Coiled-coil domain-containing protein 150 (CCDC150)	OT6YEW3D	CC150_HUMAN	Decreases Expression	[37]
5'(3')-deoxyribonucleotidase, cytosolic type (NT5C)	OTFN3RPP	NT5C_HUMAN	Decreases Expression	[37]
Apoptosis-stimulating of p53 protein 1 (PPP1R13B)	OTC88VQO	ASPP1_HUMAN	Decreases Expression	[37]
PHD finger protein 12 (PHF12)	OTECRO7N	PHF12_HUMAN	Decreases Expression	[37]
Chloride channel CLIC-like protein 1 (CLCC1)	OTTXCXVT	CLCC1_HUMAN	Decreases Expression	[37]
MAP kinase-interacting serine/threonine-protein kinase 1 (MKNK1)	OTGBRJDQ	MKNK1_HUMAN	Decreases Expression	[37]
Transmembrane protein 70, mitochondrial (TMEM70)	OTLTKYXG	TMM70_HUMAN	Increases Expression	[37]
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (AGPAT4)	OT5CTQKO	PLCD_HUMAN	Increases Expression	[37]
C-type mannose receptor 2 (MRC2)	OTLWQAX1	MRC2_HUMAN	Decreases Expression	[37]
Guanine deaminase (GDA)	OTW394V5	GUAD_HUMAN	Decreases Expression	[37]
Serine-threonine kinase receptor-associated protein (STRAP)	OTT3T7QT	STRAP_HUMAN	Increases Expression	[37]
Phospholipid phosphatase 1 (PLPP1)	OT0IIMI5	PLPP1_HUMAN	Increases Expression	[38]
Acyl carrier protein, mitochondrial (NDUFAB1)	OTF906UR	ACPM_HUMAN	Increases Expression	[38]
Ectoderm-neural cortex protein 1 (ENC1)	OTJEUB6U	ENC1_HUMAN	Decreases Expression	[38]
17-beta-hydroxysteroid dehydrogenase type 6 (HSD17B6)	OTSB55D2	H17B6_HUMAN	Increases Expression	[38]
Long-chain fatty acid transport protein 2 (SLC27A2)	OT7JEG5F	S27A2_HUMAN	Increases Expression	[38]
Serine protease HTRA2, mitochondrial (HTRA2)	OTC7616F	HTRA2_HUMAN	Increases Expression	[38]
Forkhead box protein O3 (FOXO3)	OTHXQG4P	FOXO3_HUMAN	Decreases Expression	[38]
S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1)	OTX8L3M5	SAHH2_HUMAN	Increases Expression	[38]
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (PDE8A)	OT4RF9Z4	PDE8A_HUMAN	Increases Expression	[38]
Checkpoint protein HUS1 (HUS1)	OTY1XON9	HUS1_HUMAN	Increases Expression	[38]
ICOS ligand (ICOSLG)	OTAD976B	ICOSL_HUMAN	Decreases Expression	[38]
NADH dehydrogenase iron-sulfur protein 2, mitochondrial (NDUFS2)	OTBT8KW9	NDUS2_HUMAN	Increases Expression	[38]
Claudin-11 (CLDN11)	OTNN6UTL	CLD11_HUMAN	Decreases Expression	[38]
Protein phosphatase 1 regulatory subunit 15A (PPP1R15A)	OTYG179K	PR15A_HUMAN	Decreases Expression	[38]
Calsyntenin-1 (CLSTN1)	OTQN35G2	CSTN1_HUMAN	Decreases Expression	[38]
NADH dehydrogenase 1 alpha subcomplex subunit 10, mitochondrial (NDUFA10)	OTBURQ3A	NDUAA_HUMAN	Increases Expression	[38]
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2)	OTDLEXPN	PAPS2_HUMAN	Increases Expression	[38]
Tumor necrosis factor receptor superfamily member 6B (TNFRSF6B)	OTKAN9G7	TNF6B_HUMAN	Decreases Expression	[38]
Protein transport protein Sec24B (SEC24B)	OT6W8CWP	SC24B_HUMAN	Increases Expression	[38]
Protein phosphatase 1 regulatory subunit 3D (PPP1R3D)	OTZNC7R2	PPR3D_HUMAN	Decreases Expression	[38]
Chromobox protein homolog 7 (CBX7)	OTNELDIB	CBX7_HUMAN	Decreases Expression	[38]
Methyl-CpG-binding domain protein 3 (MBD3)	OTRL76H5	MBD3_HUMAN	Decreases Expression	[38]
Anterior gradient protein 2 homolog (AGR2)	OTRRZT7W	AGR2_HUMAN	Increases Expression	[38]
Serine/threonine-protein kinase Chk2 (CHEK2)	OT8ZPCNS	CHK2_HUMAN	Increases Expression	[38]
Phosphoglycerate kinase 1 (PGK1)	OT6V1ICH	PGK1_HUMAN	Increases Expression	[38]
Apolipoprotein E (APOE)	OTFOWL2H	APOE_HUMAN	Decreases Expression	[38]
Metallothionein-2 (MT2A)	OTHOACHD	MT2_HUMAN	Decreases Expression	[38]
Annexin A1 (ANXA1)	OT5OFDJC	ANXA1_HUMAN	Increases Expression	[38]
Superoxide dismutase , mitochondrial (SOD2)	OTIWXGZ9	SODM_HUMAN	Increases Expression	[38]
Metallothionein-1F (MT1F)	OTZVUYG1	MT1F_HUMAN	Decreases Expression	[38]
Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCA)	OTWJTCRK	PCCA_HUMAN	Increases Expression	[38]
Glucose-6-phosphate isomerase (GPI)	OTEGSRXG	G6PI_HUMAN	Increases Expression	[38]
Histone H1.0 (H1-0)	OTRLJK4Z	H10_HUMAN	Decreases Expression	[38]
Metallothionein-1B (MT1B)	OTUA4FFH	MT1B_HUMAN	Decreases Expression	[38]
Fumarate hydratase, mitochondrial (FH)	OTEQWU6Q	FUMH_HUMAN	Increases Expression	[38]
Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (PDHA1)	OTGEU8IK	ODPA_HUMAN	Increases Expression	[38]
Monocyte differentiation antigen CD14 (CD14)	OT83GJ47	CD14_HUMAN	Decreases Expression	[38]
Cytochrome c1, heme protein, mitochondrial (CYC1)	OT0962IM	CY1_HUMAN	Increases Expression	[38]
Fibroblast growth factor 2 (FGF2)	OT7YUJ9F	FGF2_HUMAN	Decreases Expression	[38]
cAMP-dependent protein kinase type I-alpha regulatory subunit (PRKAR1A)	OT589JA2	KAP0_HUMAN	Increases Expression	[38]
Clusterin (CLU)	OTQGG0JM	CLUS_HUMAN	Increases Expression	[38]
Solute carrier family 2, facilitated glucose transporter member 3 (SLC2A3)	OT2HZK5M	GTR3_HUMAN	Increases Expression	[38]
Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2)	OTPG0K7E	IMDH2_HUMAN	Increases Expression	[38]
Plastin-2 (LCP1)	OTK61F2A	PLSL_HUMAN	Increases Expression	[38]
Electron transfer flavoprotein subunit alpha, mitochondrial (ETFA)	OTXX61VZ	ETFA_HUMAN	Increases Expression	[38]
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)	OT18H1B0	ERF3A_HUMAN	Increases Expression	[38]
Ezrin (EZR)	OTHBPF1Z	EZRI_HUMAN	Increases Expression	[38]
Tyrosine-protein phosphatase non-receptor type 1 (PTPN1)	OTO4ZVIA	PTN1_HUMAN	Decreases Expression	[38]
General transcription and DNA repair factor IIH helicase subunit XPD (ERCC2)	OT1C8HQ4	ERCC2_HUMAN	Decreases Expression	[38]
Cytochrome c oxidase subunit 5A, mitochondrial (COX5A)	OTP0961M	COX5A_HUMAN	Increases Expression	[38]
Cyclin-dependent kinase 11B (CDK11B)	OTN9ZP68	CD11B_HUMAN	Decreases Expression	[38]
Glutathione S-transferase Mu 3 (GSTM3)	OTLA2WJT	GSTM3_HUMAN	Increases Expression	[38]
5'-nucleotidase (NT5E)	OT7J5LT6	5NTD_HUMAN	Decreases Expression	[38]
Trifunctional purine biosynthetic protein adenosine-3 (GART)	OT01JWJB	PUR2_HUMAN	Increases Expression	[38]
Receptor-type tyrosine-protein phosphatase epsilon (PTPRE)	OTOD5NID	PTPRE_HUMAN	Increases Expression	[38]
Adenosylhomocysteinase (AHCY)	OT8UC40I	SAHH_HUMAN	Increases Expression	[38]
Interleukin-4 receptor subunit alpha (IL4R)	OTTXOTCW	IL4RA_HUMAN	Decreases Expression	[38]
Acetyl-CoA acetyltransferase, mitochondrial (ACAT1)	OTJC60Q7	THIL_HUMAN	Increases Expression	[38]
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (NDUFS1)	OTTIZDFR	NDUS1_HUMAN	Increases Expression	[38]
Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	OTJ8UM8O	TNR8_HUMAN	Increases Expression	[38]
SHC-transforming protein 1 (SHC1)	OT1J5IRN	SHC1_HUMAN	Increases Expression	[38]
Guanine nucleotide-binding protein subunit alpha-11 (GNA11)	OT0K99TO	GNA11_HUMAN	Decreases Expression	[38]
NK-tumor recognition protein (NKTR)	OTIADJNW	NKTR_HUMAN	Decreases Expression	[38]
Aldehyde dehydrogenase X, mitochondrial (ALDH1B1)	OTXW9TE2	AL1B1_HUMAN	Increases Expression	[38]
3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH)	OTCMMMIZ	3HIDH_HUMAN	Increases Expression	[38]
ATP synthase subunit gamma, mitochondrial (ATP5F1C)	OTV5GZK5	ATPG_HUMAN	Increases Expression	[38]
Macrophage-capping protein (CAPG)	OTJ86KI6	CAPG_HUMAN	Increases Expression	[38]
C-X-C motif chemokine 5 (CXCL5)	OTZOUPCA	CXCL5_HUMAN	Increases Expression	[38]
Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD2)	OTV232Y7	GPDM_HUMAN	Increases Expression	[38]
Nestin (NES)	OTZ9PZ14	NEST_HUMAN	Increases Expression	[38]
Glycogen synthase kinase-3 beta (GSK3B)	OTL3L14B	GSK3B_HUMAN	Increases Expression	[38]
Sulfotransferase 1A1 (SULT1A1)	OT0K7JIE	ST1A1_HUMAN	Increases Expression	[38]
Sulfotransferase 1A2 (SULT1A2)	OT7EJ6LQ	ST1A2_HUMAN	Increases Expression	[38]
Carnitine O-palmitoyltransferase 1, liver isoform (CPT1A)	OTI862QH	CPT1A_HUMAN	Increases Expression	[38]
Spermine synthase (SMS)	OT8JYKNH	SPSY_HUMAN	Increases Expression	[38]
Mismatch repair endonuclease PMS2 (PMS2)	OTNLWTMI	PMS2_HUMAN	Increases Expression	[38]
Histone deacetylase 4 (HDAC4)	OTQNGD32	HDAC4_HUMAN	Increases Expression	[38]
Beta-secretase 1 (BACE1)	OTCA7B6A	BACE1_HUMAN	Decreases Expression	[38]
Ras-related protein Rab-15 (RAB15)	OTU0GGR3	RAB15_HUMAN	Decreases Expression	[38]
Actin-related protein 3 (ACTR3)	OT05LJSH	ARP3_HUMAN	Increases Expression	[38]
Fibroblast growth factor 12 (FGF12)	OTBM9QIO	FGF12_HUMAN	Increases Expression	[38]
Transforming protein RhoA (RHOA)	OT6YOJ9N	RHOA_HUMAN	Increases Expression	[38]
Histone H4 (H4C1)	OTB71W46	H4_HUMAN	Decreases Expression	[38]
Transformer-2 protein homolog beta (TRA2B)	OTZYQW52	TRA2B_HUMAN	Decreases Expression	[38]
Gamma-aminobutyric acid receptor subunit epsilon (GABRE)	OTXF5ICU	GBRE_HUMAN	Decreases Expression	[38]
DENN domain-containing protein 2B (DENND2B)	OT7UH61B	DEN2B_HUMAN	Decreases Expression	[38]
Sushi repeat-containing protein SRPX (SRPX)	OT5B9LXS	SRPX_HUMAN	Increases Expression	[38]
Metallothionein-1X (MT1X)	OT9AKFVS	MT1X_HUMAN	Decreases Expression	[38]
Disabled homolog 2 (DAB2)	OTRMQTMZ	DAB2_HUMAN	Decreases Expression	[38]
Cytochrome c (CYCS)	OTBFALJD	CYC_HUMAN	Increases Expression	[38]
Beta-1,4 N-acetylgalactosaminyltransferase 1 (B4GALNT1)	OTCY80HS	B4GN1_HUMAN	Increases Expression	[38]
Fatty acid-binding protein 5 (FABP5)	OTNM186C	FABP5_HUMAN	Increases Expression	[38]
N-acylethanolamine-hydrolyzing acid amidase (NAAA)	OTS2PQ0O	NAAA_HUMAN	Increases Expression	[38]
Pro-neuregulin-1, membrane-bound isoform (NRG1)	OTZO6F1X	NRG1_HUMAN	Increases Expression	[38]
D-beta-hydroxybutyrate dehydrogenase, mitochondrial (BDH1)	OT62RL5P	BDH_HUMAN	Decreases Expression	[38]
Collagen alpha-1(VII) chain (COL7A1)	OT3MIRZJ	CO7A1_HUMAN	Decreases Expression	[38]
Dual specificity mitogen-activated protein kinase kinase 1 (MAP2K1)	OT4Y9NQI	MP2K1_HUMAN	Increases Expression	[38]
Dystonin (DST)	OTHZBM4X	DYST_HUMAN	Increases Expression	[38]
Glutathione S-transferase Mu 4 (GSTM4)	OTOTF8DU	GSTM4_HUMAN	Increases Expression	[38]
Amidophosphoribosyltransferase (PPAT)	OTXK12ZB	PUR1_HUMAN	Increases Expression	[38]
Prolow-density lipoprotein receptor-related protein 1 (LRP1)	OTHTEH4G	LRP1_HUMAN	Decreases Expression	[38]
3',5'-cyclic-AMP phosphodiesterase 4D (PDE4D)	OT1RWFV0	PDE4D_HUMAN	Increases Expression	[38]
Dihydropyrimidine dehydrogenase (DPYD)	OTWRF2NR	DPYD_HUMAN	Increases Expression	[38]
Protoheme IX farnesyltransferase, mitochondrial (COX10)	OTCYIS0L	COX10_HUMAN	Increases Expression	[38]
Heat shock protein 75 kDa, mitochondrial (TRAP1)	OTNG0L8J	TRAP1_HUMAN	Increases Expression	[38]
S-methyl-5'-thioadenosine phosphorylase (MTAP)	OTOWN2K9	MTAP_HUMAN	Increases Expression	[38]
DNA excision repair protein ERCC-8 (ERCC8)	OT0T4WKI	ERCC8_HUMAN	Increases Expression	[38]
Pappalysin-1 (PAPPA)	OTTTG9PG	PAPP1_HUMAN	Decreases Expression	[38]
Frizzled-5 (FZD5)	OTXFFY56	FZD5_HUMAN	Increases Expression	[38]
Proteasome activator complex subunit 4 (PSME4)	OTDGF53O	PSME4_HUMAN	Increases Expression	[38]
Pericentriolar material 1 protein (PCM1)	OTFM133C	PCM1_HUMAN	Decreases Expression	[38]
2,4-dienoyl-CoA reductase , mitochondrial (DECR1)	OTCDIR6X	DECR_HUMAN	Increases Expression	[38]
NADH dehydrogenase 1 alpha subcomplex subunit 9, mitochondrial (NDUFA9)	OTMKQJJ8	NDUA9_HUMAN	Increases Expression	[38]
PWWP domain-containing DNA repair factor 3A (PWWP3A)	OTXQVL4U	PWP3A_HUMAN	Decreases Expression	[38]
Akirin-2 (AKIRIN2)	OTQ6WSKW	AKIR2_HUMAN	Increases Expression	[38]
Disabled homolog 2-interacting protein (DAB2IP)	OTF456VC	DAB2P_HUMAN	Decreases Expression	[38]
Muscleblind-like protein 2 (MBNL2)	OTF7CF1F	MBNL2_HUMAN	Increases Expression	[38]
Pyridoxal-dependent decarboxylase domain-containing protein 1 (PDXDC1)	OTKH7U5Q	PDXD1_HUMAN	Increases Expression	[38]
Monofunctional C1-tetrahydrofolate synthase, mitochondrial (MTHFD1L)	OTV01EFP	C1TM_HUMAN	Increases Expression	[38]
Ankyrin repeat domain-containing protein 11 (ANKRD11)	OTV0V70M	ANR11_HUMAN	Decreases Expression	[38]
Heme A synthase COX15 (COX15)	OTUIYHIW	COX15_HUMAN	Increases Expression	[38]
eIF5-mimic protein 2 (BZW1)	OT4GUFIG	5MP2_HUMAN	Increases Expression	[38]
Lipolysis-stimulated lipoprotein receptor (LSR)	OTR8Y32X	LSR_HUMAN	Decreases Expression	[38]
RNA-binding protein MEX3D (MEX3D)	OTAUWRK7	MEX3D_HUMAN	Decreases Expression	[38]
5'-3' exonuclease PLD3 (PLD3)	OTL07SP2	PLD3_HUMAN	Decreases Expression	[38]
LIX1-like protein (LIX1L)	OTAK119S	LIX1L_HUMAN	Increases Expression	[38]
GRIP and coiled-coil domain-containing protein 2 (GCC2)	OTT5I9FM	GCC2_HUMAN	Increases Expression	[38]
Extracellular sulfatase Sulf-2 (SULF2)	OTIXMUVL	SULF2_HUMAN	Decreases Expression	[38]
Extracellular serine/threonine protein kinase FAM20C (FAM20C)	OTW5YZ7X	FA20C_HUMAN	Decreases Expression	[38]
Tensin-4 (TNS4)	OT32OZ75	TENS4_HUMAN	Increases Expression	[38]
Aminopeptidase O (AOPEP)	OT0MMANL	AMPO_HUMAN	Increases Expression	[38]
Interleukin-22 receptor subunit alpha-1 (IL22RA1)	OTGVKLBR	I22R1_HUMAN	Increases Expression	[38]
Protein enabled homolog (ENAH)	OTU49OK5	ENAH_HUMAN	Increases Expression	[38]
Histone-lysine N-methyltransferase 2C (KMT2C)	OTC59BCO	KMT2C_HUMAN	Increases Expression	[38]
Nuclear receptor coactivator 7 (NCOA7)	OT2CNBOG	NCOA7_HUMAN	Increases Expression	[38]
Serine/threonine-protein kinase Nek7 (NEK7)	OTGAB77A	NEK7_HUMAN	Increases Expression	[38]
Elongator complex protein 5 (ELP5)	OTW5R7YD	ELP5_HUMAN	Increases Expression	[38]
Secreted and transmembrane protein 1 (SECTM1)	OT5500CF	SCTM1_HUMAN	Decreases Expression	[38]
Microprocessor complex subunit DGCR8 (DGCR8)	OT62LXE4	DGCR8_HUMAN	Decreases Expression	[38]
Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1B)	OTDNRW37	CPT1B_HUMAN	Decreases Expression	[38]
Homeobox protein DLX-4 (DLX4)	OTLWVCN4	DLX4_HUMAN	Decreases Expression	[38]
Major histocompatibility complex class I-related gene protein (MR1)	OTZU3XX7	HMR1_HUMAN	Increases Expression	[38]
Kinesin-like protein KIFC2 (KIFC2)	OTLTVM7V	KIFC2_HUMAN	Decreases Expression	[38]
Secreted frizzled-related protein 2 (SFRP2)	OT8GZ0CA	SFRP2_HUMAN	Decreases Expression	[38]
Kinetochore-associated protein NSL1 homolog (NSL1)	OT5L56A1	NSL1_HUMAN	Increases Expression	[38]
ADP-ribosylation factor-like protein 5B (ARL5B)	OTYYBIDG	ARL5B_HUMAN	Increases Expression	[38]
Histone-lysine N-methyltransferase EHMT2 (EHMT2)	OTC4DWB6	EHMT2_HUMAN	Decreases Expression	[38]
Protein PRRC1 (PRRC1)	OT3YMI6Z	PRRC1_HUMAN	Increases Expression	[38]
Serine/threonine-protein kinase Nek1 (NEK1)	OTBUCUW6	NEK1_HUMAN	Increases Expression	[38]
Remodeling and spacing factor 1 (RSF1)	OTA1HKVP	RSF1_HUMAN	Decreases Expression	[38]
Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (SDHC)	OTC8G2MX	C560_HUMAN	Increases Expression	[38]
RANBP2-like and GRIP domain-containing protein 5/6 (RGPD6)	OT1KQSOB	RGPD5_HUMAN	Increases Expression	[38]
Calcium and integrin-binding protein 1 (CIB1)	OT4BVCRU	CIB1_HUMAN	Increases Expression	[38]
Histone H4 transcription factor (HINFP)	OTLNEEPK	HINFP_HUMAN	Decreases Expression	[38]
Single-stranded DNA-binding protein 3 (SSBP3)	OTJRGHFG	SSBP3_HUMAN	Decreases Expression	[38]
Receptor for retinol uptake STRA6 (STRA6)	OT2IDF27	STRA6_HUMAN	Decreases Expression	[38]
Histone deacetylase 8 (HDAC8)	OT5L4RYX	HDAC8_HUMAN	Increases Expression	[38]
Histone-lysine N-methyltransferase NSD3 (NSD3)	OT3677ZG	NSD3_HUMAN	Decreases Expression	[38]
Opsin-3 (OPN3)	OTON6BFU	OPN3_HUMAN	Increases Expression	[38]
Band 4.1-like protein 4B (EPB41L4B)	OT2K30P7	E41LB_HUMAN	Increases Expression	[38]
Transmembrane protein 245 (TMEM245)	OTR7KEXW	TM245_HUMAN	Increases Expression	[38]
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1)	OTYEJAGZ	GPT_HUMAN	Increases Expression	[38]
TATA box-binding protein-associated factor RNA polymerase I subunit D (TAF1D)	OTOXUDV1	TAF1D_HUMAN	Increases Expression	[38]
Anthrax toxin receptor 1 (ANTXR1)	OT5W1GPC	ANTR1_HUMAN	Increases Expression	[38]
Histone-lysine N-methyltransferase SMYD3 (SMYD3)	OT9YR20G	SMYD3_HUMAN	Increases Expression	[38]
Splicing factor, arginine/serine-rich 19 (SCAF1)	OT16TM3N	SFR19_HUMAN	Decreases Expression	[38]
Histone acetyltransferase KAT8 (KAT8)	OT5LPQTR	KAT8_HUMAN	Increases Expression	[38]
Ceramide synthase 4 (CERS4)	OTV5ENAX	CERS4_HUMAN	Decreases Expression	[38]
Placenta-specific protein 1 (PLAC1)	OTWRWYVK	PLAC1_HUMAN	Increases Expression	[38]
DNA polymerase delta subunit 4 (POLD4)	OTG578YH	DPOD4_HUMAN	Increases Expression	[38]
Nectin-3 (NECTIN3)	OTS8N7MK	NECT3_HUMAN	Decreases Expression	[38]
Tyrosyl-DNA phosphodiesterase 1 (TDP1)	OTYINMBR	TYDP1_HUMAN	Increases Expression	[38]
Required for meiotic nuclear division protein 1 homolog (RMND1)	OT7I6RBT	RMND1_HUMAN	Increases Expression	[38]
DNA damage-inducible transcript 4 protein (DDIT4)	OTHY8SY4	DDIT4_HUMAN	Increases Expression	[38]
Abl interactor 2 (ABI2)	OT8GIIS5	ABI2_HUMAN	Increases Expression	[38]
Core histone macro-H2A.2 (MACROH2A2)	OTAKSVYV	H2AW_HUMAN	Decreases Expression	[38]
Alpha-catulin (CTNNAL1)	OTESJ6JD	CTNL1_HUMAN	Increases Expression	[38]
Serine/threonine-protein kinase 17A (STK17A)	OTS87MOT	ST17A_HUMAN	Increases Expression	[38]
A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1)	OTTLJH8W	ATS1_HUMAN	Increases Expression	[38]
C-type lectin domain family 2 member D (CLEC2D)	OTVRLKPM	CLC2D_HUMAN	Increases Expression	[38]
Jupiter microtubule associated homolog 1 (JPT1)	OT6CRZEU	JUPI1_HUMAN	Increases Expression	[38]
Protein NDRG4 (NDRG4)	OTJBOTD8	NDRG4_HUMAN	Increases Expression	[38]
Unconventional myosin-Vb (MYO5B)	OTCKL3W3	MYO5B_HUMAN	Increases Expression	[38]
Potassium channel subfamily K member 6 (KCNK6)	OTCY281R	KCNK6_HUMAN	Decreases Expression	[38]
Disks large-associated protein 4 (DLGAP4)	OTNELLIN	DLGP4_HUMAN	Decreases Expression	[38]
Acyl-coenzyme A thioesterase 9, mitochondrial (ACOT9)	OTBOQE6N	ACOT9_HUMAN	Increases Expression	[38]
Complex I intermediate-associated protein 30, mitochondrial (NDUFAF1)	OTYK9JU6	CIA30_HUMAN	Increases Expression	[38]
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2)	OT4ZSEEE	IF2B2_HUMAN	Decreases Expression	[38]
Cytochrome c oxidase assembly protein COX11, mitochondrial (COX11)	OT0N3WL9	COX11_HUMAN	Increases Expression	[38]
Sestrin-1 (SESN1)	OTSFDZWL	SESN1_HUMAN	Increases Expression	[38]
MAU2 chromatid cohesion factor homolog (MAU2)	OTALDF8Q	SCC4_HUMAN	Decreases Expression	[38]
Interleukin-1 beta (IL1B)	OT0DWXXB	IL1B_HUMAN	Decreases Expression	[95]
Interleukin-11 (IL11)	OTXHN86R	IL11_HUMAN	Increases Expression	[95]
Proteinase-activated receptor 1 (F2R)	OT4WVWBO	PAR1_HUMAN	Increases Expression	[95]
Caldesmon (CALD1)	OTNJKJ6Q	CALD1_HUMAN	Increases Expression	[95]
Metallothionein-1A (MT1A)	OTKBH52X	MT1A_HUMAN	Decreases Expression	[96]
Metallothionein-1E (MT1E)	OTXJKU4Y	MT1E_HUMAN	Decreases Expression	[96]
Metallothionein-3 (MT3)	OTVCZ7HI	MT3_HUMAN	Decreases Expression	[96]
Carbonyl reductase 1 (CBR1)	OTQ3A541	CBR1_HUMAN	Increases Expression	[97]
Caspase-9 (CASP9)	OTD4RFFG	CASP9_HUMAN	Decreases Expression	[98]
N-arachidonyl glycine receptor (GPR18)	OTL2VFIV	GPR18_HUMAN	Increases Expression	[99]
Glutathione-specific gamma-glutamylcyclotransferase 1 (CHAC1)	OTJGE772	CHAC1_HUMAN	Increases Expression	[99]
Large neutral amino acids transporter small subunit 3 (SLC43A1)	OTQJQY3S	LAT3_HUMAN	Increases Expression	[39]
Signal transducing adapter molecule 2 (STAM2)	OT9OBWPH	STAM2_HUMAN	Increases Expression	[39]
Amino acid transporter heavy chain SLC3A2 (SLC3A2)	OTBR33M9	4F2_HUMAN	Increases Expression	[39]
Endoplasmic reticulum chaperone BiP (HSPA5)	OTFUIRAO	BIP_HUMAN	Decreases Expression	[39]
Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial (MTHFD2)	OT1LQSGX	MTDC_HUMAN	Increases Expression	[39]
Protein EVI2A (EVI2A)	OTR8RUXQ	EVI2A_HUMAN	Increases Expression	[39]
B-cell lymphoma 6 protein (BCL6)	OTQAWWO1	BCL6_HUMAN	Increases Expression	[39]
Sestrin-2 (SESN2)	OT889IXY	SESN2_HUMAN	Increases Expression	[39]
Transmembrane protein 267 (TMEM267)	OTEAAVK7	TM267_HUMAN	Increases Expression	[39]
Uracil nucleotide/cysteinyl leukotriene receptor (GPR17)	OT02OX35	GPR17_HUMAN	Decreases Expression	[39]
Inactive phospholipase C-like protein 1 (PLCL1)	OTJL2C79	PLCL1_HUMAN	Increases Expression	[39]
Transmembrane protein 177 (TMEM177)	OT3KLW01	TM177_HUMAN	Decreases Expression	[39]
Protein shisa-2 homolog (SHISA2)	OT4GMTML	SHSA2_HUMAN	Decreases Expression	[39]
Prostamide/prostaglandin F synthase (PRXL2B)	OTY5G543	PXL2B_HUMAN	Decreases Expression	[39]
Alanine aminotransferase 2 (GPT2)	OTS5VF7N	ALAT2_HUMAN	Increases Expression	[39]
F-box only protein 32 (FBXO32)	OTUE978R	FBX32_HUMAN	Increases Expression	[39]
Insulin gene enhancer protein ISL-2 (ISL2)	OT43PD2V	ISL2_HUMAN	Increases Expression	[39]
Transmembrane and coiled-coil domain-containing protein 6 (TMCO6)	OTSTFFER	TMCO6_HUMAN	Decreases Expression	[39]
E3 ubiquitin-protein ligase pellino homolog 1 (PELI1)	OTMLBCLC	PELI1_HUMAN	Increases Expression	[39]
Tribbles homolog 3 (TRIB3)	OTG5OS7X	TRIB3_HUMAN	Increases Expression	[39]
Sulfiredoxin-1 (SRXN1)	OTYDBO4L	SRXN1_HUMAN	Increases Expression	[39]
Transmembrane 6 superfamily member 1 (TM6SF1)	OTQR4I2N	TM6S1_HUMAN	Increases Expression	[39]
Protein FAM107B (FAM107B)	OT5RG4J0	F107B_HUMAN	Increases Expression	[39]
Semaphorin-3G (SEMA3G)	OTBLVF8V	SEM3G_HUMAN	Decreases Expression	[39]
SLAM family member 5 (CD84)	OTAY5B0F	SLAF5_HUMAN	Increases Expression	[39]
Dual specificity protein phosphatase 10 (DUSP10)	OTNG467B	DUS10_HUMAN	Increases Expression	[39]
Apoptotic protease-activating factor 1 (APAF1)	OTJWIVY0	APAF_HUMAN	Increases Expression	[40]
Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT2)	OT8L6EGI	BCAT2_HUMAN	Increases Expression	[40]
Sialic acid-binding Ig-like lectin 5 (SIGLEC5)	OTYC440J	SIGL5_HUMAN	Decreases Expression	[40]
PHD finger protein 1 (PHF1)	OTW2PSIR	PHF1_HUMAN	Increases Expression	[40]
Zinc finger protein SNAI2 (SNAI2)	OT7Y8EJ2	SNAI2_HUMAN	Decreases Expression	[40]
Growth arrest and DNA damage-inducible protein GADD45 beta (GADD45B)	OTL9I7LO	GA45B_HUMAN	Increases Expression	[40]
Poly(A)-specific ribonuclease PARN (PARN)	OTTG4PE3	PARN_HUMAN	Increases Expression	[40]
Protein LDOC1 (LDOC1)	OTWZH4O9	LDOC1_HUMAN	Increases Expression	[40]
Insulin-like growth factor II (IGF2)	OTJ4O6MW	IGF2_HUMAN	Increases Expression	[40]
Alpha-crystallin B chain (CRYAB)	OTY4JGYU	CRYAB_HUMAN	Increases Expression	[40]
Calpain-1 catalytic subunit (CAPN1)	OTK6OQZR	CAN1_HUMAN	Increases Cleavage	[40]
Porphobilinogen deaminase (HMBS)	OT3P47DC	HEM3_HUMAN	Increases Expression	[40]
High mobility group protein B1 (HMGB1)	OT4B7CPF	HMGB1_HUMAN	Increases Expression	[40]
Cytochrome c oxidase subunit 6C (COX6C)	OT3V7JE5	COX6C_HUMAN	Increases Expression	[40]
ADP/ATP translocase 1 (SLC25A4)	OTKYLK2J	ADT1_HUMAN	Increases Expression	[40]
Small nuclear ribonucleoprotein-associated proteins B and B' (SNRPB)	OT3UJ4ZU	RSMB_HUMAN	Increases Expression	[40]
Integrin alpha-2 (ITGA2)	OTPFL017	ITA2_HUMAN	Decreases Expression	[40]
Cytochrome c oxidase subunit 7B, mitochondrial (COX7B)	OT67PIDP	COX7B_HUMAN	Increases Expression	[40]
Peroxiredoxin-5, mitochondrial (PRDX5)	OTUEKZ18	PRDX5_HUMAN	Increases Expression	[40]
Neurotensin receptor type 1 (NTSR1)	OTTJUTE3	NTR1_HUMAN	Decreases Expression	[40]
Lipocalin-1 (LCN1)	OT8BWXTV	LCN1_HUMAN	Decreases Expression	[40]
Myosin-9 (MYH9)	OT94Z706	MYH9_HUMAN	Decreases Expression	[40]
ETS translocation variant 3 (ETV3)	OTEN03BM	ETV3_HUMAN	Increases Expression	[40]
Small ribosomal subunit protein eS27 (RPS27)	OTFXKY7P	RS27_HUMAN	Increases Expression	[40]
Proteasome subunit beta type-3 (PSMB3)	OTVBON40	PSB3_HUMAN	Increases Expression	[40]
Emerin (EMD)	OTR8ZANE	EMD_HUMAN	Increases Expression	[40]
Matrix metalloproteinase-16 (MMP16)	OTSFQ2BJ	MMP16_HUMAN	Decreases Expression	[40]
Rap1 GTPase-GDP dissociation stimulator 1 (RAP1GDS1)	OTH70UHD	GDS1_HUMAN	Increases Expression	[40]
Stanniocalcin-1 (STC1)	OTGVVXYF	STC1_HUMAN	Decreases Expression	[40]
Arfaptin-2 (ARFIP2)	OTK9JXIJ	ARFP2_HUMAN	Increases Expression	[40]
Proteinase-activated receptor 2 (F2RL1)	OTMRMJ8N	PAR2_HUMAN	Increases Expression	[40]
Phosphoserine phosphatase (PSPH)	OTV1PVAX	SERB_HUMAN	Increases Expression	[40]
Heat shock factor protein 2 (HSF2)	OTXNJIJ9	HSF2_HUMAN	Increases Expression	[40]
Max dimerization protein 1 (MXD1)	OTS5CTHX	MAD1_HUMAN	Increases Expression	[40]
Prolyl endopeptidase FAP (FAP)	OTYABIQL	SEPR_HUMAN	Increases Expression	[40]
Protein AF1q (MLLT11)	OTG5RVHC	AF1Q_HUMAN	Increases Expression	[40]
Mothers against decapentaplegic homolog 2 (SMAD2)	OTC6VB4K	SMAD2_HUMAN	Decreases Expression	[40]
Histone H2A type 2-C (H2AC20)	OTEIVLM1	H2A2C_HUMAN	Increases Expression	[40]
Tyrosine-protein phosphatase non-receptor type 21 (PTPN21)	OTQBZWSE	PTN21_HUMAN	Decreases Expression	[40]
Amine oxidase 3 (AOC3)	OT30YKV0	AOC3_HUMAN	Increases Expression	[40]
Protein-glucosylgalactosylhydroxylysine glucosidase (PGGHG)	OT1WM75A	PGGHG_HUMAN	Decreases Expression	[40]
Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1)	OTN7XAUD	LRRF1_HUMAN	Affects Expression	[40]
Low-density lipoprotein receptor class A domain-containing protein 1 (LDLRAD1)	OTG1GL9H	LRAD1_HUMAN	Increases Expression	[40]
Teashirt homolog 3 (TSHZ3)	OTAN7RY5	TSH3_HUMAN	Decreases Expression	[40]
KRAB domain-containing protein 5 (KRBOX5)	OTVBVUAV	KRBX5_HUMAN	Decreases Expression	[40]
HAUS augmin-like complex subunit 6 (HAUS6)	OT7ZVR57	HAUS6_HUMAN	Decreases Expression	[40]
Microtubule organization protein AKNA (AKNA)	OTQ6E2C8	AKNA_HUMAN	Decreases Expression	[40]
Kinesin-like protein KIF27 (KIF27)	OTV70I2Q	KIF27_HUMAN	Increases Expression	[40]
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (GSPT2)	OTN0K7F3	ERF3B_HUMAN	Increases Expression	[40]
Neuropilin and tolloid-like protein 2 (NETO2)	OT0YAMC0	NETO2_HUMAN	Decreases Expression	[40]
Hyaluronan synthase 2 (HAS2)	OTTD3PAL	HYAS2_HUMAN	Decreases Expression	[40]
Gamma-glutamyl hydrolase (GGH)	OTL71J7T	GGH_HUMAN	Increases Expression	[40]
Reticulocalbin-3 (RCN3)	OTHWE0NF	RCN3_HUMAN	Increases Expression	[40]
Fumarylacetoacetate hydrolase domain-containing protein 2A (FAHD2A)	OTHQP0L5	FAH2A_HUMAN	Increases Expression	[40]
G-protein coupled receptor 78 (GPR78)	OT8TKE6F	GPR78_HUMAN	Increases Expression	[40]
Heparan sulfate glucosamine 3-O-sulfotransferase 6 (HS3ST6)	OTGSRHS4	HS3S6_HUMAN	Decreases Expression	[40]
Glutathione peroxidase 7 (GPX7)	OTINT9Z4	GPX7_HUMAN	Increases Expression	[40]
Proheparin-binding EGF-like growth factor (HBEGF)	OTLU00JS	HBEGF_HUMAN	Increases Expression	[40]
Chemerin-like receptor 1 (CMKLR1)	OTHA8ESR	CML1_HUMAN	Decreases Expression	[40]
Cyclic AMP-dependent transcription factor ATF-6 beta (ATF6B)	OTT2ZGSR	ATF6B_HUMAN	Increases Expression	[40]
P2Y purinoceptor 13 (P2RY13)	OTP146P1	P2Y13_HUMAN	Increases Expression	[40]
EF-hand calcium-binding domain-containing protein 4B (CRACR2A)	OTJUGSVE	EFC4B_HUMAN	Increases Expression	[40]
Glucose-6-phosphatase 3 (G6PC3)	OTH7BWNL	G6PC3_HUMAN	Increases Expression	[40]
Carbohydrate sulfotransferase 5 (CHST5)	OT9P35BV	CHST5_HUMAN	Increases Expression	[40]
C-X-C motif chemokine 16 (CXCL16)	OTD49T9R	CXL16_HUMAN	Increases Expression	[40]
Odorant-binding protein 2b (OBP2B)	OTVKMIM4	OBP2B_HUMAN	Decreases Expression	[40]
Neutral ceramidase (ASAH2)	OT47TIF3	ASAH2_HUMAN	Increases Expression	[40]
Very-long-chain enoyl-CoA reductase (TECR)	OT2NT4MV	TECR_HUMAN	Increases Expression	[40]
A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5)	OT953SV2	ATS5_HUMAN	Decreases Expression	[40]
SH2B adapter protein 3 (SH2B3)	OT4ALHBQ	SH2B3_HUMAN	Decreases Expression	[40]
Trafficking protein particle complex subunit 4 (TRAPPC4)	OT3THRCA	TPPC4_HUMAN	Increases Expression	[40]
RNA 3'-terminal phosphate cyclase-like protein (RCL1)	OT7O00YX	RCL1_HUMAN	Increases Expression	[40]
Chromatin target of PRMT1 protein (CHTOP)	OTMMNZ65	CHTOP_HUMAN	Increases Expression	[40]
Glypican-6 (GPC6)	OTNJBESF	GPC6_HUMAN	Increases Expression	[40]
26S proteasome non-ATPase regulatory subunit 12 (PSMD12)	OTWICA51	PSD12_HUMAN	Increases Expression	[41]
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF1)	OTFK8KDP	NHRF1_HUMAN	Increases Expression	[41]
Histone acetyltransferase type B catalytic subunit (HAT1)	OT307KEN	HAT1_HUMAN	Increases Expression	[41]
NPC intracellular cholesterol transporter 1 (NPC1)	OTRIPICX	NPC1_HUMAN	Decreases Expression	[41]
Actin-related protein 2/3 complex subunit 3 (ARPC3)	OTKWVF8P	ARPC3_HUMAN	Increases Expression	[41]
Serine palmitoyltransferase 1 (SPTLC1)	OTN0Z98K	SPTC1_HUMAN	Increases Expression	[41]
Filamin-B (FLNB)	OTPCOYL6	FLNB_HUMAN	Decreases Expression	[41]
Mitochondrial-processing peptidase subunit beta (PMPCB)	OTRMBHNM	MPPB_HUMAN	Increases Expression	[41]
Barrier-to-autointegration factor (BANF1)	OTP7Z38L	BAF_HUMAN	Decreases Expression	[41]
Echinoderm microtubule-associated protein-like 2 (EML2)	OTRX2NTA	EMAL2_HUMAN	Increases Expression	[41]
Keratin, type I cytoskeletal 14 (KRT14)	OTUVZ1DW	K1C14_HUMAN	Decreases Expression	[41]
Calpain small subunit 1 (CAPNS1)	OT95EBBD	CPNS1_HUMAN	Increases Expression	[41]
Lupus La protein (SSB)	OTCCTPBR	LA_HUMAN	Decreases Expression	[41]
Keratin, type II cytoskeletal 8 (KRT8)	OTTM4X11	K2C8_HUMAN	Decreases Expression	[41]
Protein S100-A6 (S100A6)	OTHHPZQ8	S10A6_HUMAN	Increases Expression	[41]
Involucrin (IVL)	OT4VPNGY	INVO_HUMAN	Increases Expression	[41]
Keratin, type II cytoskeletal 7 (KRT7)	OTLT3JFN	K2C7_HUMAN	Decreases Expression	[41]
Guanine nucleotide-binding protein G(i) subunit alpha-3 (GNAI3)	OT89UWAR	GNAI3_HUMAN	Increases Expression	[41]
U1 small nuclear ribonucleoprotein A (SNRPA)	OT02TSQT	SNRPA_HUMAN	Decreases Expression	[41]
Glucose-6-phosphate 1-dehydrogenase (G6PD)	OT300SMK	G6PD_HUMAN	Decreases Expression	[41]
Cation-independent mannose-6-phosphate receptor (IGF2R)	OTDXPQVX	MPRI_HUMAN	Decreases Expression	[41]
Ribose-phosphate pyrophosphokinase 2 (PRPS2)	OTCY1B1O	PRPS2_HUMAN	Increases Expression	[41]
Keratin, type I cytoskeletal 13 (KRT13)	OTTYSKGX	K1C13_HUMAN	Increases Expression	[41]
Heterogeneous nuclear ribonucleoprotein L (HNRNPL)	OT0DJX74	HNRPL_HUMAN	Decreases Expression	[41]
Aspartate--tRNA ligase, cytoplasmic (DARS1)	OT0WGC2T	SYDC_HUMAN	Increases Expression	[41]
Desmoplakin (DSP)	OTB2MOP8	DESP_HUMAN	Increases Expression	[41]
Probable ATP-dependent RNA helicase DDX5 (DDX5)	OTLS124U	DDX5_HUMAN	Decreases Expression	[41]
DNA-directed RNA polymerases I, II, and III subunit RPABC1 (POLR2E)	OTH5IL2A	RPAB1_HUMAN	Increases Expression	[41]
Succinate dehydrogenase iron-sulfur subunit, mitochondrial (SDHB)	OTRE1M1T	SDHB_HUMAN	Increases Expression	[41]
Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1)	OTBZKX4P	ROA2_HUMAN	Decreases Expression	[41]
Moesin (MSN)	OTZJ4J6G	MOES_HUMAN	Decreases Expression	[41]
Peptidyl-prolyl cis-trans isomerase FKBP2 (FKBP2)	OTHBZHX0	FKBP2_HUMAN	Increases Expression	[41]
Protein S100-A2 (S100A2)	OTTGHJ1H	S10A2_HUMAN	Increases Expression	[41]
Elongation factor 1-delta (EEF1D)	OTM5ZD8Y	EF1D_HUMAN	Decreases Expression	[41]
Myristoylated alanine-rich C-kinase substrate (MARCKS)	OT7N056G	MARCS_HUMAN	Increases Expression	[41]
Succinate dehydrogenase flavoprotein subunit, mitochondrial (SDHA)	OTOJ8QFF	SDHA_HUMAN	Increases Expression	[41]
Large ribosomal subunit protein eL22 (RPL22)	OTVCN8K0	RL22_HUMAN	Decreases Expression	[41]
Glycogen debranching enzyme (AGL)	OTWBM7WY	GDE_HUMAN	Increases Expression	[41]
Coatomer subunit beta' (COPB2)	OT82JIGC	COPB2_HUMAN	Increases Expression	[41]
Electron transfer flavoprotein subunit beta (ETFB)	OT6Q6FBD	ETFB_HUMAN	Increases Expression	[41]
Platelet-activating factor acetylhydrolase IB subunit beta (PAFAH1B1)	OT9T2TCJ	LIS1_HUMAN	Increases Expression	[41]
Small ribosomal subunit protein uS4 (RPS9)	OTPV69Q0	RS9_HUMAN	Decreases Expression	[41]
Isocitrate dehydrogenase , mitochondrial (IDH2)	OTTQA4PB	IDHP_HUMAN	Increases Expression	[41]
Fatty acid synthase (FASN)	OTFII9KG	FAS_HUMAN	Increases Expression	[41]
Peroxisomal multifunctional enzyme type 2 (HSD17B4)	OT8733D7	DHB4_HUMAN	Increases Expression	[41]
Arginine--tRNA ligase, cytoplasmic (RARS1)	OTHPZ6JN	SYRC_HUMAN	Increases Expression	[41]
Heat shock-related 70 kDa protein 2 (HSPA2)	OTSDET7B	HSP72_HUMAN	Increases Expression	[41]
Adenosine kinase (ADK)	OTXR6VDI	ADK_HUMAN	Decreases Expression	[41]
NHP2-like protein 1 (SNU13)	OTH56TIH	NH2L1_HUMAN	Decreases Expression	[41]
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (DAD1)	OTUUNQBT	DAD1_HUMAN	Decreases Expression	[41]
Ras-related protein R-Ras2 (RRAS2)	OT83NCEB	RRAS2_HUMAN	Increases Expression	[41]
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PPP1CA)	OT7Y43A1	PP1A_HUMAN	Decreases Expression	[41]
Small ribosomal subunit protein uS14 (RPS29)	OTCC1872	RS29_HUMAN	Decreases Expression	[41]
Small nuclear ribonucleoprotein Sm D3 (SNRPD3)	OTZXBQ45	SMD3_HUMAN	Increases Expression	[41]
Small ribosomal subunit protein eS6 (RPS6)	OTT4D1LN	RS6_HUMAN	Decreases Expression	[41]
Large ribosomal subunit protein eL30 (RPL30)	OTLQVY1Z	RL30_HUMAN	Decreases Expression	[41]
Small ribosomal subunit protein eS21 (RPS21)	OT6P58W6	RS21_HUMAN	Increases Expression	[41]
Eukaryotic translation initiation factor 5A-1 (EIF5A)	OTQ8DJX5	IF5A1_HUMAN	Decreases Expression	[41]
Keratin, type II cuticular Hb5 (KRT85)	OT67IP7F	KRT85_HUMAN	Decreases Expression	[41]
Enhancer of rudimentary homolog (ERH)	OTJDWX99	ERH_HUMAN	Decreases Expression	[41]
Spectrin beta chain, non-erythrocytic 1 (SPTBN1)	OTOVM4D4	SPTB2_HUMAN	Increases Expression	[41]
ATP-dependent 6-phosphofructokinase, platelet type (PFKP)	OTFP7AA8	PFKAP_HUMAN	Decreases Expression	[41]
RNA-binding protein EWS (EWSR1)	OT7SRHV3	EWS_HUMAN	Increases Expression	[41]
Large ribosomal subunit protein eL18 (RPL18)	OTJCH62J	RL18_HUMAN	Decreases Expression	[41]
Rho GTPase-activating protein 1 (ARHGAP1)	OT0H2ZBZ	RHG01_HUMAN	Increases Expression	[41]
Galectin-3-binding protein (LGALS3BP)	OT9AGQKH	LG3BP_HUMAN	Increases Expression	[41]
Bifunctional coenzyme A synthase (COASY)	OTBEPPMS	COASY_HUMAN	Increases Expression	[41]
Serine/arginine-rich splicing factor 9 (SRSF9)	OT2STDP4	SRSF9_HUMAN	Decreases Expression	[41]
Plakophilin-1 (PKP1)	OT9HSQ8F	PKP1_HUMAN	Increases Expression	[41]
Spliceosome RNA helicase DDX39B (DDX39B)	OTEVCFVU	DX39B_HUMAN	Increases Expression	[41]
Dihydropyrimidinase-related protein 3 (DPYSL3)	OTINJV20	DPYL3_HUMAN	Increases Expression	[41]
E3 ubiquitin/ISG15 ligase TRIM25 (TRIM25)	OT35SG1R	TRI25_HUMAN	Increases Expression	[41]
Major vault protein (MVP)	OTJGHJRB	MVP_HUMAN	Increases Expression	[41]
Nuclear mitotic apparatus protein 1 (NUMA1)	OTTKAVG4	NUMA1_HUMAN	Increases Expression	[41]
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (NSDHL)	OTK3EJFD	NSDHL_HUMAN	Decreases Expression	[41]
DNA damage-binding protein 1 (DDB1)	OTTR2L3Z	DDB1_HUMAN	Increases Expression	[41]
Serine/arginine-rich splicing factor 7 (SRSF7)	OTRS4W4S	SRSF7_HUMAN	Decreases Expression	[41]
Keratin, type II cytoskeletal 71 (KRT71)	OTI91X9Z	K2C71_HUMAN	Decreases Expression	[41]
COP9 signalosome complex subunit 6 (COPS6)	OTG9AAG0	CSN6_HUMAN	Increases Expression	[41]
PHD finger-like domain-containing protein 5A (PHF5A)	OTS94JFM	PHF5A_HUMAN	Decreases Expression	[41]
Keratin, type I cytoskeletal 27 (KRT27)	OTEP7X9Z	K1C27_HUMAN	Decreases Expression	[41]
Kinectin (KTN1)	OTQAV541	KTN1_HUMAN	Increases Expression	[41]
Histone-arginine methyltransferase CARM1 (CARM1)	OT0IPRVR	CARM1_HUMAN	Increases Expression	[41]
DnaJ homolog subfamily C member 10 (DNAJC10)	OTD2EG0R	DJC10_HUMAN	Decreases Expression	[41]
Minor histocompatibility antigen H13 (HM13)	OTGEO1LP	HM13_HUMAN	Decreases Expression	[41]
ATP-dependent RNA helicase DDX1 (DDX1)	OT3U8FD0	DDX1_HUMAN	Decreases Expression	[41]
CCR4-NOT transcription complex subunit 9 (CNOT9)	OT1NIIQD	CNOT9_HUMAN	Decreases Expression	[41]
Caveolae-associated protein 3 (CAVIN3)	OTOLBK79	CAVN3_HUMAN	Decreases Expression	[41]
Leucine-rich repeat-containing protein 59 (LRRC59)	OT6BQJ5E	LRC59_HUMAN	Decreases Expression	[41]
Phosphopentomutase (PGM2)	OTIR1VDW	PGM2_HUMAN	Increases Expression	[41]
Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5)	OT6Q5M0C	PGAM5_HUMAN	Decreases Expression	[41]
2-oxoadipate dehydrogenase complex component E1 (DHTKD1)	OTDQLSNT	DHTK1_HUMAN	Increases Expression	[41]
DnaJ homolog subfamily C member 7 (DNAJC7)	OTQ5AL3F	DNJC7_HUMAN	Decreases Expression	[41]
Myb-binding protein 1A (MYBBP1A)	OTIVEMIU	MBB1A_HUMAN	Decreases Expression	[41]
FYVE and coiled-coil domain-containing protein 1 (FYCO1)	OTKZHTZ5	FYCO1_HUMAN	Increases Expression	[41]
Extended synaptotagmin-1 (ESYT1)	OTA8NSJF	ESYT1_HUMAN	Increases Expression	[41]
Serrate RNA effector molecule homolog (SRRT)	OTMYPSWV	SRRT_HUMAN	Increases Expression	[41]
Aminopeptidase B (RNPEP)	OT1DIWA0	AMPB_HUMAN	Increases Expression	[41]
Echinoderm microtubule-associated protein-like 4 (EML4)	OTJC45TA	EMAL4_HUMAN	Increases Expression	[41]
Nucleolar RNA helicase 2 (DDX21)	OTV73GMZ	DDX21_HUMAN	Decreases Expression	[41]
GTP-binding protein SAR1a (SAR1A)	OTSSRVGV	SAR1A_HUMAN	Decreases Expression	[41]
Large ribosomal subunit protein bL17m (MRPL17)	OTBPCPVW	RM17_HUMAN	Increases Expression	[41]
ATPase family AAA domain-containing protein 3A (ATAD3A)	OTWF6HBP	ATD3A_HUMAN	Decreases Expression	[41]
SUMO-activating enzyme subunit 1 (SAE1)	OT18HFX5	SAE1_HUMAN	Increases Expression	[41]
Switch-associated protein 70 (SWAP70)	OTPHT2QD	SWP70_HUMAN	Increases Expression	[41]
NADH dehydrogenase 1 alpha subcomplex subunit 12 (NDUFA12)	OTCD6I5M	NDUAC_HUMAN	Decreases Expression	[41]
RNA-binding protein Raly (RALY)	OT78NNWY	RALY_HUMAN	Decreases Expression	[41]
Protein argonaute-2 (AGO2)	OT4JY32Q	AGO2_HUMAN	Decreases Expression	[41]
Proteasome activator complex subunit 2 (PSME2)	OTYPP33T	PSME2_HUMAN	Increases Expression	[41]
Talin-1 (TLN1)	OTTD2YXM	TLN1_HUMAN	Increases Expression	[41]
Neuroplastin (NPTN)	OTAQKSAU	NPTN_HUMAN	Increases Expression	[41]
Peripheral-type benzodiazepine receptor-associated protein 1 (TSPOAP1)	OTAM8SGF	RIMB1_HUMAN	Decreases Expression	[100]
2-aminomuconic semialdehyde dehydrogenase (ALDH8A1)	OTINY3MW	AL8A1_HUMAN	Decreases Expression	[100]
Phosphoribosylformylglycinamidine synthase (PFAS)	OTCOBYYK	PUR4_HUMAN	Increases Expression	[42]
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1)	OTY3TQYA	PAPS1_HUMAN	Decreases Expression	[42]
Fibulin-1 (FBLN1)	OT5MHHOP	FBLN1_HUMAN	Increases Expression	[42]
Progranulin (GRN)	OTXXSJ53	GRN_HUMAN	Increases Expression	[42]
Glypican-1 (GPC1)	OTQKRSSV	GPC1_HUMAN	Increases Expression	[42]
Host cell factor 1 (HCFC1)	OT0UCK62	HCFC1_HUMAN	Increases Expression	[42]
Histone H2B type 1-D (H2BC5)	OTXDTDHN	H2B1D_HUMAN	Decreases Expression	[42]
Elongator complex protein 6 (ELP6)	OT0T3BLP	ELP6_HUMAN	Decreases Expression	[42]
Protocadherin Fat 1 (FAT1)	OTF174DH	FAT1_HUMAN	Increases Expression	[42]
Putative PRAME family member 13 (PRAMEF13)	OTVJTEXT	PRA13_HUMAN	Increases Expression	[42]
C-Maf-inducing protein (CMIP)	OTZN8Z4A	CMIP_HUMAN	Increases Expression	[42]
Prolyl 3-hydroxylase OGFOD1 (OGFOD1)	OTTUQ5O3	OGFD1_HUMAN	Decreases Expression	[42]
Autism susceptibility gene 2 protein (AUTS2)	OTAEXHSC	AUTS2_HUMAN	Increases Expression	[42]
Ester hydrolase C11orf54 (C11ORF54)	OT5B6EU8	CK054_HUMAN	Decreases Expression	[42]
Ketosamine-3-kinase (FN3KRP)	OT9HR05S	KT3K_HUMAN	Increases Expression	[42]
GPN-loop GTPase 1 (GPN1)	OTM03SFL	GPN1_HUMAN	Decreases Expression	[42]
CTP synthase 2 (CTPS2)	OT2X9YO1	PYRG2_HUMAN	Decreases Expression	[42]
Nitric oxide synthase, inducible (NOS2)	OTKKIOJ1	NOS2_HUMAN	Increases Expression	[101]
Pro-epidermal growth factor (EGF)	OTANRJ0L	EGF_HUMAN	Increases Expression	[102]
Rho-related GTP-binding protein RhoC (RHOC)	OTOLE1FT	RHOC_HUMAN	Decreases Expression	[102]
Integrin alpha-4 (ITGA4)	OTSCAL0V	ITA4_HUMAN	Decreases Expression	[102]
Dipeptidyl peptidase 4 (DPP4)	OT16MVL9	DPP4_HUMAN	Decreases Expression	[102]
Myosin-10 (MYH10)	OTXN2WXS	MYH10_HUMAN	Decreases Expression	[102]
Rho-related GTP-binding protein RhoE (RND3)	OTXMXPIH	RND3_HUMAN	Decreases Expression	[102]
Rho-related GTP-binding protein RhoB (RHOB)	OTHQFQF7	RHOB_HUMAN	Decreases Expression	[102]
Ras-related C3 botulinum toxin substrate 1 (RAC1)	OTKRO61U	RAC1_HUMAN	Decreases Expression	[102]
Rho-associated protein kinase 1 (ROCK1)	OTSXYVW1	ROCK1_HUMAN	Decreases Expression	[102]
Myosin light chain kinase, smooth muscle (MYLK)	OT78QB4A	MYLK_HUMAN	Decreases Expression	[102]
Transcription factor E2F8 (E2F8)	OTQKZGFP	E2F8_HUMAN	Decreases Expression	[43]
Serine-rich and transmembrane domain-containing protein 1 (SERTM1)	OTSKB02R	SRTM1_HUMAN	Decreases Expression	[43]
Meiosis-specific coiled-coil domain-containing protein MEIOC (MEIOC)	OTME1FFG	MEIOC_HUMAN	Decreases Expression	[43]
TLC domain-containing protein 2 (TLCD2)	OTF1TZAP	TLCD2_HUMAN	Decreases Expression	[43]
Potassium channel subfamily U member 1 (KCNU1)	OTEGV1XY	KCNU1_HUMAN	Increases Expression	[43]
Putative uncharacterized protein C5orf58 (C5ORF58)	OTLETU3X	CE058_HUMAN	Decreases Expression	[43]
Uncharacterized membrane protein C3orf80 (C3ORF80)	OTJ16ATH	CC080_HUMAN	Decreases Expression	[43]
Hyaluronan synthase 3 (HAS3)	OTPM8IL8	HYAS3_HUMAN	Increases Expression	[43]
Sulfotransferase 1C2 (SULT1C2)	OT07MMZS	ST1C2_HUMAN	Increases Expression	[43]
Matrilin-2 (MATN2)	OTVDR68G	MATN2_HUMAN	Decreases Expression	[43]
Serine/threonine-protein kinase PLK4 (PLK4)	OTV8KZDZ	PLK4_HUMAN	Decreases Expression	[43]
Transcription factor SOX-1 (SOX1)	OTVI1RAR	SOX1_HUMAN	Decreases Expression	[43]
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)	OTA1CPBV	TR10B_HUMAN	Increases Expression	[43]
RIMS-binding protein 2 (RIMBP2)	OTUNSVUJ	RIMB2_HUMAN	Decreases Expression	[43]
Chloride intracellular channel protein 2 (CLIC2)	OTDBURM4	CLIC2_HUMAN	Increases Expression	[43]
Prosaposin receptor GPR37 (GPR37)	OTIMDDI3	GPR37_HUMAN	Decreases Expression	[43]
Neural cell adhesion molecule 2 (NCAM2)	OT8LBJN8	NCAM2_HUMAN	Decreases Expression	[43]
Fibroblast growth factor 10 (FGF10)	OTDSATGA	FGF10_HUMAN	Decreases Expression	[43]
Fatty acid-binding protein, brain (FABP7)	OTRE2H4G	FABP7_HUMAN	Decreases Expression	[43]
Septin-4 (SEPTIN4)	OTD16B30	SEPT4_HUMAN	Decreases Expression	[43]
Homeobox protein Hox-A2 (HOXA2)	OT6G6ZIK	HXA2_HUMAN	Decreases Expression	[43]
Homeobox protein Hox-A3 (HOXA3)	OTIX5XFB	HXA3_HUMAN	Decreases Expression	[43]
Ras GTPase-activating protein 4 (RASA4)	OTW0178L	RASL2_HUMAN	Decreases Expression	[43]
LIM domain-binding protein 2 (LDB2)	OT6Y8IEK	LDB2_HUMAN	Decreases Expression	[43]
Carbohydrate sulfotransferase 1 (CHST1)	OT2GRC5R	CHST1_HUMAN	Decreases Expression	[43]
Multiple epidermal growth factor-like domains protein 6 (MEGF6)	OTEUYTP1	MEGF6_HUMAN	Decreases Expression	[43]
Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5)	OTMVHF9E	LGR5_HUMAN	Decreases Expression	[43]
Sulfotransferase 1C4 (SULT1C4)	OTKLXS53	ST1C4_HUMAN	Increases Expression	[43]
Stanniocalcin-2 (STC2)	OT86YP8G	STC2_HUMAN	Increases Expression	[43]
Potassium channel subfamily K member 2 (KCNK2)	OTWBT8MG	KCNK2_HUMAN	Decreases Expression	[43]
Neurexophilin-2 (NXPH2)	OTHD8HPU	NXPH2_HUMAN	Decreases Expression	[43]
Chondroitin sulfate proteoglycan 5 (CSPG5)	OTXFEBWR	CSPG5_HUMAN	Decreases Expression	[43]
GTP-binding protein Di-Ras3 (DIRAS3)	OT3XHLQA	DIRA3_HUMAN	Decreases Expression	[43]
Eyes absent homolog 4 (EYA4)	OTINGR3Z	EYA4_HUMAN	Decreases Expression	[43]
C-X-C motif chemokine 14 (CXCL14)	OTM189TA	CXL14_HUMAN	Decreases Expression	[43]
Heat shock 70 kDa protein 4L (HSPA4L)	OT181WZB	HS74L_HUMAN	Increases Expression	[43]
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (NDST3)	OT8TWYOG	NDST3_HUMAN	Decreases Expression	[43]
Caveolae-associated protein 2 (CAVIN2)	OTFHHDRU	CAVN2_HUMAN	Increases Expression	[43]
Claudin-1 (CLDN1)	OT27KV99	CLD1_HUMAN	Increases Expression	[43]
Angiopoietin-related protein 1 (ANGPTL1)	OTXIN6V5	ANGL1_HUMAN	Decreases Expression	[43]
Integrin beta-like protein 1 (ITGBL1)	OTJDHE17	ITGBL_HUMAN	Decreases Expression	[43]
Leucine-rich glioma-inactivated protein 1 (LGI1)	OTPS77HO	LGI1_HUMAN	Decreases Expression	[43]
Endothelin-1 (EDN1)	OTZCACEG	EDN1_HUMAN	Increases Expression	[43]
Thrombomodulin (THBD)	OT8VHLKY	TRBM_HUMAN	Decreases Expression	[43]
Acylphosphatase-1 (ACYP1)	OTR77NZD	ACYP1_HUMAN	Decreases Expression	[43]
Decorin (DCN)	OTWLJL7K	PGS2_HUMAN	Decreases Expression	[43]
Matrix Gla protein (MGP)	OTZWU3FU	MGP_HUMAN	Decreases Expression	[43]
Keratin, type I cytoskeletal 19 (KRT19)	OTDGDQ75	K1C19_HUMAN	Decreases Expression	[43]
Alpha-2A adrenergic receptor (ADRA2A)	OTZFGOTP	ADA2A_HUMAN	Decreases Expression	[43]
Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2)	OTI4EOAR	IFIT2_HUMAN	Increases Expression	[43]
Myocardial zonula adherens protein (MYZAP)	OTAZCNBT	MYZAP_HUMAN	Decreases Expression	[43]
LIM and senescent cell antigen-like-containing domain protein 3 (LIMS3)	OTTMS7V8	LIMS3_HUMAN	Increases Expression	[43]
Serglycin (SRGN)	OTFAVSX0	SRGN_HUMAN	Increases Expression	[43]
Secretogranin-2 (SCG2)	OTUHXX8U	SCG2_HUMAN	Decreases Expression	[43]
Hematopoietic lineage cell-specific protein (HCLS1)	OTX7WGYN	HCLS1_HUMAN	Increases Expression	[43]
Neuromodulin (GAP43)	OT2OTGGV	NEUM_HUMAN	Decreases Expression	[43]
Muscarinic acetylcholine receptor M3 (CHRM3)	OTKSD095	ACM3_HUMAN	Decreases Expression	[43]
Mimecan (OGN)	OTKP5S4L	MIME_HUMAN	Decreases Expression	[43]
Prostaglandin G/H synthase 1 (PTGS1)	OTHCRLEC	PGH1_HUMAN	Decreases Expression	[43]
Gamma-aminobutyric acid receptor subunit rho-1 (GABRR1)	OT02WX1H	GBRR1_HUMAN	Decreases Expression	[43]
Endothelin receptor type B (EDNRB)	OTLLZV3P	EDNRB_HUMAN	Decreases Expression	[43]
Gamma-aminobutyric acid receptor subunit beta-3 (GABRB3)	OT80C3D4	GBRB3_HUMAN	Increases Expression	[43]
Aquaporin-1 (AQP1)	OTX5MYX9	AQP1_HUMAN	Decreases Expression	[43]
Type-1 angiotensin II receptor (AGTR1)	OT2NRMJP	AGTR1_HUMAN	Decreases Expression	[43]
Somatostatin receptor type 2 (SSTR2)	OTFN8JM1	SSR2_HUMAN	Decreases Expression	[43]
Neurotensin/neuromedin N (NTS)	OTPGDNQS	NEUT_HUMAN	Decreases Expression	[43]
Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	OTOB6J6R	RIR2_HUMAN	Decreases Expression	[43]
DNA replication licensing factor MCM5 (MCM5)	OTAHLB62	MCM5_HUMAN	Decreases Expression	[43]
DNA replication licensing factor MCM7 (MCM7)	OT6FXC6K	MCM7_HUMAN	Decreases Expression	[43]
Nuclear receptor ROR-alpha (RORA)	OTGQT12P	RORA_HUMAN	Increases Expression	[43]
Lamina-associated polypeptide 2, isoform alpha (TMPO)	OTL68EL4	LAP2A_HUMAN	Decreases Expression	[43]
Cyclin-dependent kinase 4 inhibitor C (CDKN2C)	OTCLOV90	CDN2C_HUMAN	Decreases Expression	[43]
Prostaglandin F2-alpha receptor (PTGFR)	OTUI456H	PF2R_HUMAN	Decreases Expression	[43]
Nuclear receptor subfamily 4 group A member 2 (NR4A2)	OT3F9IR2	NR4A2_HUMAN	Decreases Expression	[43]
Collagenase 3 (MMP13)	OTY8BZIE	MMP13_HUMAN	Decreases Expression	[43]
Retinaldehyde dehydrogenase 3 (ALDH1A3)	OT1C9NKQ	AL1A3_HUMAN	Decreases Expression	[43]
Neuronal pentraxin-2 (NPTX2)	OT3SSJDP	NPTX2_HUMAN	Decreases Expression	[43]
G protein-activated inward rectifier potassium channel 1 (KCNJ3)	OTHQG16J	KCNJ3_HUMAN	Decreases Expression	[43]
Alpha-aminoadipic semialdehyde dehydrogenase (ALDH7A1)	OTV57BZD	AL7A1_HUMAN	Decreases Expression	[43]
CCAAT/enhancer-binding protein delta (CEBPD)	OTNBIPMY	CEBPD_HUMAN	Increases Expression	[43]
Homeobox protein MOX-1 (MEOX1)	OTJEMT2D	MEOX1_HUMAN	Decreases Expression	[43]
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)	OTK13JKC	MP2K6_HUMAN	Decreases Expression	[43]
Dipeptidyl peptidase 1 (CTSC)	OT79WJZZ	CATC_HUMAN	Decreases Expression	[43]
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (PDE1A)	OTU7J3F7	PDE1A_HUMAN	Decreases Expression	[43]
Growth arrest-specific protein 1 (GAS1)	OTKJXG52	GAS1_HUMAN	Decreases Expression	[43]
Cadherin-8 (CDH8)	OTS3SRZ6	CADH8_HUMAN	Decreases Expression	[43]
Paired box protein Pax-9 (PAX9)	OT25J0F7	PAX9_HUMAN	Decreases Expression	[43]
Homeobox protein DLX-1 (DLX1)	OT7BH057	DLX1_HUMAN	Decreases Expression	[43]
MAP3K7 C-terminal-like protein (MAP3K7CL)	OT9J7RLC	M3KCL_HUMAN	Increases Expression	[43]
Myelin proteolipid protein (PLP1)	OT8CM9CX	MYPR_HUMAN	Decreases Expression	[43]
Histone H3.1 (H3C1)	OTGBGOZW	H31_HUMAN	Decreases Expression	[43]
Acid-sensing ion channel 1 (ASIC1)	OT59NTWQ	ASIC1_HUMAN	Decreases Expression	[43]
Single-stranded DNA-binding protein 2 (SSBP2)	OTYG1G80	SSBP2_HUMAN	Decreases Expression	[43]
ADAMTS-like protein 3 (ADAMTSL3)	OTMC2WFG	ATL3_HUMAN	Decreases Expression	[43]
Norrin (NDP)	OTGDJ4US	NDP_HUMAN	Decreases Expression	[43]
Sodium channel protein type 7 subunit alpha (SCN7A)	OTK05PXY	SCN7A_HUMAN	Decreases Expression	[43]
Transforming growth factor beta receptor type 3 (TGFBR3)	OTQOOUC4	TGBR3_HUMAN	Decreases Expression	[43]
Transducin-like enhancer protein 2 (TLE2)	OT2KSZ9B	TLE2_HUMAN	Decreases Expression	[43]
Fibromodulin (FMOD)	OT9EJ5H8	FMOD_HUMAN	Decreases Expression	[43]
Early growth response protein 3 (EGR3)	OTGPJIRA	EGR3_HUMAN	Decreases Expression	[43]
Forkhead box protein M1 (FOXM1)	OT5887KR	FOXM1_HUMAN	Decreases Expression	[43]
Schlafen family member 5 (SLFN5)	OTT1AESL	SLFN5_HUMAN	Increases Expression	[43]
Cingulin-like protein 1 (CGNL1)	OTRE9DGT	CGNL1_HUMAN	Decreases Expression	[43]
Nuclear factor 1 A-type (NFIA)	OTDHQ9CG	NFIA_HUMAN	Decreases Expression	[43]
Contactin-1 (CNTN1)	OT7RNPEY	CNTN1_HUMAN	Decreases Expression	[43]
Glutamate receptor ionotropic, kainate 3 (GRIK3)	OTX6K345	GRIK3_HUMAN	Decreases Expression	[43]
Dehydrogenase/reductase SDR family member 2, mitochondrial (DHRS2)	OTFHWIY8	DHRS2_HUMAN	Increases Expression	[43]
Limbic system-associated membrane protein (LSAMP)	OTYXVQX2	LSAMP_HUMAN	Decreases Expression	[43]
Neuronal membrane glycoprotein M6-b (GPM6B)	OT8Q1582	GPM6B_HUMAN	Decreases Expression	[43]
Integrin alpha-9 (ITGA9)	OTHN1IKA	ITA9_HUMAN	Decreases Expression	[43]
Four and a half LIM domains protein 2 (FHL2)	OT0OAYWT	FHL2_HUMAN	Increases Expression	[43]
Semaphorin-3A (SEMA3A)	OTQJSV7W	SEM3A_HUMAN	Decreases Expression	[43]
Transmembrane glycoprotein NMB (GPNMB)	OTB7KQKV	GPNMB_HUMAN	Increases Expression	[43]
Periostin (POSTN)	OTWP62UA	POSTN_HUMAN	Decreases Expression	[43]
Ras suppressor protein 1 (RSU1)	OTO5GHT1	RSU1_HUMAN	Decreases Expression	[43]
Metallophosphoesterase MPPED2 (MPPED2)	OT7XLMJ6	MPPD2_HUMAN	Decreases Expression	[43]
BDNF/NT-3 growth factors receptor (NTRK2)	OTD557PU	NTRK2_HUMAN	Decreases Expression	[43]
Receptor-type tyrosine-protein phosphatase O (PTPRO)	OTFLKWOY	PTPRO_HUMAN	Decreases Expression	[43]
Endothelial cell-specific chemotaxis regulator (ECSCR)	OT9L72MD	ECSCR_HUMAN	Decreases Expression	[43]
Solute carrier family 35 member G1 (SLC35G1)	OTKZUA8O	S35G1_HUMAN	Decreases Expression	[43]
Phospholipid phosphatase-related protein type 5 (PLPPR5)	OTVL01TR	PLPR5_HUMAN	Decreases Expression	[43]
Transmembrane protein 119 (TMEM119)	OT0HFEIC	TM119_HUMAN	Decreases Expression	[43]
Angiomotin (AMOT)	OTWHDG9B	AMOT_HUMAN	Decreases Expression	[43]
Fibronectin type III domain-containing protein 1 (FNDC1)	OTU2BA12	FNDC1_HUMAN	Decreases Expression	[43]
Protein Largen (PRR16)	OTG4TEGR	LARGN_HUMAN	Decreases Expression	[43]
Caspase recruitment domain-containing protein 16 (CARD16)	OT4NUHWB	CAR16_HUMAN	Increases Expression	[43]
KN motif and ankyrin repeat domain-containing protein 4 (KANK4)	OT5WC0Q8	KANK4_HUMAN	Decreases Expression	[43]
DEP domain-containing protein 1A (DEPDC1)	OT0JWE1B	DEP1A_HUMAN	Decreases Expression	[43]
Very-long-chain (HACD4)	OT85HPZE	HACD4_HUMAN	Increases Expression	[43]
Muscular LMNA-interacting protein (MLIP)	OTMT7AII	MLIP_HUMAN	Decreases Expression	[43]
Renalase (RNLS)	OTVP2WJM	RNLS_HUMAN	Increases Expression	[43]
Protein sel-1 homolog 3 (SEL1L3)	OT10N6Z2	SE1L3_HUMAN	Increases Expression	[43]
Scavenger receptor class A member 3 (SCARA3)	OT46I38Y	SCAR3_HUMAN	Decreases Expression	[43]
Uncharacterized protein C11orf87 (C11ORF87)	OTGRLIXD	CK087_HUMAN	Decreases Expression	[43]
NIPA-like protein 3 (NIPAL3)	OTI858LL	NPAL3_HUMAN	Increases Expression	[43]
Transmembrane protein 154 (TMEM154)	OTEAFLJE	TM154_HUMAN	Increases Expression	[43]
Kv channel-interacting protein 4 (KCNIP4)	OTB1BS0X	KCIP4_HUMAN	Decreases Expression	[43]
Transmembrane protein 107 (TMEM107)	OT9RMLBJ	TM107_HUMAN	Decreases Expression	[43]
Interleukin-20 receptor subunit beta (IL20RB)	OTHFXK95	I20RB_HUMAN	Increases Expression	[43]
R-spondin-2 (RSPO2)	OT3HHXU0	RSPO2_HUMAN	Decreases Expression	[43]
Sclerostin domain-containing protein 1 (SOSTDC1)	OTAKDNSM	SOSD1_HUMAN	Decreases Expression	[43]
PDZ domain-containing RING finger protein 4 (PDZRN4)	OTHPD5LB	PZRN4_HUMAN	Decreases Expression	[43]
Lysine-specific demethylase 7A (KDM7A)	OT1VGYCX	KDM7A_HUMAN	Increases Expression	[43]
Zinc finger protein basonuclin-2 (BNC2)	OTU22H9Z	BNC2_HUMAN	Decreases Expression	[43]
TLR4 interactor with leucine rich repeats (TRIL)	OTLLAAAH	TRIL_HUMAN	Decreases Expression	[43]
Transcription factor 24 (TCF24)	OTL7QHMZ	TCF24_HUMAN	Decreases Expression	[43]
MAM domain-containing protein 2 (MAMDC2)	OT4GICNY	MAMC2_HUMAN	Decreases Expression	[43]
Suppressor APC domain-containing protein 2 (SAPCD2)	OTXS0EXM	SAPC2_HUMAN	Decreases Expression	[43]
Regulating synaptic membrane exocytosis protein 1 (RIMS1)	OT10T7CK	RIMS1_HUMAN	Decreases Expression	[43]
Protein O-mannosyl-transferase TMTC1 (TMTC1)	OTZ7NW96	TMTC1_HUMAN	Decreases Expression	[43]
Epidermal growth factor-like protein 6 (EGFL6)	OT331X59	EGFL6_HUMAN	Decreases Expression	[43]
Dynein axonemal intermediate chain 3 (DNAI3)	OTG1A0QP	DNAI3_HUMAN	Increases Expression	[43]
Sodium channel subunit beta-4 (SCN4B)	OT3JSUWO	SCN4B_HUMAN	Decreases Expression	[43]
Solute carrier family 22 member 15 (SLC22A15)	OT60WAAI	S22AF_HUMAN	Increases Expression	[43]
Adhesion G protein-coupled receptor F5 (ADGRF5)	OTWU7AOO	AGRF5_HUMAN	Decreases Expression	[43]
Adhesion G-protein coupled receptor G2 (ADGRG2)	OTPAD5S1	AGRG2_HUMAN	Decreases Expression	[43]
Myocardin (MYOCD)	OTSJNHTH	MYCD_HUMAN	Increases Expression	[43]
Protein THEMIS (THEMIS)	OTXODBXJ	THMS1_HUMAN	Decreases Expression	[43]
Neuroligin-1 (NLGN1)	OTGHRRFQ	NLGN1_HUMAN	Decreases Expression	[43]
ELMO domain-containing protein 1 (ELMOD1)	OT0WRVJC	ELMD1_HUMAN	Decreases Expression	[43]
Protein O-mannosyl-transferase TMTC2 (TMTC2)	OTY1QWYU	TMTC2_HUMAN	Decreases Expression	[43]
Transmembrane protein 130 (TMEM130)	OTKA3N5Q	TM130_HUMAN	Decreases Expression	[43]
Follistatin-related protein 5 (FSTL5)	OT18C29S	FSTL5_HUMAN	Decreases Expression	[43]
Dehydrogenase/reductase SDR family member on chromosome X (DHRSX)	OT7DSYRO	DHRSX_HUMAN	Increases Expression	[43]
Protocadherin-20 (PCDH20)	OTFSNRXK	PCD20_HUMAN	Decreases Expression	[43]
Inactive phospholipase D5 (PLD5)	OTEVPYNY	PLD5_HUMAN	Decreases Expression	[43]
Transmembrane protein 178A (TMEM178A)	OTQZY4NP	T178A_HUMAN	Decreases Expression	[43]
Proprotein convertase subtilisin/kexin type 9 (PCSK9)	OTI0DU9Y	PCSK9_HUMAN	Decreases Expression	[43]
SLAIN motif-containing protein 1 (SLAIN1)	OTMT25MN	SLAI1_HUMAN	Decreases Expression	[43]
Biorientation of chromosomes in cell division protein 1-like 1 (BOD1L1)	OTTD5FJ8	BD1L1_HUMAN	Increases Expression	[43]
Syntaxin-binding protein 6 (STXBP6)	OTUEKTIP	STXB6_HUMAN	Decreases Expression	[43]
Semaphorin-6D (SEMA6D)	OTU0UAZS	SEM6D_HUMAN	Decreases Expression	[43]
Transmembrane protein 163 (TMEM163)	OTCT1Y1L	TM163_HUMAN	Decreases Expression	[43]
A disintegrin and metalloproteinase with thrombospondin motifs 15 (ADAMTS15)	OTYB6JS3	ATS15_HUMAN	Decreases Expression	[43]
Folliculin-interacting protein 1 (FNIP1)	OTB1CC41	FNIP1_HUMAN	Increases Expression	[43]
VPS10 domain-containing receptor SorCS1 (SORCS1)	OTP8PAKU	SORC1_HUMAN	Decreases Expression	[43]
CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (ST8SIA4)	OTENME7S	SIA8D_HUMAN	Decreases Expression	[43]
Rap guanine nucleotide exchange factor 5 (RAPGEF5)	OT53VS75	RPGF5_HUMAN	Decreases Expression	[43]
Delta-sarcoglycan (SGCD)	OTRBL3NQ	SGCD_HUMAN	Decreases Expression	[43]
Coronin-2A (CORO2A)	OTVK7PK3	COR2A_HUMAN	Decreases Expression	[43]
Amyloid beta precursor protein binding family B member 2 (APBB2)	OT1VD51B	APBB2_HUMAN	Increases Expression	[43]
Fibroblast growth factor 14 (FGF14)	OT7KKRDI	FGF14_HUMAN	Decreases Expression	[43]
Receptor-type tyrosine-protein phosphatase N2 (PTPRN2)	OTL6SH28	PTPR2_HUMAN	Increases Expression	[43]
Histone H2B type 1-H (H2BC9)	OTQ9XX72	H2B1H_HUMAN	Decreases Expression	[43]
Transmembrane protein 106A (TMEM106A)	OTHTBYDN	T106A_HUMAN	Increases Expression	[43]
Ras-related and estrogen-regulated growth inhibitor (RERG)	OTF6MMLV	RERG_HUMAN	Decreases Expression	[43]
Transmembrane protein 18 (TMEM18)	OT05YQ1E	TMM18_HUMAN	Decreases Expression	[43]
Melanocortin-2 receptor accessory protein 2 (MRAP2)	OTCQS7DB	MRAP2_HUMAN	Decreases Expression	[43]
MAGUK p55 subfamily member 4 (MPP4)	OT7YG0AY	MPP4_HUMAN	Increases Expression	[43]
Regulator of microtubule dynamics protein 2 (RMDN2)	OTK5WSFI	RMD2_HUMAN	Decreases Expression	[43]
Leucine-rich repeat-containing protein 3B (LRRC3B)	OT9VDGPR	LRC3B_HUMAN	Decreases Expression	[43]
Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2)	OTB71I02	DCBD2_HUMAN	Increases Expression	[43]
Lipase maturation factor 1 (LMF1)	OTOL14ZD	LMF1_HUMAN	Decreases Expression	[43]
Sodium channel protein type 2 subunit alpha (SCN2A)	OTUSYE4Z	SCN2A_HUMAN	Increases Expression	[43]
Epiphycan (EPYC)	OTTRI5WO	EPYC_HUMAN	Decreases Expression	[43]
Neurturin (NRTN)	OT4PAKUY	NRTN_HUMAN	Decreases Expression	[43]
Homeodomain-only protein (HOPX)	OTBSR6C9	HOP_HUMAN	Decreases Expression	[43]
Potassium voltage-gated channel subfamily S member 3 (KCNS3)	OTHDD9F6	KCNS3_HUMAN	Decreases Expression	[43]
Chordin-like protein 1 (CHRDL1)	OTGMWVVA	CRDL1_HUMAN	Decreases Expression	[43]
Meiotic nuclear division protein 1 homolog (MND1)	OTS87F3H	MND1_HUMAN	Decreases Expression	[43]
Brother of CDO (BOC)	OTXBCY9W	BOC_HUMAN	Decreases Expression	[43]
Complement C1q tumor necrosis factor-related protein 7 (C1QTNF7)	OTN1IFTK	C1QT7_HUMAN	Decreases Expression	[43]
Complement C1q tumor necrosis factor-related protein 4 (C1QTNF4)	OTHD4Y9D	C1QT4_HUMAN	Decreases Expression	[43]
G-protein coupled receptor 87 (GPR87)	OTQX45UM	GPR87_HUMAN	Increases Expression	[43]
Anoctamin-3 (ANO3)	OTM34U6Q	ANO3_HUMAN	Decreases Expression	[43]
Thrombospondin type-1 domain-containing protein 7B (THSD7B)	OTMDDIPT	THS7B_HUMAN	Decreases Expression	[43]
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (CTDSP1)	OTH0J5CV	CTDS1_HUMAN	Decreases Expression	[43]
Sphingosine 1-phosphate receptor 5 (S1PR5)	OTQF1R0U	S1PR5_HUMAN	Decreases Expression	[43]
Synaptotagmin-4 (SYT4)	OTA1D7VL	SYT4_HUMAN	Decreases Expression	[43]
Small conductance calcium-activated potassium channel protein 2 (KCNN2)	OTQVTMK5	KCNN2_HUMAN	Decreases Expression	[43]
Regulator of cell cycle RGCC (RGCC)	OTYJMLWM	RGCC_HUMAN	Decreases Expression	[43]
Endogenous retroviral envelope protein HEMO (ERVMER34-1)	OTECWJ0Y	MER34_HUMAN	Decreases Expression	[43]
Chondrolectin (CHODL)	OTVCNOUQ	CHODL_HUMAN	Decreases Expression	[43]
Claspin (CLSPN)	OTZZXNDK	CLSPN_HUMAN	Decreases Expression	[43]
Kinetochore protein Spc25 (SPC25)	OTCAS0OH	SPC25_HUMAN	Decreases Expression	[43]
Spondin-1 (SPON1)	OTC06MY4	SPON1_HUMAN	Decreases Expression	[43]
Neurexin-3-beta (NRXN3)	OTJ0I7HJ	NRX3B_HUMAN	Decreases Expression	[43]
3',5'-cyclic-AMP phosphodiesterase 7B (PDE7B)	OTK3SHT2	PDE7B_HUMAN	Decreases Expression	[43]
Homeobox protein SIX2 (SIX2)	OTYOVGSC	SIX2_HUMAN	Decreases Expression	[43]
Interleukin-26 (IL26)	OT2WYCW4	IL26_HUMAN	Increases Expression	[43]
Signal peptide, CUB and EGF-like domain-containing protein 2 (SCUBE2)	OT661S7D	SCUB2_HUMAN	Decreases Expression	[43]
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC (MAN1C1)	OT44TM7D	MA1C1_HUMAN	Decreases Expression	[43]
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (AGPAT5)	OTNY3VMD	PLCE_HUMAN	Decreases Expression	[43]
Spermatogenesis-associated protein 6 (SPATA6)	OTWQQONT	SPAT6_HUMAN	Decreases Expression	[43]
Very long chain fatty acid elongase 2 (ELOVL2)	OTDAF6U3	ELOV2_HUMAN	Decreases Expression	[43]
Ninjurin-2 (NINJ2)	OTUG1AOV	NINJ2_HUMAN	Decreases Expression	[43]
Contactin-3 (CNTN3)	OTC1274J	CNTN3_HUMAN	Decreases Expression	[43]
Kelch-like protein 14 (KLHL14)	OTYOS55H	KLH14_HUMAN	Decreases Expression	[43]
Hairy/enhancer-of-split related with YRPW motif protein 2 (HEY2)	OTU4J3ZI	HEY2_HUMAN	Decreases Expression	[43]
Tight junction protein ZO-2 (TJP2)	OTQUY6BV	ZO2_HUMAN	Decreases Expression	[43]
Alpha-methylacyl-CoA racemase (AMACR)	OTUU22PK	AMACR_HUMAN	Decreases Expression	[43]
Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAIAP2L1)	OTZ71SK9	BI2L1_HUMAN	Increases Expression	[43]
Tomoregulin-2 (TMEFF2)	OT1WZ2QO	TEFF2_HUMAN	Decreases Expression	[43]
Lysosome-associated membrane glycoprotein 5 (LAMP5)	OTC672RM	LAMP5_HUMAN	Decreases Expression	[43]
Heat shock protein beta-8 (HSPB8)	OT0I83YS	HSPB8_HUMAN	Increases Expression	[43]
Cytoplasmic phosphatidylinositol transfer protein 1 (PITPNC1)	OT64TTGC	PITC1_HUMAN	Increases Expression	[43]
Teneurin-1 (TENM1)	OTSKSU4V	TEN1_HUMAN	Decreases Expression	[43]
Procollagen C-endopeptidase enhancer 2 (PCOLCE2)	OTSUEQZ1	PCOC2_HUMAN	Decreases Expression	[43]
Endomucin (EMCN)	OTS03CZC	MUCEN_HUMAN	Decreases Expression	[43]
Neurabin-1 (PPP1R9A)	OTJL2TOC	NEB1_HUMAN	Decreases Expression	[43]
Transcription factor MafF (MAFF)	OT9B7MX0	MAFF_HUMAN	Increases Expression	[43]
Dynamin-3 (DNM3)	OTDMUGCR	DYN3_HUMAN	Decreases Expression	[43]
Regulating synaptic membrane exocytosis protein 2 (RIMS2)	OTQASWDH	RIMS2_HUMAN	Decreases Expression	[43]
Calcium-activated chloride channel regulator 2 (CLCA2)	OTF191LZ	CLCA2_HUMAN	Increases Expression	[43]
Transcription factor 19 (TCF19)	OT7NKLF9	TCF19_HUMAN	Decreases Expression	[43]
Atrial natriuretic peptide-converting enzyme (CORIN)	OT4SK7DK	CORIN_HUMAN	Decreases Expression	[43]
Krueppel-like factor 2 (KLF2)	OTIP1UFX	KLF2_HUMAN	Decreases Expression	[43]
Tolloid-like protein 2 (TLL2)	OTHZ4TBL	TLL2_HUMAN	Decreases Expression	[43]
Proton-coupled zinc antiporter SLC30A1 (SLC30A1)	OTY8J0S4	ZNT1_HUMAN	Increases Expression	[43]
Calpain-6 (CAPN6)	OT8K5PR5	CAN6_HUMAN	Decreases Expression	[43]
Lymphocyte antigen 96 (LY96)	OTN4HXA2	LY96_HUMAN	Increases Expression	[43]
Sperm acrosome membrane-associated protein 6 (SPACA6)	OTSWJOWL	SACA6_HUMAN	Decreases Expression	[43]
Proliferation marker protein Ki-67 (MKI67)	OTA8N1QI	KI67_HUMAN	Decreases Expression	[103]
Serine/threonine-protein kinase PINK1, mitochondrial (PINK1)	OT50NR57	PINK1_HUMAN	Increases Expression	[103]
Microtubule-associated proteins 1A/1B light chain 3 beta 2 (MAP1LC3B2)	OTFQ44V2	MP3B2_HUMAN	Increases Expression	[44]
Butyrophilin subfamily 3 member A3 (BTN3A3)	OTKMSJRA	BT3A3_HUMAN	Decreases Expression	[44]
GDH/6PGL endoplasmic bifunctional protein (H6PD)	OTO7TNDD	G6PE_HUMAN	Decreases Expression	[44]
Persulfide dioxygenase ETHE1, mitochondrial (ETHE1)	OTP9A2BQ	ETHE1_HUMAN	Decreases Expression	[44]
Complement C5 (C5)	OTSL3OIC	CO5_HUMAN	Decreases Expression	[44]
Protein AMBP (AMBP)	OTLU8GU8	AMBP_HUMAN	Increases Expression	[44]
C-X-C motif chemokine 10 (CXCL10)	OTTLQ6S0	CXL10_HUMAN	Decreases Expression	[44]
Histidine-rich glycoprotein (HRG)	OTPLUFOG	HRG_HUMAN	Increases Expression	[44]
Small ribosomal subunit protein uS2 (RPSA)	OTJZHEGT	RSSA_HUMAN	Decreases Expression	[44]
Peroxisomal coenzyme A diphosphatase NUDT7 (NUDT7)	OTCPOQ6W	NUDT7_HUMAN	Decreases Expression	[44]
Farnesyl pyrophosphate synthase (FDPS)	OT6CKWV5	FPPS_HUMAN	Decreases Expression	[44]
Acylphosphatase-2 (ACYP2)	OTRB4S6X	ACYP2_HUMAN	Increases Expression	[44]
Homeobox protein Hox-B9 (HOXB9)	OTMVHQOU	HXB9_HUMAN	Increases Expression	[44]
Serine protease inhibitor Kazal-type 2 (SPINK2)	OTSFBT0G	ISK2_HUMAN	Decreases Expression	[44]
Phosphatidylcholine translocator ABCB4 (ABCB4)	OTE6PY83	MDR3_HUMAN	Increases Expression	[44]
Myelin protein P0 (MPZ)	OTAR2YXH	MYP0_HUMAN	Increases Expression	[44]
Transcription factor 7 (TCF7)	OT1ID822	TCF7_HUMAN	Increases Expression	[44]
Beta-centractin (ACTR1B)	OTGBCKLO	ACTY_HUMAN	Decreases Expression	[44]
Sodium- and chloride-dependent glycine transporter 1 (SLC6A9)	OTHRUON2	SC6A9_HUMAN	Increases Expression	[44]
Serpin H1 (SERPINH1)	OTKGI7BS	SERPH_HUMAN	Increases Expression	[44]
Amiloride-sensitive sodium channel subunit beta (SCNN1B)	OT61QQTL	SCNNB_HUMAN	Increases Expression	[44]
C-C chemokine receptor type 8 (CCR8)	OTSCMH06	CCR8_HUMAN	Decreases Expression	[44]
Junctional adhesion molecule B (JAM2)	OTHVJJRJ	JAM2_HUMAN	Increases Expression	[44]
Inhibin beta E chain (INHBE)	OTOI2NYG	INHBE_HUMAN	Increases Expression	[44]
Tyrosine-protein phosphatase non-receptor type substrate 1 (SIRPA)	OT2CEYTT	SHPS1_HUMAN	Increases Expression	[44]
Contactin-associated protein 1 (CNTNAP1)	OT5Y03EU	CNTP1_HUMAN	Decreases Expression	[44]
Butyrophilin subfamily 3 member A2 (BTN3A2)	OT3DIBU3	BT3A2_HUMAN	Decreases Expression	[44]
Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMGCS1)	OTCO26FV	HMCS1_HUMAN	Decreases Expression	[44]
Amyloid beta precursor like protein 2 (APLP2)	OTTFE53M	APLP2_HUMAN	Increases Expression	[44]
Mitotic spindle assembly checkpoint protein MAD2A (MAD2L1)	OTXNGZCG	MD2L1_HUMAN	Decreases Expression	[44]
Sequestosome-1 (SQSTM1)	OTGY5D5J	SQSTM_HUMAN	Increases Expression	[44]
Squalene monooxygenase (SQLE)	OT0GGRDO	ERG1_HUMAN	Decreases Expression	[44]
Inositol 1,4,5-trisphosphate receptor type 1 (ITPR1)	OTX7MWW1	ITPR1_HUMAN	Increases Expression	[44]
AT-rich interactive domain-containing protein 5B (ARID5B)	OTUQ4CQY	ARI5B_HUMAN	Decreases Expression	[44]
Neuronal acetylcholine receptor subunit alpha-6 (CHRNA6)	OTT6W86V	ACHA6_HUMAN	Decreases Expression	[44]
Voltage-dependent R-type calcium channel subunit alpha-1E (CACNA1E)	OTHATMLU	CAC1E_HUMAN	Increases Expression	[44]
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4)	OTQYEXL2	F264_HUMAN	Decreases Expression	[44]
Erythroid differentiation-related factor 1 (EDRF1)	OTM7TWJZ	EDRF1_HUMAN	Decreases Expression	[44]
Alpha-(1,3)-fucosyltransferase 11 (FUT11)	OTD0CDN5	FUT11_HUMAN	Decreases Expression	[44]
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (PAN2)	OTB65N2I	PAN2_HUMAN	Decreases Expression	[44]
Epithelial splicing regulatory protein 1 (ESRP1)	OTNCS4SL	ESRP1_HUMAN	Increases Expression	[44]
Dynamin-binding protein (DNMBP)	OTMHH14H	DNMBP_HUMAN	Decreases Expression	[44]
Protein spinster homolog 3 (SPNS3)	OTCTX3H4	SPNS3_HUMAN	Increases Expression	[44]
Ran-binding protein 3-like (RANBP3L)	OTKOCHVJ	RNB3L_HUMAN	Increases Expression	[44]
Dyslexia-associated protein KIAA0319-like protein (KIAA0319L)	OTZ5X6IM	K319L_HUMAN	Decreases Expression	[44]
Solute carrier family 38 member 6 (SLC38A6)	OTIC8SHQ	S38A6_HUMAN	Increases Expression	[44]
Rho GTPase-activating protein 18 (ARHGAP18)	OTYMJP6H	RHG18_HUMAN	Decreases Expression	[44]
3-oxoacyl- reductase (CBR4)	OT43V4UN	CBR4_HUMAN	Decreases Expression	[44]
Eukaryotic translation initiation factor 4E type 3 (EIF4E3)	OTTWVS2R	IF4E3_HUMAN	Increases Expression	[44]
Blood vessel epicardial substance (BVES)	OT4GT1WC	POPD1_HUMAN	Increases Expression	[44]
Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1)	OTA1STFZ	LIRB1_HUMAN	Decreases Expression	[44]
F-box only protein 30 (FBXO30)	OTD1P6LA	FBX30_HUMAN	Increases Expression	[44]
Histone-lysine N-methyltransferase SETD7 (SETD7)	OTT49OXF	SETD7_HUMAN	Increases Expression	[44]
Phospholipase ABHD3 (ABHD3)	OTH8P977	ABHD3_HUMAN	Increases Expression	[44]
Kelch-like protein 6 (KLHL6)	OTLDECOX	KLHL6_HUMAN	Increases Expression	[44]
(3R)-3-hydroxyacyl-CoA dehydrogenase (HSD17B8)	OTX1DWEF	DHB8_HUMAN	Decreases Expression	[44]
Neogenin (NEO1)	OTGJ1997	NEO1_HUMAN	Increases Expression	[44]
Fermitin family homolog 2 (FERMT2)	OTZNPWWX	FERM2_HUMAN	Increases Expression	[44]
Tetratricopeptide repeat protein 28 (TTC28)	OTFOOYC3	TTC28_HUMAN	Increases Expression	[44]
4-hydroxybenzoate polyprenyltransferase, mitochondrial (COQ2)	OTDAKEY4	COQ2_HUMAN	Decreases Expression	[44]
Ethanolamine-phosphate cytidylyltransferase (PCYT2)	OTT8TAEA	PCY2_HUMAN	Decreases Expression	[44]
Leucine-rich repeat-containing G-protein coupled receptor 4 (LGR4)	OTIMWEK5	LGR4_HUMAN	Decreases Expression	[44]
Probable G-protein coupled receptor 174 (GPR174)	OTI9OG9Y	GP174_HUMAN	Decreases Expression	[44]
Cell adhesion molecule 1 (CADM1)	OTRWG9QS	CADM1_HUMAN	Decreases Expression	[44]
Actin-related protein 3C (ACTR3C)	OTLAWZPC	ARP3C_HUMAN	Increases Expression	[44]
Testis-specific Y-encoded-like protein 2 (TSPYL2)	OTGGW2EF	TSYL2_HUMAN	Increases Expression	[44]
Calcium-binding protein 39-like (CAB39L)	OTQEBL0W	CB39L_HUMAN	Increases Expression	[44]
Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2)	OTB1FZJU	ACSA_HUMAN	Decreases Expression	[44]
Epimerase family protein SDR39U1 (SDR39U1)	OTYHG7B0	D39U1_HUMAN	Decreases Expression	[44]
Dapper homolog 1 (DACT1)	OT19Z704	DACT1_HUMAN	Decreases Expression	[44]
NCK-interacting protein with SH3 domain (NCKIPSD)	OT24UORN	SPN90_HUMAN	Decreases Expression	[44]
Leucine-rich repeat transmembrane protein FLRT3 (FLRT3)	OT3XMZU3	FLRT3_HUMAN	Decreases Expression	[44]
Folliculin-interacting protein 2 (FNIP2)	OT7EX8JJ	FNIP2_HUMAN	Increases Expression	[44]
HEAT repeat-containing protein 5B (HEATR5B)	OTQLWV88	HTR5B_HUMAN	Decreases Expression	[44]
Klotho (KL)	OTD4VWU6	KLOT_HUMAN	Increases Expression	[44]
DNA polymerase subunit gamma-2 (POLG2)	OTDBMZJB	DPOG2_HUMAN	Decreases Expression	[44]
Kelch-like protein 21 (KLHL21)	OT28Y2LQ	KLH21_HUMAN	Increases Expression	[44]
Zinc transporter ZIP10 (SLC39A10)	OT04411Q	S39AA_HUMAN	Decreases Expression	[44]
Serine/threonine-protein kinase ICK (CILK1)	OTWOYEYP	CILK1_HUMAN	Increases Expression	[44]
Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE)	OTNONPMB	GLCNE_HUMAN	Decreases Expression	[44]
Ankyrin repeat domain-containing protein 6 (ANKRD6)	OTM86B04	ANKR6_HUMAN	Increases Expression	[44]
R3H domain-containing protein 2 (R3HDM2)	OTMJ3S6J	R3HD2_HUMAN	Decreases Expression	[44]
Dehydrogenase/reductase SDR family member 7 (DHRS7)	OTV729DT	DHRS7_HUMAN	Increases Expression	[44]
eIF5-mimic protein 1 (BZW2)	OTBT0A1B	5MP1_HUMAN	Decreases Expression	[44]
Transcription regulator protein BACH1 (BACH1)	OTY8004K	BACH1_HUMAN	Increases Expression	[104]
Cyclic AMP-dependent transcription factor ATF-2 (ATF2)	OTNIZPEA	ATF2_HUMAN	Increases Phosphorylation	[105]
Cyclic AMP-dependent transcription factor ATF-4 (ATF4)	OTRFV19J	ATF4_HUMAN	Increases Expression	[105]
Long-chain-fatty-acid--CoA ligase 1 (ACSL1)	OTB06ESI	ACSL1_HUMAN	Increases Expression	[105]
cAMP-regulated phosphoprotein 19 (ARPP19)	OTZS3IT6	ARP19_HUMAN	Increases Expression	[105]
Cyclin-dependent kinase 6 (CDK6)	OTR95N0X	CDK6_HUMAN	Decreases Expression	[105]
ATPase family AAA domain-containing protein 2 (ATAD2)	OT8MCRNY	ATAD2_HUMAN	Increases Expression	[105]
Sucrase-isomaltase, intestinal (SI)	OTUP724T	SUIS_HUMAN	Decreases Expression	[45]
Signal transducer CD24 (CD24)	OT7CODJ4	CD24_HUMAN	Increases Expression	[106]
Myotubularin-related protein 11 (MTMR11)	OTHL2O08	MTMRB_HUMAN	Decreases Expression	[46]
Inositol monophosphatase 2 (IMPA2)	OTNFB9YN	IMPA2_HUMAN	Decreases Expression	[46]
Proteasome subunit alpha type-7 (PSMA7)	OTPHI6ST	PSA7_HUMAN	Increases Expression	[46]
Serine/threonine-protein kinase DCLK1 (DCLK1)	OTVSPS98	DCLK1_HUMAN	Decreases Expression	[46]
Mitogen-activated protein kinase 13 (MAPK13)	OT0W9GE7	MK13_HUMAN	Increases Expression	[46]
26S proteasome non-ATPase regulatory subunit 3 (PSMD3)	OT585WY8	PSMD3_HUMAN	Increases Expression	[46]
U4/U6.U5 tri-snRNP-associated protein 1 (SART1)	OTHMOGO1	SNUT1_HUMAN	Increases Expression	[46]
PH domain leucine-rich repeat-containing protein phosphatase 1 (PHLPP1)	OTIFXW8D	PHLP1_HUMAN	Increases Expression	[46]
Tyrosine-protein kinase JAK2 (JAK2)	OTBIDOOR	JAK2_HUMAN	Increases Expression	[46]
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)	OTTK8MUO	KS6A4_HUMAN	Increases Expression	[46]
Aldehyde dehydrogenase 1A1 (ALDH1A1)	OTCUWZKB	AL1A1_HUMAN	Decreases Expression	[46]
Complement factor D (CFD)	OTLNRXB6	CFAD_HUMAN	Decreases Expression	[46]
Alpha-1-antitrypsin (SERPINA1)	OTACYW9J	A1AT_HUMAN	Decreases Expression	[46]
Complement C3 (C3)	OTCH5GS0	CO3_HUMAN	Decreases Expression	[46]
GTPase HRas (HRAS)	OTWQN0DP	RASH_HUMAN	Increases Expression	[46]
Plasma kallikrein (KLKB1)	OTGSEISX	KLKB1_HUMAN	Decreases Expression	[46]
Complement factor I (CFI)	OTQYYX0P	CFAI_HUMAN	Decreases Expression	[46]
Complement decay-accelerating factor (CD55)	OTZ3HWTO	DAF_HUMAN	Decreases Expression	[46]
Extracellular superoxide dismutase (SOD3)	OTIOZQAB	SODE_HUMAN	Decreases Expression	[46]
Inhibin beta B chain (INHBB)	OT2QLD11	INHBB_HUMAN	Increases Expression	[46]
Platelet-derived growth factor receptor beta (PDGFRB)	OTYSNK9Q	PGFRB_HUMAN	Increases Expression	[46]
Complement C4-A (C4A)	OTXMOYXU	CO4A_HUMAN	Decreases Expression	[46]
Serine/threonine-protein kinase B-raf (BRAF)	OT7S81XQ	BRAF_HUMAN	Increases Expression	[46]
Fos-related antigen 1 (FOSL1)	OT9YTYMB	FOSL1_HUMAN	Increases Expression	[46]
Tyrosine-protein kinase Fer (FER)	OT9JR7AE	FER_HUMAN	Increases Expression	[46]
26S proteasome regulatory subunit 6A (PSMC3)	OTSKT0JI	PRS6A_HUMAN	Increases Expression	[46]
Proteasome subunit beta type-1 (PSMB1)	OTYRFBAH	PSB1_HUMAN	Increases Expression	[46]
fMet-Leu-Phe receptor (FPR1)	OTFF9I6W	FPR1_HUMAN	Decreases Expression	[46]
Integrin alpha-6 (ITGA6)	OT3FA39C	ITA6_HUMAN	Increases Expression	[46]
G0/G1 switch protein 2 (G0S2)	OT8FL49L	G0S2_HUMAN	Increases Expression	[46]
DNA polymerase delta catalytic subunit (POLD1)	OTWO4UCJ	DPOD1_HUMAN	Increases Expression	[46]
Bifunctional purine biosynthesis protein ATIC (ATIC)	OT8XE052	PUR9_HUMAN	Increases Expression	[46]
Interferon gamma receptor 2 (IFNGR2)	OTVOPCHW	INGR2_HUMAN	Increases Expression	[46]
Serine/threonine-protein kinase mTOR (MTOR)	OTHH8KU7	MTOR_HUMAN	Increases Expression	[46]
26S proteasome regulatory subunit 6B (PSMC4)	OTS3XN41	PRS6B_HUMAN	Increases Expression	[46]
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)	OTI2OREX	MP2K3_HUMAN	Increases Expression	[46]
26S proteasome non-ATPase regulatory subunit 7 (PSMD7)	OT7PZZ4K	PSMD7_HUMAN	Increases Expression	[46]
Peregrin (BRPF1)	OTPC9GXB	BRPF1_HUMAN	Increases Expression	[46]
Nuclear factor NF-kappa-B p100 subunit (NFKB2)	OTS231V7	NFKB2_HUMAN	Increases Expression	[46]
Nuclear factor of activated T-cells, cytoplasmic 3 (NFATC3)	OTYOORME	NFAC3_HUMAN	Decreases Expression	[46]
Cullin-1 (CUL1)	OTXPE1UZ	CUL1_HUMAN	Decreases Expression	[46]
Laminin subunit beta-3 (LAMB3)	OTFPU6W8	LAMB3_HUMAN	Increases Expression	[46]
Caspase-8 (CASP8)	OTA8TVI8	CASP8_HUMAN	Increases Expression	[46]
RalA-binding protein 1 (RALBP1)	OTBIGB1D	RBP1_HUMAN	Increases Expression	[46]
HHIP-like protein 2 (HHIPL2)	OTB7P4GV	HIPL2_HUMAN	Increases Expression	[46]
Tetraspanin-14 (TSPAN14)	OT29167O	TSN14_HUMAN	Decreases Expression	[46]
Proto-oncogene FRAT1 (FRAT1)	OT1PS84E	FRAT1_HUMAN	Decreases Expression	[46]
Phosphatidate cytidylyltransferase 1 (CDS1)	OT2F591M	CDS1_HUMAN	Increases Expression	[46]
Succinate--CoA ligase subunit beta, mitochondrial (SUCLG2)	OT0KHLY2	SUCB2_HUMAN	Decreases Expression	[46]
V-type proton ATPase 21 kDa proteolipid subunit c'' (ATP6V0B)	OT8GTI1V	VATO_HUMAN	Increases Expression	[46]
Transcription factor 7-like 1 (TCF7L1)	OTTUTF0O	TF7L1_HUMAN	Decreases Expression	[46]
Homer protein homolog 2 (HOMER2)	OT4JGKJF	HOME2_HUMAN	Decreases Expression	[46]
Secretion-regulating guanine nucleotide exchange factor (SERGEF)	OT2AX2QL	SRGEF_HUMAN	Increases Expression	[46]
Chromatin-remodeling ATPase INO80 (INO80)	OTJBMS8T	INO80_HUMAN	Increases Expression	[46]
Axin-2 (AXIN2)	OTRMGQNU	AXIN2_HUMAN	Decreases Expression	[46]
Alanine aminotransferase 1 (GPT)	OTOXOA0Q	ALAT1_HUMAN	Increases Activity	[107]
Cytochrome P450 1B1 (CYP1B1)	OTYXFLSD	CP1B1_HUMAN	Decreases Expression	[108]
Serine/threonine-protein kinase Sgk1 (SGK1)	OT301T1U	SGK1_HUMAN	Increases Expression	[48]
Activator of apoptosis harakiri (HRK)	OTR4GWJ0	HRK_HUMAN	Increases Expression	[109]
Tumor necrosis factor receptor superfamily member 10A (TNFRSF10A)	OTBPCU2O	TR10A_HUMAN	Increases Expression	[110]
NF-kappa-B inhibitor epsilon (NFKBIE)	OTLAYEL9	IKBE_HUMAN	Decreases Expression	[109]
E3 SUMO-protein ligase CBX4 (CBX4)	OT4XVRRF	CBX4_HUMAN	Increases Sumoylation	[69]
Claudin-5 (CLDN5)	OTUX60YO	CLD5_HUMAN	Decreases Expression	[111]
Transcription factor E2F3 (E2F3)	OT5VQMWY	E2F3_HUMAN	Increases Expression	[112]
Chromodomain-helicase-DNA-binding protein 2 (CHD2)	OTRKL6YC	CHD2_HUMAN	Affects Methylation	[55]
Telomerase reverse transcriptase (TERT)	OT085VVA	TERT_HUMAN	Decreases Expression	[113]
Serine/threonine-protein kinase Chk1 (CHEK1)	OTTTI622	CHK1_HUMAN	Increases Phosphorylation	[114]
Aurora kinase A (AURKA)	OTMX0HYT	AURKA_HUMAN	Increases Expression	[115]
Synaptojanin-2 (SYNJ2)	OTLRHXP1	SYNJ2_HUMAN	Decreases Expression	[116]
Guanine nucleotide exchange factor DBS (MCF2L)	OTEURA8N	MCF2L_HUMAN	Decreases Expression	[116]
Inhibitor of nuclear factor kappa-B kinase subunit alpha (CHUK)	OTLF4ZB1	IKKA_HUMAN	Decreases Expression	[117]
Protein phosphatase 1D (PPM1D)	OT8NLZ9D	PPM1D_HUMAN	Decreases Expression	[118]
Tumor protein p73 (TP73)	OT0LUO47	P73_HUMAN	Increases Expression	[70]
Baculoviral IAP repeat-containing protein 5 (BIRC5)	OTILXZYL	BIRC5_HUMAN	Decreases Expression	[119]
ATP-binding cassette sub-family C member 3 (ABCC3)	OTC3IJV4	MRP3_HUMAN	Decreases Expression	[77]
ATP-binding cassette sub-family C member 4 (ABCC4)	OTO27PAL	MRP4_HUMAN	Decreases Expression	[120]
CASP8 and FADD-like apoptosis regulator (CFLAR)	OTX14BAS	CFLAR_HUMAN	Decreases Expression	[61]
Suppressor of cytokine signaling 1 (SOCS1)	OTWA9KFU	SOCS1_HUMAN	Decreases Methylation	[121]
3-phosphoinositide-dependent protein kinase 1 (PDPK1)	OTT09ZVP	PDPK1_HUMAN	Decreases Activity	[122]
ATP-dependent RNA helicase DHX15 (DHX15)	OT4F98TK	DHX15_HUMAN	Decreases Expression	[123]
Beta-1,4-galactosyltransferase 5 (B4GALT5)	OTHMZY12	B4GT5_HUMAN	Decreases Expression	[124]
Krueppel-like factor 4 (KLF4)	OT4O9RQW	KLF4_HUMAN	Increases Expression	[125]
Prominin-1 (PROM1)	OTBHV8NX	PROM1_HUMAN	Decreases Expression	[126]
DNA repair protein RAD51 homolog 3 (RAD51C)	OTUD6SY5	RA51C_HUMAN	Affects Expression	[81]
ATPase GET3 (GET3)	OTQ8KDFX	GET3_HUMAN	Increases Expression	[127]
Protein SCO2 homolog, mitochondrial (SCO2)	OTJQQDRS	SCO2_HUMAN	Decreases Expression	[49]
Glucose-6-phosphate exchanger SLC37A4 (SLC37A4)	OTLCYA32	G6PT1_HUMAN	Increases Expression	[128]
Double-strand-break repair protein rad21 homolog (RAD21)	OTQS84ZF	RAD21_HUMAN	Affects Methylation	[55]
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (BNIP3L)	OTJKOMXE	BNI3L_HUMAN	Increases Expression	[129]
Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (BUB1B)	OT8KME51	BUB1B_HUMAN	Increases Phosphorylation	[130]
Toll-like receptor 2 (TLR2)	OTGO5P4R	TLR2_HUMAN	Decreases Expression	[109]
Transcription factor MafK (MAFK)	OTZJUE4P	MAFK_HUMAN	Affects Methylation	[55]
Serine/threonine-protein kinase/endoribonuclease IRE1 (ERN1)	OTY9R6FZ	ERN1_HUMAN	Increases Expression	[131]
Transcription factor E2F6 (E2F6)	OT2PN28R	E2F6_HUMAN	Affects Methylation	[55]
Probable cytosolic iron-sulfur protein assembly protein CIAO1 (CIAO1)	OTCU8PFI	CIAO1_HUMAN	Decreases Expression	[49]
Ubiquitin-like protein ATG12 (ATG12)	OTJRO09Y	ATG12_HUMAN	Increases Expression	[67]
Solute carrier organic anion transporter family member 2B1 (SLCO2B1)	OTERJ4VQ	SO2B1_HUMAN	Increases Expression	[77]
Ubiquitin-like modifier-activating enzyme ATG7 (ATG7)	OTVT4YA1	ATG7_HUMAN	Increases Expression	[67]
Phospholipid-transporting ATPase ABCA1 (ABCA1)	OT94G6BQ	ABCA1_HUMAN	Decreases Expression	[132]
Apoptosis-inducing factor 1, mitochondrial (AIFM1)	OTKPWB7Q	AIFM1_HUMAN	Affects Localization	[133]
Zinc finger protein SNAI1 (SNAI1)	OTDPYAMC	SNAI1_HUMAN	Decreases Expression	[134]
Epidermal growth factor receptor (EGFR)	OTAPLO1S	EGFR_HUMAN	Decreases Expression	[135]
Plasminogen (PLG)	OTWWIPPY	PLMN_HUMAN	Decreases Activity	[136]
Urokinase-type plasminogen activator (PLAU)	OTX0QGKK	UROK_HUMAN	Decreases Expression	[137]
Alpha-2-macroglobulin (A2M)	OTFTX90K	A2MG_HUMAN	Decreases Expression	[49]
Metalloproteinase inhibitor 1 (TIMP1)	OTOXC51H	TIMP1_HUMAN	Increases Expression	[137]
Myc proto-oncogene protein (MYC)	OTPV5LUK	MYC_HUMAN	Decreases Expression	[138]
Transforming growth factor beta-1 proprotein (TGFB1)	OTV5XHVH	TGFB1_HUMAN	Increases Expression	[139]
Pro-neuropeptide Y (NPY)	OT4ICV3P	NPY_HUMAN	Increases Expression	[140]
Tumor necrosis factor (TNF)	OT4IE164	TNFA_HUMAN	Decreases Expression	[141]
Interferon gamma (IFNG)	OTXG9JM7	IFNG_HUMAN	Decreases Expression	[142]
Collagen alpha-1(I) chain (COL1A1)	OTI31178	CO1A1_HUMAN	Decreases Expression	[143]
Glycophorin-A (GYPA)	OTABU4YV	GLPA_HUMAN	Decreases Expression	[144]
Alpha-fetoprotein (AFP)	OT9GG3ZI	FETA_HUMAN	Decreases Expression	[145]
Transferrin receptor protein 1 (TFRC)	OT8ZPBDL	TFR1_HUMAN	Decreases Expression	[61]
Ferritin heavy chain (FTH1)	OT6IFS0O	FRIH_HUMAN	Increases Expression	[146]
Estrogen receptor (ESR1)	OTKLU61J	ESR1_HUMAN	Decreases Methylation	[147]
NADH-ubiquinone oxidoreductase chain 4 (ND4)	OT4RQVAA	NU4M_HUMAN	Increases Expression	[146]
Thymidine kinase, cytosolic (TK1)	OTY5JFM1	KITH_HUMAN	Decreases Expression	[148]
N-myc proto-oncogene protein (MYCN)	OTWD33K1	MYCN_HUMAN	Decreases Expression	[149]
High affinity nerve growth factor receptor (NTRK1)	OTJORQAU	NTRK1_HUMAN	Increases Expression	[150]
Cytochrome P450 1A1 (CYP1A1)	OTE4EFH8	CP1A1_HUMAN	Decreases Expression	[151]
Integrin beta-3 (ITGB3)	OTWCK1K6	ITB3_HUMAN	Increases Expression	[144]
Interleukin-4 (IL4)	OTOXBWAU	IL4_HUMAN	Decreases Expression	[152]
Plasminogen activator inhibitor 2 (SERPINB2)	OT72QLZB	PAI2_HUMAN	Affects Expression	[153]
Alkaline phosphatase, placental type (ALPP)	OTZU4G9W	PPB1_HUMAN	Decreases Expression	[49]
Eukaryotic translation initiation factor 2 subunit 1 (EIF2S1)	OTM0GDTP	IF2A_HUMAN	Increases Expression	[154]
Interleukin-6 (IL6)	OTUOSCCU	IL6_HUMAN	Decreases Expression	[141]
Intercellular adhesion molecule 1 (ICAM1)	OTTOIX77	ICAM1_HUMAN	Decreases Expression	[109]
Transcription factor Jun (JUN)	OTCYBO6X	JUN_HUMAN	Decreases Expression	[109]
Integrin beta-1 (ITGB1)	OT6G1IAR	ITB1_HUMAN	Decreases Expression	[116]
Retinoblastoma-associated protein (RB1)	OTQJUJMZ	RB_HUMAN	Decreases Expression	[155]
Prothymosin alpha (PTMA)	OT2W4T1M	PTMA_HUMAN	Affects Expression	[156]
Cyclin-dependent kinase 1 (CDK1)	OTW1SC2N	CDK1_HUMAN	Increases Expression	[112]
Eukaryotic translation initiation factor 4E (EIF4E)	OTDAWNLA	IF4E_HUMAN	Increases Phosphorylation	[157]
Tyrosine 3-monooxygenase (TH)	OT6ZORKP	TY3H_HUMAN	Decreases Expression	[140]
Thyroid peroxidase (TPO)	OTJJLL20	PERT_HUMAN	Decreases Activity	[158]
Cathepsin D (CTSD)	OTQZ36F3	CATD_HUMAN	Increases Expression	[159]
Annexin A2 (ANXA2)	OTFNS0CC	ANXA2_HUMAN	Decreases Expression	[160]
Trypsin-2 (PRSS2)	OTOMVUWL	TRY2_HUMAN	Affects Expression	[156]
Cathepsin B (CTSB)	OTP9G5QB	CATB_HUMAN	Decreases Expression	[161]
Transcription factor Sp1 (SP1)	OTISPT4X	SP1_HUMAN	Decreases Expression	[135]
Zinc finger protein GLI1 (GLI1)	OT1BTAJO	GLI1_HUMAN	Decreases Expression	[162]
72 kDa type IV collagenase (MMP2)	OT5NIWA2	MMP2_HUMAN	Decreases Expression	[137]
Receptor-type tyrosine-protein phosphatase C (PTPRC)	OT6KOR77	PTPRC_HUMAN	Increases Expression	[163]
Alpha-2-antiplasmin (SERPINF2)	OTZGAF8B	A2AP_HUMAN	Increases Expression	[164]
Poly polymerase 1 (PARP1)	OT310QSG	PARP1_HUMAN	Decreases Expression	[165]
Heat shock 70 kDa protein 1A (HSPA1A)	OTKGIE76	HS71A_HUMAN	Increases Expression	[166]
Zinc finger protein GLI2 (GLI2)	OTIRV97L	GLI2_HUMAN	Decreases Expression	[162]
Apoptosis regulator Bcl-2 (BCL2)	OT9DVHC0	BCL2_HUMAN	Decreases Expression	[167]
Osteopontin (SPP1)	OTJGC23Y	OSTP_HUMAN	Decreases Expression	[109]
Mast/stem cell growth factor receptor Kit (KIT)	OTHUY3VZ	KIT_HUMAN	Decreases Expression	[168]
Retinoic acid receptor beta (RARB)	OT367U3E	RARB_HUMAN	Decreases Expression	[169]
Laminin subunit gamma-1 (LAMC1)	OTIG527N	LAMC1_HUMAN	Decreases Expression	[116]
Solute carrier family 2, facilitated glucose transporter member 2 (SLC2A2)	OTBL2W7R	GTR2_HUMAN	Increases Expression	[77]
Integrin alpha-M (ITGAM)	OTAG6HWU	ITAM_HUMAN	Increases Expression	[170]
Lysosome-associated membrane glycoprotein 1 (LAMP1)	OTYE92QY	LAMP1_HUMAN	Increases Expression	[67]
DNA topoisomerase 2-alpha (TOP2A)	OT6LPS08	TOP2A_HUMAN	Decreases Expression	[171]
Cholesteryl ester transfer protein (CETP)	OTAGPPOE	CETP_HUMAN	Increases Expression	[172]
Proliferating cell nuclear antigen (PCNA)	OTHZ1RIA	PCNA_HUMAN	Increases Expression	[173]
Creatine kinase B-type (CKB)	OTUCKOTT	KCRB_HUMAN	Decreases Expression	[49]
High affinity immunoglobulin gamma Fc receptor I (FCGR1A)	OTOBCS2O	FCGR1_HUMAN	Increases Expression	[174]
Cadherin-1 (CDH1)	OTFJMXPM	CADH1_HUMAN	Decreases Expression	[175]
Tissue factor (F3)	OT3MSU3B	TF_HUMAN	Decreases Expression	[176]
Glycogen synthase, muscle (GYS1)	OTJZJRWK	GYS1_HUMAN	Decreases Phosphorylation	[177]
Pyruvate kinase PKM (PKM)	OTLHHMC2	KPYM_HUMAN	Decreases Expression	[178]
Matrix metalloproteinase-9 (MMP9)	OTB2QDAV	MMP9_HUMAN	Decreases Expression	[137]
Leukemia inhibitory factor (LIF)	OTO46S5S	LIF_HUMAN	Decreases Expression	[128]
Nucleoside diphosphate kinase A (NME1)	OT0NELQ1	NDKA_HUMAN	Increases Expression	[149]
Erythroid transcription factor (GATA1)	OTX1R7O1	GATA1_HUMAN	Decreases Expression	[144]
Metalloproteinase inhibitor 2 (TIMP2)	OT8S1RRP	TIMP2_HUMAN	Decreases Expression	[137]
CD44 antigen (CD44)	OT9TTJ41	CD44_HUMAN	Decreases Expression	[59]
Histone H2AX (H2AX)	OT18UX57	H2AX_HUMAN	Increases Expression	[179]
P-selectin (SELP)	OTWR90PK	LYAM3_HUMAN	Decreases Expression	[164]
Beta-galactosidase (GLB1)	OTB0TKAG	BGAL_HUMAN	Increases Activity	[180]
Platelet endothelial cell adhesion molecule (PECAM1)	OTXOM4D9	PECA1_HUMAN	Decreases Expression	[181]
Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (PPP3CB)	OTEGNEHW	PP2BB_HUMAN	Increases Expression	[182]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (PLCG2)	OTGVC9MY	PLCG2_HUMAN	Decreases Phosphorylation	[183]
Stathmin (STMN1)	OTDJ4RV0	STMN1_HUMAN	Decreases Expression	[184]
Heat shock 70 kDa protein 6 (HSPA6)	OTH4S7WB	HSP76_HUMAN	Increases Expression	[185]
T-cell acute lymphocytic leukemia protein 1 (TAL1)	OTX4K6QZ	TAL1_HUMAN	Decreases Expression	[144]
Calpain-2 catalytic subunit (CAPN2)	OTIAPE5J	CAN2_HUMAN	Increases Expression	[165]
CCAAT/enhancer-binding protein beta (CEBPB)	OTM9MQIA	CEBPB_HUMAN	Decreases Expression	[109]
Insulin-like growth factor-binding protein 3 (IGFBP3)	OTIX63TX	IBP3_HUMAN	Increases Expression	[186]
Transcription factor PU.1 (SPI1)	OTVCA1D0	SPI1_HUMAN	Increases Methylation	[55]
Vascular endothelial growth factor receptor 1 (FLT1)	OTT0OGYS	VGFR1_HUMAN	Decreases Expression	[187]
Large ribosomal subunit protein uL30 (RPL7)	OT4WCQBE	RL7_HUMAN	Decreases Expression	[116]
Large ribosomal subunit protein uL22 (RPL17)	OTTYMPS6	RL17_HUMAN	Decreases Expression	[116]
Cyclic AMP-dependent transcription factor ATF-6 alpha (ATF6)	OTAFHAVI	ATF6A_HUMAN	Increases Expression	[131]
Cadherin-2 (CDH2)	OTH0Y56P	CADH2_HUMAN	Decreases Expression	[178]
Erythropoietin receptor (EPOR)	OTUIOEU3	EPOR_HUMAN	Decreases Expression	[144]
ETS domain-containing protein Elk-1 (ELK1)	OTH9MXD6	ELK1_HUMAN	Increases Phosphorylation	[188]
Transcription factor EB (TFEB)	OTJUJJQY	TFEB_HUMAN	Increases Expression	[67]
Interferon-induced, double-stranded RNA-activated protein kinase (EIF2AK2)	OT8DXMS3	E2AK2_HUMAN	Increases Phosphorylation	[125]
Neutrophil cytosol factor 2 (NCF2)	OTAUW7L2	NCF2_HUMAN	Increases Expression	[189]
Plasma membrane calcium-transporting ATPase 1 (ATP2B1)	OT5MXG9W	AT2B1_HUMAN	Decreases Expression	[116]
TATA-box-binding protein (TBP)	OT6C0S52	TBP_HUMAN	Affects Methylation	[55]
Integrin alpha-X (ITGAX)	OTOGIMHE	ITAX_HUMAN	Decreases Expression	[61]
Transcription initiation factor TFIID subunit 1 (TAF1)	OTDYS5G4	TAF1_HUMAN	Affects Methylation	[55]
E3 ubiquitin-protein ligase CBL (CBL)	OTTKELCU	CBL_HUMAN	Increases Expression	[190]
Insulin-like growth factor-binding protein 4 (IGFBP4)	OT2HZRBD	IBP4_HUMAN	Increases Expression	[186]
Solute carrier family 2, facilitated glucose transporter member 5 (SLC2A5)	OTZNYEKF	GTR5_HUMAN	Increases Expression	[77]
Ribosomal protein S6 kinase beta-1 (RPS6KB1)	OTAELNGX	KS6B1_HUMAN	Decreases Activity	[122]
Tyrosine-protein kinase JAK1 (JAK1)	OT0X3D17	JAK1_HUMAN	Decreases Expression	[128]
Brain-derived neurotrophic factor (BDNF)	OTLGH7EW	BDNF_HUMAN	Decreases Expression	[191]
Eukaryotic translation initiation factor 4B (EIF4B)	OTE8TXA8	IF4B_HUMAN	Decreases Expression	[62]
Endothelial transcription factor GATA-2 (GATA2)	OTBP2QQ2	GATA2_HUMAN	Increases Expression	[144]
Ribonucleoside-diphosphate reductase large subunit (RRM1)	OTXGQOR9	RIR1_HUMAN	Decreases Expression	[148]
Insulin-like growth factor-binding protein 5 (IGFBP5)	OTRE5V0C	IBP5_HUMAN	Increases Expression	[186]
G1/S-specific cyclin-E1 (CCNE1)	OTLD7UID	CCNE1_HUMAN	Decreases Expression	[192]
Tumor necrosis factor receptor superfamily member 6 (FAS)	OTP9XG86	TNR6_HUMAN	Increases Expression	[149]
Cathepsin S (CTSS)	OT3PXIPM	CATS_HUMAN	Increases Expression	[193]
Tumor necrosis factor receptor superfamily member 5 (CD40)	OT5YU2XB	TNR5_HUMAN	Increases Expression	[186]
NF-kappa-B inhibitor alpha (NFKBIA)	OTFT924M	IKBA_HUMAN	Decreases Expression	[141]
Pentraxin-related protein PTX3 (PTX3)	OTPXHRKU	PTX3_HUMAN	Increases Expression	[52]
Protein S100-A4 (S100A4)	OTLRGFSQ	S10A4_HUMAN	Decreases Expression	[49]
High mobility group protein B2 (HMGB2)	OTGEGAOK	HMGB2_HUMAN	Increases Expression	[146]
Interleukin-3 receptor subunit alpha (IL3RA)	OTDC3Y8O	IL3RA_HUMAN	Decreases Expression	[194]
Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1)	OT5BZ1J9	P85A_HUMAN	Decreases Expression	[195]
Proteasome subunit beta type-6 (PSMB6)	OT9VXPNW	PSB6_HUMAN	Increases Expression	[116]
ETS domain-containing protein Elk-4 (ELK4)	OTVSSEOE	ELK4_HUMAN	Decreases Methylation	[55]
Retinoblastoma-like protein 1 (RBL1)	OTDEBFYC	RBL1_HUMAN	Decreases Methylation	[196]
Hematopoietic progenitor cell antigen CD34 (CD34)	OT1MOFLZ	CD34_HUMAN	Decreases Expression	[197]
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	OTG0TTX7	CD38_HUMAN	Increases Expression	[197]
Tyrosine-protein phosphatase non-receptor type 6 (PTPN6)	OT33XNZM	PTN6_HUMAN	Increases Expression	[198]
Caspase-1 (CASP1)	OTZ3YQFU	CASP1_HUMAN	Increases Expression	[199]
CD40 ligand (CD40LG)	OT75Z6A6	CD40L_HUMAN	Increases Expression	[186]
Thioredoxin-dependent peroxide reductase, mitochondrial (PRDX3)	OTLB2WEU	PRDX3_HUMAN	Decreases Expression	[200]
M-phase inducer phosphatase 1 (CDC25A)	OTSLKKCO	MPIP1_HUMAN	Increases Expression	[112]
M-phase inducer phosphatase 2 (CDC25B)	OT12MSRY	MPIP2_HUMAN	Decreases Expression	[201]
M-phase inducer phosphatase 3 (CDC25C)	OTPQI71S	MPIP3_HUMAN	Decreases Expression	[201]
Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIF)	OTRA8ZVE	PPIF_HUMAN	Increases Oxidation	[65]
Homeobox protein Hox-A9 (HOXA9)	OTKNK5H0	HXA9_HUMAN	Decreases Expression	[202]
ETS-related transcription factor Elf-1 (ELF1)	OTV5LKIA	ELF1_HUMAN	Affects Methylation	[55]
Syndecan-2 (SDC2)	OTEEHY1D	SDC2_HUMAN	Decreases Expression	[116]
Catenin beta-1 (CTNNB1)	OTZ932A3	CTNB1_HUMAN	Decreases Expression	[203]
Interleukin-13 (IL13)	OTI4YS3Y	IL13_HUMAN	Decreases Expression	[204]
Merlin (NF2)	OT6E5ACG	MERL_HUMAN	Decreases Expression	[60]
Pro-adrenomedullin (ADM)	OT7T0TA4	ADML_HUMAN	Decreases Expression	[109]
Phosphoenolpyruvate carboxykinase, cytosolic (PCK1)	OTNWEJ5Y	PCKGC_HUMAN	Increases Expression	[128]
Basigin (BSG)	OTD0CVEC	BASI_HUMAN	Decreases Expression	[205]
Vascular endothelial growth factor receptor 3 (FLT4)	OTRAA26B	VGFR3_HUMAN	Decreases Expression	[206]
Vascular endothelial growth factor receptor 2 (KDR)	OT15797V	VGFR2_HUMAN	Decreases Expression	[181]
Dual specificity mitogen-activated protein kinase kinase 2 (MAP2K2)	OTUE7Z91	MP2K2_HUMAN	Decreases Activity	[207]
Receptor-type tyrosine-protein kinase FLT3 (FLT3)	OTMSRYMK	FLT3_HUMAN	Decreases Phosphorylation	[208]
Sterol regulatory element-binding protein 1 (SREBF1)	OTWBRPAI	SRBP1_HUMAN	Decreases Expression	[132]
Serine/threonine-protein kinase receptor R3 (ACVRL1)	OT1HQR88	ACVL1_HUMAN	Decreases Expression	[48]
TGF-beta receptor type-2 (TGFBR2)	OT3P7GZP	TGFR2_HUMAN	Decreases Expression	[116]
Peroxisome proliferator-activated receptor gamma (PPARG)	OTHMARHO	PPARG_HUMAN	Increases Expression	[209]
RNA-binding motif protein, X chromosome (RBMX)	OTFZN66E	RBMX_HUMAN	Decreases Expression	[116]
Cyclin-dependent kinase inhibitor 1 (CDKN1A)	OTQWHCZE	CDN1A_HUMAN	Decreases Expression	[196]
T-cell surface protein tactile (CD96)	OT3SGX8W	TACT_HUMAN	Decreases Expression	[197]
Signal transducer and activator of transcription 3 (STAT3)	OTAAGKYZ	STAT3_HUMAN	Decreases Expression	[145]
Cyclin-F (CCNF)	OTJFVU43	CCNF_HUMAN	Decreases Expression	[196]
DNA-binding protein inhibitor ID-1 (ID1)	OTKGNZN5	ID1_HUMAN	Decreases Expression	[210]
Regulator of G-protein signaling 2 (RGS2)	OT0FSRW7	RGS2_HUMAN	Decreases Expression	[116]
Signal transducer and activator of transcription 5A (STAT5A)	OTBSJGN3	STA5A_HUMAN	Decreases Expression	[211]
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PIK3CB)	OTO8JQJA	PK3CB_HUMAN	Decreases Expression	[195]
Phosphatidylinositol 4-kinase alpha (PI4KA)	OT2L2G6C	PI4KA_HUMAN	Decreases Expression	[116]
Cyclin-dependent kinase inhibitor 2A (CDKN2A)	OTN0ZWAE	CDN2A_HUMAN	Decreases Methylation	[212]
Netrin receptor DCC (DCC)	OT2C1SHW	DCC_HUMAN	Increases Expression	[60]
Nicotinamide phosphoribosyltransferase (NAMPT)	OTVJR3GL	NAMPT_HUMAN	Decreases Expression	[213]
Transcription factor GATA-4 (GATA4)	OTQHWAZG	GATA4_HUMAN	Increases Expression	[180]
Mitogen-activated protein kinase 8 (MAPK8)	OTEREYS5	MK08_HUMAN	Increases Activity	[207]
Mitogen-activated protein kinase 9 (MAPK9)	OTCEVJ9E	MK09_HUMAN	Increases Activity	[214]
Cyclin-dependent kinase inhibitor 1B (CDKN1B)	OTNY5LLZ	CDN1B_HUMAN	Increases Expression	[113]
Neurogenic locus notch homolog protein 1 (NOTCH1)	OTI1WADQ	NOTC1_HUMAN	Decreases Expression	[215]
F-actin-capping protein subunit beta (CAPZB)	OTF1A4N0	CAPZB_HUMAN	Increases Expression	[116]
Homeobox protein CDX-1 (CDX1)	OTOHTMJE	CDX1_HUMAN	Decreases Expression	[216]
Tumor necrosis factor ligand superfamily member 6 (FASLG)	OTZARCHH	TNFL6_HUMAN	Decreases Expression	[62]
Transcription factor SOX-2 (SOX2)	OTFAWCAU	SOX2_HUMAN	Decreases Expression	[217]
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PIK3CG)	OT3FAU4Y	PK3CG_HUMAN	Decreases Expression	[195]
Cysteine--tRNA ligase, cytoplasmic (CARS1)	OTOUZF6O	SYCC_HUMAN	Decreases Expression	[116]
Caspase-4 (CASP4)	OTVQTV1L	CASP4_HUMAN	Increases Expression	[60]
Transcriptional repressor CTCF (CTCF)	OT8ZB70U	CTCF_HUMAN	Affects Methylation	[55]
CCAAT/enhancer-binding protein alpha (CEBPA)	OTOM9OE4	CEBPA_HUMAN	Decreases Expression	[218]
Matrix metalloproteinase-14 (MMP14)	OT9C197Z	MMP14_HUMAN	Decreases Expression	[137]
Breast cancer type 2 susceptibility protein (BRCA2)	OTF1XSV1	BRCA2_HUMAN	Decreases Expression	[109]
Interleukin-1 receptor-associated kinase 1 (IRAK1)	OT133G8J	IRAK1_HUMAN	Decreases Expression	[62]
Glypican-3 (GPC3)	OTWS8WSW	GPC3_HUMAN	Decreases Expression	[128]
Signal transducer and activator of transcription 5B (STAT5B)	OTZVPEBT	STA5B_HUMAN	Decreases Expression	[211]
Caspase-5 (CASP5)	OT0F2THD	CASP5_HUMAN	Increases Expression	[199]
Cyclin-H (CCNH)	OTKDU3SR	CCNH_HUMAN	Decreases Expression	[60]
Tyrosine-protein kinase JAK3 (JAK3)	OTQ8QW2L	JAK3_HUMAN	Decreases Expression	[57]
Transcription initiation factor IIA subunit 1 (GTF2A1)	OTWW4PN0	TF2AA_HUMAN	Increases Sumoylation	[69]
Hexokinase-2 (HK2)	OTC0GCQO	HXK2_HUMAN	Decreases Activity	[219]
Serine/threonine-protein kinase PLK1 (PLK1)	OTRZX45T	PLK1_HUMAN	Increases Phosphorylation	[179]
Atrophin-1 (ATN1)	OTNZFLKY	ATN1_HUMAN	Increases Sumoylation	[69]
Telomeric repeat-binding factor 1 (TERF1)	OTIJCMGB	TERF1_HUMAN	Increases Expression	[220]
Epithelial membrane protein 2 (EMP2)	OTPS2H0L	EMP2_HUMAN	Affects Expression	[156]
Oxysterols receptor LXR-beta (NR1H2)	OT4APA60	NR1H2_HUMAN	Decreases Expression	[172]
Aquaporin-4 (AQP4)	OTA9MYD5	AQP4_HUMAN	Increases Expression	[77]
Caspase-7 (CASP7)	OTAPJ040	CASP7_HUMAN	Increases Activity	[221]
Caspase-6 (CASP6)	OTXLD3EC	CASP6_HUMAN	Increases Expression	[60]
Hepatocyte nuclear factor 3-alpha (FOXA1)	OTEBY0TD	FOXA1_HUMAN	Affects Methylation	[55]
BH3-interacting domain death agonist (BID)	OTOSHSHU	BID_HUMAN	Decreases Expression	[222]
NACHT, LRR and PYD domains-containing protein 12 (NLRP12)	OTGR132Z	NAL12_HUMAN	Increases Expression	[109]
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN)	OTOWDUNT	PTEN_HUMAN	Decreases Expression	[223]
Ras-related protein Rab-2A (RAB2A)	OT6SK83U	RAB2A_HUMAN	Decreases Expression	[49]
C-X-C chemokine receptor type 4 (CXCR4)	OTUFSBX2	CXCR4_HUMAN	Decreases Expression	[224]
DNA-directed RNA polymerases I, II, and III subunit RPABC2 (POLR2F)	OTF9T8I2	RPAB2_HUMAN	Decreases Expression	[49]
Protein max (MAX)	OTKZ0YKM	MAX_HUMAN	Decreases Expression	[55]
V-type proton ATPase subunit d 1 (ATP6V0D1)	OT9GU2NW	VA0D1_HUMAN	Increases Expression	[67]
Heterogeneous nuclear ribonucleoprotein K (HNRNPK)	OTNPRM8U	HNRPK_HUMAN	Decreases Expression	[225]
Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PPP1CB)	OTYFTYFR	PP1B_HUMAN	Decreases Expression	[116]
Small ribosomal subunit protein uS8 (RPS15A)	OT0BUA12	RS15A_HUMAN	Increases Expression	[146]
Protein BTG1 (BTG1)	OTVJ2CDM	BTG1_HUMAN	Increases Expression	[48]
Actin, aortic smooth muscle (ACTA2)	OTEDLG8E	ACTA_HUMAN	Decreases Expression	[143]
Large ribosomal subunit protein uL14 (RPL23)	OTXI1YLM	RL23_HUMAN	Increases Expression	[146]
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PPP2CA)	OT83PT85	PP2AA_HUMAN	Decreases Expression	[224]
E3 ubiquitin-protein ligase RNF4 (RNF4)	OTCMXQRE	RNF4_HUMAN	Affects Localization	[226]
Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2)	OTEO98CR	IF4G2_HUMAN	Increases Cleavage	[227]
C-C motif chemokine 7 (CCL7)	OTDIS99H	CCL7_HUMAN	Increases Expression	[228]
Neutrophil gelatinase-associated lipocalin (LCN2)	OTSB42BR	NGAL_HUMAN	Increases Expression	[70]
Mothers against decapentaplegic homolog 3 (SMAD3)	OTNA96MR	SMAD3_HUMAN	Decreases Expression	[229]
Heat shock factor protein 1 (HSF1)	OTYNJ4KP	HSF1_HUMAN	Increases Activity	[230]
Transcription factor E2F1 (E2F1)	OTLKYBBC	E2F1_HUMAN	Increases Expression	[231]
POU domain, class 5, transcription factor 1 (POU5F1)	OTDHHN7O	PO5F1_HUMAN	Decreases Expression	[128]
Transcription factor Sp4 (SP4)	OTWB30IZ	SP4_HUMAN	Decreases Expression	[135]
Transcription factor Sp3 (SP3)	OTYDQZ1T	SP3_HUMAN	Decreases Expression	[135]
Large ribosomal subunit protein eL6 (RPL6)	OTRU71O4	RL6_HUMAN	Decreases Expression	[60]
Transcription factor p65 (RELA)	OTUJP9CN	TF65_HUMAN	Decreases Expression	[215]
Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1)	OT2CF1E6	IF4G1_HUMAN	Decreases Expression	[62]
Proto-oncogene c-Rel (REL)	OTTCKMAC	REL_HUMAN	Decreases Expression	[211]
Tyrosine-protein phosphatase non-receptor type 11 (PTPN11)	OTFH9M73	PTN11_HUMAN	Decreases Expression	[70]
Tyrosine-protein kinase BTK (BTK)	OTG3CDVK	BTK_HUMAN	Increases Expression	[62]
Lymphotoxin-beta (LTB)	OTUFS8CF	TNFC_HUMAN	Increases Expression	[199]
Tumor necrosis factor receptor superfamily member 9 (TNFRSF9)	OTNOM26L	TNR9_HUMAN	Increases Expression	[232]
Cytoskeleton-associated protein 4 (CKAP4)	OTDUC9ME	CKAP4_HUMAN	Decreases Expression	[116]
Apoptosis regulator BAX (BAX)	OTAW0V4V	BAX_HUMAN	Decreases Expression	[60]
Bcl-2-like protein 1 (BCL2L1)	OTRC5K9O	B2CL1_HUMAN	Decreases Expression	[70]
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1)	OT2YYI1A	MCL1_HUMAN	Decreases Expression	[233]
Peroxisome proliferator-activated receptor alpha (PPARA)	OTK095PP	PPARA_HUMAN	Decreases Expression	[218]
Protein phosphatase 3 catalytic subunit alpha (PPP3CA)	OT58PUEN	PP2BA_HUMAN	Increases Expression	[131]
Forkhead box protein O1 (FOXO1)	OTPJRB6D	FOXO1_HUMAN	Increases Expression	[62]
Cell division cycle protein 20 homolog (CDC20)	OTCOEZRV	CDC20_HUMAN	Decreases Expression	[234]
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3)	OT4SO7J4	BNIP3_HUMAN	Increases Expression	[129]
Interleukin-24 (IL24)	OT4VUWH1	IL24_HUMAN	Increases Activity	[235]
FAS-associated death domain protein (FADD)	OTV7GFHH	FADD_HUMAN	Increases Expression	[236]
Serine/arginine-rich splicing factor 5 (SRSF5)	OTC5WP98	SRSF5_HUMAN	Increases Expression	[146]
S-phase kinase-associated protein 2 (SKP2)	OTD5B41X	SKP2_HUMAN	Decreases Expression	[148]
Serine-protein kinase ATM (ATM)	OTQVOHLT	ATM_HUMAN	Decreases Expression	[70]
Bcl-2-interacting killer (BIK)	OTTH1T3D	BIK_HUMAN	Increases Expression	[199]
Metastasis-associated protein MTA1 (MTA1)	OTBHW3S9	MTA1_HUMAN	Decreases Expression	[149]
Peptidyl-prolyl cis-trans isomerase FKBP5 (FKBP5)	OT404F9K	FKBP5_HUMAN	Affects Expression	[237]
Baculoviral IAP repeat-containing protein 3 (BIRC3)	OT3E95KB	BIRC3_HUMAN	Decreases Expression	[70]
Baculoviral IAP repeat-containing protein 2 (BIRC2)	OTFXFREP	BIRC2_HUMAN	Decreases Expression	[238]
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1)	OTDS5WAU	PIN1_HUMAN	Decreases Expression	[49]
Serine/threonine-protein kinase ATR (ATR)	OTH0OP1J	ATR_HUMAN	Increases Expression	[239]
Eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1)	OTHBQVD5	4EBP1_HUMAN	Decreases Phosphorylation	[240]
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1)	OTC41R1E	RIPK1_HUMAN	Increases Cleavage	[241]
Protein patched homolog 1 (PTCH1)	OTMG07H5	PTC1_HUMAN	Decreases Expression	[162]
Spectrin alpha chain, non-erythrocytic 1 (SPTAN1)	OT6VY3A3	SPTN1_HUMAN	Increases Expression	[116]
Exosome complex component RRP4 (EXOSC2)	OTN6NVKL	EXOS2_HUMAN	Decreases Expression	[48]
Ras-specific guanine nucleotide-releasing factor 1 (RASGRF1)	OTNWJ7EN	RGRF1_HUMAN	Increases Expression	[60]
Interleukin-18 (IL18)	OTBB2A8O	IL18_HUMAN	Increases Secretion	[242]
Protein-tyrosine kinase 2-beta (PTK2B)	OTGAS0I8	FAK2_HUMAN	Affects Expression	[156]
Beclin-1 (BECN1)	OT4X293M	BECN1_HUMAN	Increases Expression	[243]
Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2)	OTPHGZ19	ITPR2_HUMAN	Increases Expression	[49]
ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL6IP1)	OT536XAV	AR6P1_HUMAN	Increases Expression	[146]
Histone-lysine N-methyltransferase SETDB1 (SETDB1)	OTWVUA1B	SETB1_HUMAN	Affects Methylation	[55]
Interferon regulatory factor 4 (IRF4)	OT1DHQ1P	IRF4_HUMAN	Affects Methylation	[55]
Sonic hedgehog protein (SHH)	OTOG2BXF	SHH_HUMAN	Decreases Activity	[162]
Telomeric repeat-binding factor 2 (TERF2)	OTBSAS0V	TERF2_HUMAN	Increases Expression	[220]
Homeobox protein TGIF1 (TGIF1)	OTN9VHAG	TGIF1_HUMAN	Increases Expression	[244]
NF-kappa-B inhibitor beta (NFKBIB)	OTY1ZJXH	IKBB_HUMAN	Decreases Expression	[109]
Mitogen-activated protein kinase 11 (MAPK11)	OT0AS010	MK11_HUMAN	Increases Activity	[245]
Adiponectin (ADIPOQ)	OTNX23LE	ADIPO_HUMAN	Increases Expression	[246]
Histone-lysine N-methyltransferase EZH2 (EZH2)	OTIEHTKW	EZH2_HUMAN	Decreases Expression	[247]
Nuclear factor erythroid 2-related factor 2 (NFE2L2)	OT0HENJ5	NF2L2_HUMAN	Increases Expression	[143]
NT-3 growth factor receptor (NTRK3)	OTII30MY	NTRK3_HUMAN	Increases Expression	[150]
Mitogen-activated protein kinase 14 (MAPK14)	OT5TCO3O	MK14_HUMAN	Increases Phosphorylation	[248]
Interleukin-17A (IL17A)	OTY72FT2	IL17_HUMAN	Decreases Expression	[152]
Bcl-2 homologous antagonist/killer (BAK1)	OTDP6ILW	BAK_HUMAN	Decreases Expression	[60]
Occludin (OCLN)	OTSUTVWL	OCLN_HUMAN	Decreases Expression	[188]
Nuclear respiratory factor 1 (NRF1)	OTOXWNV8	NRF1_HUMAN	Affects Methylation	[55]
Dual specificity protein phosphatase 5 (DUSP5)	OTH96RA7	DUS5_HUMAN	Decreases Expression	[231]
Carbonic anhydrase 9 (CA9)	OTNA51XT	CAH9_HUMAN	Decreases Expression	[161]
Discoidin domain-containing receptor 2 (DDR2)	OT9IHOGZ	DDR2_HUMAN	Increases Expression	[49]
MHC class I polypeptide-related sequence B (MICB)	OTS2DVDW	MICB_HUMAN	Increases Expression	[66]
MHC class I polypeptide-related sequence A (MICA)	OTPEIEAR	MICA_HUMAN	Increases Expression	[66]
Transcription factor HES-5 (HES5)	OTW7JEHV	HES5_HUMAN	Decreases Expression	[217]
Inactive caspase-12 (CASP12)	OTY2W6FG	CASPC_HUMAN	Increases Expression	[51]
TIR domain-containing adapter molecule 2 (TICAM2)	OTK7GIJ5	TCAM2_HUMAN	Increases Expression	[109]
Centrosomal protein of 57 kDa (CEP57)	OTPOHLIX	CEP57_HUMAN	Increases Expression	[146]
Secreted frizzled-related protein 1 (SFRP1)	OT0U9G41	SFRP1_HUMAN	Decreases Methylation	[249]
Mixed lineage kinase domain-like protein (MLKL)	OTDSLC81	MLKL_HUMAN	Increases Phosphorylation	[248]
Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3)	OTLUM9L7	PK3C3_HUMAN	Decreases Expression	[195]
GA-binding protein subunit beta-2 (GABPB2)	OTDCZYFN	GABP2_HUMAN	Decreases Expression	[116]
Transient receptor potential cation channel subfamily M member 4 (TRPM4)	OT354X8E	TRPM4_HUMAN	Increases Expression	[250]
Chromosome transmission fidelity protein 18 homolog (CHTF18)	OTQK3FI4	CTF18_HUMAN	Increases Sumoylation	[69]
DNA damage-binding protein 2 (DDB2)	OTO8HVVB	DDB2_HUMAN	Affects Expression	[237]
Aquaporin-3 (AQP3)	OT2J7JPD	AQP3_HUMAN	Increases Expression	[77]
ER degradation-enhancing alpha-mannosidase-like protein 1 (EDEM1)	OTWHN69S	EDEM1_HUMAN	Increases Expression	[251]
Histone deacetylase 2 (HDAC2)	OTUYVFKN	HDAC2_HUMAN	Increases Methylation	[55]
Histone acetyltransferase KAT2A (KAT2A)	OTN0W2SW	KAT2A_HUMAN	Affects Expression	[252]
Bcl-2-like protein 2 (BCL2L2)	OTMKVO0J	B2CL2_HUMAN	Increases Expression	[186]
Caspase-10 (CASP10)	OTE6J88E	CASPA_HUMAN	Increases Expression	[253]
Interferon regulatory factor 7 (IRF7)	OTC1A2PQ	IRF7_HUMAN	Decreases Expression	[254]
Histone acetyltransferase KAT5 (KAT5)	OTL7257A	KAT5_HUMAN	Decreases Expression	[70]
F-box/WD repeat-containing protein 7 (FBXW7)	OTJXE4OT	FBXW7_HUMAN	Increases Expression	[255]
Tumor protein p53-inducible nuclear protein 1 (TP53INP1)	OT2363Z9	T53I1_HUMAN	Affects Expression	[70]
PIN2/TERF1-interacting telomerase inhibitor 1 (PINX1)	OTAP7L6G	PINX1_HUMAN	Decreases Expression	[256]
Baculoviral IAP repeat-containing protein 7 (BIRC7)	OTITCGHB	BIRC7_HUMAN	Increases Expression	[186]
NAD-dependent protein deacetylase sirtuin-1 (SIRT1)	OTAYZMOY	SIR1_HUMAN	Decreases Expression	[70]
PRKC apoptosis WT1 regulator protein (PAWR)	OTKY7W52	PAWR_HUMAN	Increases Expression	[53]
Crossover junction endonuclease MUS81 (MUS81)	OTVZ4E60	MUS81_HUMAN	Increases Sumoylation	[69]
NACHT, LRR and PYD domains-containing protein 3 (NLRP3)	OTZM6MHU	NLRP3_HUMAN	Increases Expression	[242]
Bcl-2-binding component 3, isoforms 3/4 (BBC3)	OTUAXDAY	BBC3B_HUMAN	Increases Expression	[199]
RING finger and CHY zinc finger domain-containing protein 1 (RCHY1)	OTAE7504	ZN363_HUMAN	Increases Expression	[257]
Aquaporin-10 (AQP10)	OT8Q5UWS	AQP10_HUMAN	Increases Expression	[77]
Rho GTPase-activating protein 7 (DLC1)	OTP8LMCR	RHG07_HUMAN	Decreases Methylation	[258]
PML-RARA-regulated adapter molecule 1 (PRAM1)	OTZN3DWD	PRAM_HUMAN	Increases Expression	[259]
Paired amphipathic helix protein Sin3a (SIN3A)	OTM8OZWV	SIN3A_HUMAN	Affects Methylation	[55]
Homeobox protein CDX-2 (CDX2)	OTCG4TSY	CDX2_HUMAN	Decreases Expression	[216]
Cell cycle checkpoint control protein RAD9A (RAD9A)	OTJ3AJQU	RAD9A_HUMAN	Increases Expression	[112]
Cell division control protein 6 homolog (CDC6)	OTX93FE7	CDC6_HUMAN	Increases Expression	[112]
Protein smoothened (SMO)	OTXXE208	SMO_HUMAN	Decreases Activity	[260]
Growth/differentiation factor 15 (GDF15)	OTWQN50N	GDF15_HUMAN	Increases Expression	[261]
Immediate early response gene 2 protein (IER2)	OT5OY8BO	IER2_HUMAN	Affects Expression	[262]
Phosphatidylinositol 4-kinase type 2-alpha (PI4K2A)	OTL9L6MX	P4K2A_HUMAN	Increases Expression	[49]
Eukaryotic translation initiation factor 2A (EIF2A)	OTWXELQP	EIF2A_HUMAN	Increases Expression	[263]
MKI67 FHA domain-interacting nucleolar phosphoprotein (NIFK)	OT20GHN3	MK67I_HUMAN	Increases Expression	[146]
Protein Niban 1 (NIBAN1)	OTYOLI12	NIBA1_HUMAN	Increases Expression	[49]
Forkhead box protein P3 (FOXP3)	OTA9Z9OC	FOXP3_HUMAN	Increases Expression	[152]
NACHT, LRR and PYD domains-containing protein 1 (NLRP1)	OT4BNNOS	NLRP1_HUMAN	Increases Expression	[199]
Protein TANC1 (TANC1)	OTF6TZ8E	TANC1_HUMAN	Increases Expression	[49]
Microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B)	OTUYHB84	MLP3B_HUMAN	Increases Expression	[67]
Eukaryotic translation initiation factor 5A-2 (EIF5A2)	OT4SY4KY	IF5A2_HUMAN	Decreases Expression	[264]
Single-stranded DNA cytosine deaminase (AICDA)	OT5XBNUK	AICDA_HUMAN	Decreases Expression	[265]
Autophagy protein 5 (ATG5)	OT4T5SMS	ATG5_HUMAN	Increases Expression	[67]
Augurin (ECRG4)	OTHZYUXX	AUGN_HUMAN	Decreases Methylation	[266]
Sodium-coupled neutral amino acid symporter 1 (SLC38A1)	OTO3VD5E	S38A1_HUMAN	Increases Expression	[49]
Phosducin-like protein 3 (PDCL3)	OTD3WGV1	PDCL3_HUMAN	Decreases Expression	[49]
Microtubule-associated proteins 1A/1B light chain 3A (MAP1LC3A)	OTPMGIU4	MLP3A_HUMAN	Increases Expression	[267]
Band 4.1-like protein 1 (EPB41L1)	OT4CL5DC	E41L1_HUMAN	Increases Expression	[49]
Homeobox protein NANOG (NANOG)	OTUEY1FM	NANOG_HUMAN	Decreases Expression	[128]
Arsenite methyltransferase (AS3MT)	OTNLWD0N	AS3MT_HUMAN	Increases Expression	[242]
Resistin (RETN)	OTW5Z1NH	RETN_HUMAN	Increases Expression	[268]
NLR family CARD domain-containing protein 4 (NLRC4)	OTAIA3NA	NLRC4_HUMAN	Decreases Expression	[242]
Delta-like protein 4 (DLL4)	OTRA4K2V	DLL4_HUMAN	Decreases Expression	[269]
Ras association domain-containing protein 1 (RASSF1)	OTEZIPB7	RASF1_HUMAN	Decreases Methylation	[270]
tRNA-dihydrouridine(20) synthase -like (DUS2)	OTVBE313	DUS2L_HUMAN	Decreases Expression	[49]
Denticleless protein homolog (DTL)	OTC29RYE	DTL_HUMAN	Increases Sumoylation	[69]
Eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3)	OT0DZGY4	E2AK3_HUMAN	Increases Expression	[131]
Methyl-CpG-binding domain protein 2 (MBD2)	OTUQPP0R	MBD2_HUMAN	Increases Expression	[83]
DNA (DNMT3B)	OTZ0JCNP	DNM3B_HUMAN	Decreases Expression	[271]
Gamma-aminobutyric acid type B receptor subunit 1 (GABBR1)	OTU5A52J	GABR1_HUMAN	Decreases Expression	[48]
Death domain-associated protein 6 (DAXX)	OTX6O7PL	DAXX_HUMAN	Decreases Expression	[272]
Armadillo repeat-containing X-linked protein 3 (ARMCX3)	OTMG7RWW	ARMX3_HUMAN	Increases Expression	[49]
Death-associated protein kinase 2 (DAPK2)	OTWODUQG	DAPK2_HUMAN	Increases Expression	[273]
Drebrin-like protein (DBNL)	OTT2OQOV	DBNL_HUMAN	Increases Cleavage	[259]
Cell division cycle protein 23 homolog (CDC23)	OTC4O83E	CDC23_HUMAN	Increases Expression	[112]
Cell cycle progression protein 1 (CCPG1)	OT0IHDKL	CCPG1_HUMAN	Decreases Expression	[109]
Apoptosis-associated speck-like protein containing a CARD (PYCARD)	OT67RON3	ASC_HUMAN	Increases Expression	[199]
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2)	OTW8V2V1	ABCG2_HUMAN	Decreases Expression	[128]
C-Jun-amino-terminal kinase-interacting protein 1 (MAPK8IP1)	OTDAWAUZ	JIP1_HUMAN	Increases Expression	[274]
Protein jagged-2 (JAG2)	OTH7KRRF	JAG2_HUMAN	Decreases Expression	[223]
Small ribosomal subunit protein bS16m (MRPS16)	OT3XXKDZ	RT16_HUMAN	Increases Expression	[146]
Peptidyl-tRNA hydrolase 2, mitochondrial (PTRH2)	OTBU39Q1	PTH2_HUMAN	Increases Expression	[146]
DmX-like protein 1 (DMXL1)	OTWVL31L	DMXL1_HUMAN	Decreases Expression	[49]
Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1)	OTJQL0I3	HEY1_HUMAN	Decreases Expression	[217]
DNA (DNMT3A)	OTEJP0GH	DNM3A_HUMAN	Decreases Expression	[271]
NF-kappa-B essential modulator (IKBKG)	OTNWJWSD	NEMO_HUMAN	Decreases Expression	[70]
Glutaminase liver isoform, mitochondrial (GLS2)	OT08MSHL	GLSL_HUMAN	Affects Response To Substance	[275]
Phospholipid phosphatase 2 (PLPP2)	OT0BQAXX	PLPP2_HUMAN	Decreases Response To Substance	[71]
Ras association domain-containing protein 7 (RASSF7)	OT0V4EIZ	RASF7_HUMAN	Decreases Response To Substance	[71]
Protein Jumonji (JARID2)	OT14UM8H	JARD2_HUMAN	Increases Response To Substance	[71]
Retinoic acid receptor alpha (RARA)	OT192V9V	RARA_HUMAN	Decreases Response To Substance	[276]
Coiled-coil domain-containing protein 28B (CCDC28B)	OT1HFHN2	CC28B_HUMAN	Increases Response To Substance	[71]
Nucleolar protein 3 (NOL3)	OT1K0L0D	NOL3_HUMAN	Decreases Response To Substance	[71]
Sepiapterin reductase (SPR)	OT1ROA8B	SPRE_HUMAN	Decreases Response To Substance	[71]
Homeobox protein MSX-2 (MSX2)	OT1WDKE1	MSX2_HUMAN	Decreases Response To Substance	[71]
PTB domain-containing engulfment adapter protein 1 (GULP1)	OT1WMVDH	GULP1_HUMAN	Decreases Response To Substance	[71]
Tsukushi (TSKU)	OT1XMRIM	TSK_HUMAN	Decreases Response To Substance	[71]
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (OGT)	OT1Z1ZXE	OGT1_HUMAN	Increases Response To Substance	[71]
CD9 antigen (CD9)	OT2184XU	CD9_HUMAN	Decreases Response To Substance	[71]
Integrin beta-4 (ITGB4)	OT28UK84	ITB4_HUMAN	Decreases Response To Substance	[71]
Chimeric ERCC6-PGBD3 protein (ERCC6)	OT2QZKSF	ERPG3_HUMAN	Affects Response To Substance	[277]
Aspartyl/asparaginyl beta-hydroxylase (ASPH)	OT3KGDEE	ASPH_HUMAN	Decreases Response To Substance	[71]
Pyridoxal kinase (PDXK)	OT40AJ5J	PDXK_HUMAN	Decreases Response To Substance	[71]
Ankyrin repeat domain-containing protein 2 (ANKRD2)	OT4UYZ71	ANKR2_HUMAN	Decreases Response To Substance	[71]
Plexin-B2 (PLXNB2)	OT56I2VD	PLXB2_HUMAN	Decreases Response To Substance	[71]
MARVEL domain-containing protein 1 (MARVELD1)	OT5CPOJE	MALD1_HUMAN	Decreases Response To Substance	[64]
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (AGPAT2)	OT5I4Y9K	PLCB_HUMAN	Decreases Response To Substance	[71]
Aldehyde dehydrogenase family 3 member B1 (ALDH3B1)	OT5NEUQE	AL3B1_HUMAN	Decreases Response To Substance	[71]
Protein kinase C alpha type (PRKCA)	OT5UWNRD	KPCA_HUMAN	Affects Response To Substance	[62]
Fermitin family homolog 1 (FERMT1)	OT626PBA	FERM1_HUMAN	Decreases Response To Substance	[71]
Cyclin-O (CCNO)	OT68CH0B	CCNO_HUMAN	Decreases Response To Substance	[71]
Protein PML (PML)	OT6SM2GD	PML_HUMAN	Decreases Response To Substance	[276]
RNA-binding protein 47 (RBM47)	OT6W67VM	RBM47_HUMAN	Decreases Response To Substance	[71]
Protein-tyrosine kinase 6 (PTK6)	OT7NWIQ0	PTK6_HUMAN	Decreases Response To Substance	[71]
Somatotropin (GH1)	OT92RTRD	SOMA_HUMAN	Increases Response To Substance	[175]
Claudin-4 (CLDN4)	OT9C4PZ4	CLD4_HUMAN	Decreases Response To Substance	[71]
Protein SON (SON)	OT9VWV18	SON_HUMAN	Increases Response To Substance	[71]
Elongation factor 1-alpha 2 (EEF1A2)	OT9Z23K5	EF1A2_HUMAN	Decreases Response To Substance	[71]
Transcription intermediary factor 1-alpha (TRIM24)	OTA45FTS	TIF1A_HUMAN	Increases Response To Substance	[71]
L-seryl-tRNA(Sec) kinase (PSTK)	OTA5UXAX	PSTK_HUMAN	Decreases Response To Substance	[73]
CCN family member 5 (CCN5)	OTADU8JJ	CCN5_HUMAN	Decreases Response To Substance	[71]
Protein phosphatase 1 regulatory subunit 26 (PPP1R26)	OTAKR0DQ	PPR26_HUMAN	Decreases Response To Substance	[71]
Pleckstrin homology domain-containing family A member 6 (PLEKHA6)	OTALCXKW	PKHA6_HUMAN	Decreases Response To Substance	[71]
Rho-related GTP-binding protein RhoD (RHOD)	OTALMEIN	RHOD_HUMAN	Decreases Response To Substance	[71]
Aldehyde dehydrogenase, dimeric NADP-preferring (ALDH3A1)	OTAYZZE6	AL3A1_HUMAN	Decreases Response To Substance	[71]
RAC-beta serine/threonine-protein kinase (AKT2)	OTBB632K	AKT2_HUMAN	Decreases Response To Substance	[278]
Coagulation factor XII (F12)	OTBFD2FU	FA12_HUMAN	Decreases Response To Substance	[71]
Microtubule-associated tumor suppressor 1 (MTUS1)	OTBPALMU	MTUS1_HUMAN	Decreases Response To Substance	[71]
Protein PRRC2C (PRRC2C)	OTBX3MXM	PRC2C_HUMAN	Increases Response To Substance	[71]
Selenocysteine insertion sequence-binding protein 2 (SECISBP2)	OTBXUURJ	SEBP2_HUMAN	Decreases Response To Substance	[73]
Organic cation/carnitine transporter 2 (SLC22A5)	OTC36TYB	S22A5_HUMAN	Decreases Response To Substance	[71]
Proline-rich protein 3 (PRR3)	OTCWSM5T	PRR3_HUMAN	Increases Response To Substance	[71]
Rho GTPase-activating protein 19 (ARHGAP19)	OTD046KA	RHG19_HUMAN	Increases Response To Substance	[71]
Annexin A3 (ANXA3)	OTDD8OI7	ANXA3_HUMAN	Decreases Response To Substance	[71]
Hereditary hemochromatosis protein (HFE)	OTDD93KB	HFE_HUMAN	Decreases Response To Substance	[71]
Battenin (CLN3)	OTDDKT8R	CLN3_HUMAN	Decreases Response To Substance	[71]
DNA topoisomerase 2-beta (TOP2B)	OTDHKQZ8	TOP2B_HUMAN	Increases Response To Substance	[71]
Proto-oncogene tyrosine-protein kinase ROS (ROS1)	OTDSKUGE	ROS1_HUMAN	Affects Response To Substance	[279]
Pterin-4-alpha-carbinolamine dehydratase (PCBD1)	OTDSRUD5	PHS_HUMAN	Decreases Response To Substance	[71]
Protein delta homolog 1 (DLK1)	OTE1VLNB	DLK1_HUMAN	Affects Response To Substance	[280]
Histone-lysine N-methyltransferase SETMAR (SETMAR)	OTE2MIMZ	SETMR_HUMAN	Increases Response To Substance	[71]
Protein lifeguard 3 (TMBIM1)	OTE47B57	LFG3_HUMAN	Decreases Response To Substance	[71]
Olfactory receptor 2F1 (OR2F1)	OTEEV9TU	OR2F1_HUMAN	Decreases Response To Substance	[71]
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (MGAT4B)	OTEHCPLY	MGT4B_HUMAN	Decreases Response To Substance	[71]
Pleckstrin homology domain-containing family G member 3 (PLEKHG3)	OTF6I8RV	PKHG3_HUMAN	Decreases Response To Substance	[71]
Growth factor receptor-bound protein 7 (GRB7)	OTF8Y9XY	GRB7_HUMAN	Decreases Response To Substance	[71]
Plasmolipin (PLLP)	OTFGCB9U	PLLP_HUMAN	Decreases Response To Substance	[71]
m7GpppN-mRNA hydrolase (DCP2)	OTG3VKPS	DCP2_HUMAN	Increases Response To Substance	[71]
Multidrug resistance-associated protein 1 (ABCC1)	OTGUN89S	MRP1_HUMAN	Increases Response To Substance	[73]
C-terminal-binding protein 2 (CTBP2)	OTGZGT87	CTBP2_HUMAN	Decreases Response To Substance	[71]
Epithelial cell adhesion molecule (EPCAM)	OTHBZK5X	EPCAM_HUMAN	Decreases Response To Substance	[71]
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (PIP4K2C)	OTHRWR93	PI42C_HUMAN	Increases Response To Substance	[281]
Inositol polyphosphate 1-phosphatase (INPP1)	OTHSJCRQ	INPP_HUMAN	Decreases Response To Substance	[71]
Mucin-3A (MUC3A)	OTI4XUDY	MUC3A_HUMAN	Decreases Response To Substance	[71]
Leucine zipper transcription factor-like protein 1 (LZTFL1)	OTIEIOEW	LZTL1_HUMAN	Increases Response To Substance	[71]
Huntingtin-interacting protein 1-related protein (HIP1R)	OTIPKEJC	HIP1R_HUMAN	Decreases Response To Substance	[71]
Selenocysteine-specific elongation factor (EEFSEC)	OTJ4KKOO	SELB_HUMAN	Decreases Response To Substance	[73]
Cytochrome P450 2J2 (CYP2J2)	OTJBTEH8	CP2J2_HUMAN	Decreases Response To Substance	[71]
Macrophage-stimulating protein receptor (MST1R)	OTJIPL5T	RON_HUMAN	Decreases Response To Substance	[71]
Laminin subunit gamma-2 (LAMC2)	OTJMTM72	LAMC2_HUMAN	Decreases Response To Substance	[71]
Desmoglein-2 (DSG2)	OTJPB2TO	DSG2_HUMAN	Decreases Response To Substance	[71]
Metal regulatory transcription factor 1 (MTF1)	OTJWVLLF	MTF1_HUMAN	Affects Response To Substance	[73]
Transmembrane prolyl 4-hydroxylase (P4HTM)	OTKELL7F	P4HTM_HUMAN	Decreases Response To Substance	[71]
MAL-like protein (MALL)	OTKGZ89D	MALL_HUMAN	Decreases Response To Substance	[71]
Interferon regulatory factor 6 (IRF6)	OTKJ44EV	IRF6_HUMAN	Decreases Response To Substance	[71]
Unconventional myosin-Vc (MYO5C)	OTKLOCWZ	MYO5C_HUMAN	Decreases Response To Substance	[71]
Aquaporin-9 (AQP9)	OTLGH5ZY	AQP9_HUMAN	Increases Import	[282]
Gap junction beta-3 protein (GJB3)	OTLJ59E7	CXB3_HUMAN	Decreases Response To Substance	[71]
14-3-3 protein sigma (SFN)	OTLJCZ1U	1433S_HUMAN	Decreases Response To Substance	[71]
17S U2 SnRNP complex component HTATSF1 (HTATSF1)	OTLQ1ZLS	HTSF1_HUMAN	Increases Response To Substance	[71]
5-hydroxytryptamine receptor 1D (HTR1D)	OTLS74AF	5HT1D_HUMAN	Decreases Response To Substance	[71]
Arf-GAP with dual PH domain-containing protein 1 (ADAP1)	OTM4CHU1	ADAP1_HUMAN	Decreases Response To Substance	[71]
Sodium-dependent noradrenaline transporter (SLC6A2)	OTMHQJMP	SC6A2_HUMAN	Decreases Response To Substance	[71]
Protein kinase C zeta type (PRKCZ)	OTN2FE42	KPCZ_HUMAN	Affects Response To Substance	[62]
Large ribosomal subunit protein mL49 (MRPL49)	OTN5PNSP	RM49_HUMAN	Decreases Response To Substance	[71]
MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2)	OTNA9G8V	MKNK2_HUMAN	Decreases Response To Substance	[283]
Claudin-7 (CLDN7)	OTNE0XHQ	CLD7_HUMAN	Decreases Response To Substance	[71]
Nuclear autoantigenic sperm protein (NASP)	OTNE4THC	NASP_HUMAN	Increases Response To Substance	[71]
Metal-response element-binding transcription factor 2 (MTF2)	OTNL1O2O	MTF2_HUMAN	Increases Response To Substance	[71]
E3 ubiquitin-protein ligase TRIM15 (TRIM15)	OTNYAKP6	TRI15_HUMAN	Decreases Response To Substance	[71]
Transmembrane channel-like protein 5 (TMC5)	OTO5D86M	TMC5_HUMAN	Decreases Response To Substance	[71]
Aldo-keto reductase family 1 member B10 (AKR1B10)	OTOA4HTH	AK1BA_HUMAN	Decreases Response To Substance	[71]
tRNA (TRMT5)	OTOAZBPD	TRM5_HUMAN	Increases Response To Substance	[71]
Desmocollin-2 (DSC2)	OTODVH8K	DSC2_HUMAN	Decreases Response To Substance	[71]
Pyridoxine-5'-phosphate oxidase (PNPO)	OTOUBD05	PNPO_HUMAN	Decreases Response To Substance	[71]
O-phosphoseryl-tRNA(Sec) selenium transferase (SEPSECS)	OTP0FHOV	SPCS_HUMAN	Decreases Response To Substance	[73]
Rho-related GTP-binding protein RhoF (RHOF)	OTPA3F8Q	RHOF_HUMAN	Decreases Response To Substance	[71]
Protransforming growth factor alpha (TGFA)	OTPD1LL9	TGFA_HUMAN	Decreases Response To Substance	[71]
60 kDa heat shock protein, mitochondrial (HSPD1 HSP60 RCJMB04_7g5)	OTPI5OM0	CH60_CHICK	Increases ADR	[284]
Plakophilin-3 (PKP3)	OTPL1HRB	PKP3_HUMAN	Decreases Response To Substance	[71]
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A)	OTPLXCDN	DYR1A_HUMAN	Increases Response To Substance	[71]
Retinoic acid-induced protein 3 (GPRC5A)	OTPOCWR7	RAI3_HUMAN	Decreases Response To Substance	[71]
Nucleoporin Nup37 (NUP37)	OTPZH72U	NUP37_HUMAN	Decreases Response To Substance	[71]
Aldo-keto reductase family 1 member C1 (AKR1C1)	OTQKR4CM	AK1C1_HUMAN	Decreases Response To Substance	[71]
E3 ubiquitin-protein ligase AMFR (AMFR)	OTQRX7LC	AMFR_HUMAN	Decreases Response To Substance	[71]
NKG2-D type II integral membrane protein (KLRK1)	OTQWXK71	NKG2D_HUMAN	Increases Response To Substance	[66]
Polycomb complex protein BMI-1 (BMI1)	OTROVLJ0	BMI1_HUMAN	Decreases Response To Substance	[285]
Enoyl-CoA delta isomerase 1, mitochondrial (ECI1)	OTRQTK84	ECI1_HUMAN	Decreases Response To Substance	[71]
AT-rich interactive domain-containing protein 1A (ARID1A)	OTRWDV3P	ARI1A_HUMAN	Increases Response To Substance	[71]
Mitotic interactor and substrate of PLK1 (MISP)	OTRZDX0N	MISP_HUMAN	Decreases Response To Substance	[71]
Tumor protein D53 (TPD52L1)	OTSA6U0I	TPD53_HUMAN	Decreases Response To Substance	[71]
LIM domain-containing protein 2 (LIMD2)	OTSIFTD8	LIMD2_HUMAN	Increases Response To Substance	[71]
Serpin B5 (SERPINB5)	OTSMXQRJ	SPB5_HUMAN	Decreases Response To Substance	[71]
Transmembrane protein 59-like (TMEM59L)	OTSN3KG4	TM59L_HUMAN	Decreases Response To Substance	[71]
DNA-binding protein SATB1 (SATB1)	OTT7SUVW	SATB1_HUMAN	Decreases Response To Substance	[286]
Selenide, water dikinase 2 (SEPHS2)	OTTFXROR	SPS2_HUMAN	Decreases Response To Substance	[73]
Glycerophosphodiester phosphodiesterase 1 (GDE1)	OTU6FSBF	GDE1_HUMAN	Decreases Response To Substance	[71]
LLGL scribble cell polarity complex component 2 (LLGL2)	OTU8ZDC4	L2GL2_HUMAN	Decreases Response To Substance	[71]
Pleckstrin-2 (PLEK2)	OTUBWUUK	PLEK2_HUMAN	Decreases Response To Substance	[71]
Catenin delta-1 (CTNND1)	OTUMPSHR	CTND1_HUMAN	Decreases Response To Substance	[71]
Adapter SH3BGRL (SH3BGRL)	OTUOCTMT	SH3L1_HUMAN	Increases Response To Substance	[71]
SWI/SNF complex subunit SMARCC1 (SMARCC1)	OTUOMBE7	SMRC1_HUMAN	Increases Response To Substance	[71]
Serine/threonine-protein kinase 16 (STK16)	OTUOY83H	STK16_HUMAN	Decreases Response To Substance	[71]
ETS-related transcription factor Elf-3 (ELF3)	OTUTLEQO	ELF3_HUMAN	Decreases Response To Substance	[71]
Metal transporter CNNM4 (CNNM4)	OTUXJRM1	CNNM4_HUMAN	Decreases Response To Substance	[71]
Heat shock protein beta-1 (HSPB1)	OTUZZ67L	HSPB1_CHICK	Increases ADR	[284]
Protein S100-A14 (S100A14)	OTVFJJ91	S10AE_HUMAN	Decreases Response To Substance	[71]
SH2 domain-containing protein 3A (SH2D3A)	OTVJBSRC	SH23A_HUMAN	Decreases Response To Substance	[71]
Keratin, type I cytoskeletal 18 (KRT18)	OTVLQFIP	K1C18_HUMAN	Decreases Response To Substance	[71]
E3 ubiquitin-protein ligase MSL2 (MSL2)	OTVPQYBG	MSL2_HUMAN	Increases Response To Substance	[71]
Charged multivesicular body protein 1a (CHMP1A)	OTVQ5UWX	CHM1A_HUMAN	Decreases Response To Substance	[71]
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3)	OTVT1Q25	B3GN3_HUMAN	Decreases Response To Substance	[71]
Ras-related protein Rab-25 (RAB25)	OTW0W6NP	RAB25_HUMAN	Decreases Response To Substance	[71]
T-box transcription factor TBX6 (TBX6)	OTW1Q8RM	TBX6_HUMAN	Decreases Response To Substance	[71]
Spermatogenesis-associated protein 20 (SPATA20)	OTWKX0AZ	SPT20_HUMAN	Decreases Response To Substance	[71]
Leukotriene A-4 hydrolase (LTA4H)	OTWSZ0QT	LKHA4_HUMAN	Decreases Response To Substance	[71]
Non-receptor tyrosine-protein kinase TNK1 (TNK1)	OTXG5RWQ	TNK1_HUMAN	Decreases Response To Substance	[71]
PDZ domain-containing protein GIPC1 (GIPC1)	OTXLVCPJ	GIPC1_HUMAN	Decreases Response To Substance	[71]
3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 (FUT3)	OTXQ6P8R	FUT3_HUMAN	Decreases Response To Substance	[71]
Adenine DNA glycosylase (MUTYH)	OTXTKI7Q	MUTYH_HUMAN	Affects Activity	[287]
Haloacid dehalogenase-like hydrolase domain-containing protein 3 (HDHD3)	OTY4LG3Z	HDHD3_HUMAN	Decreases Response To Substance	[71]
AT-rich interactive domain-containing protein 4B (ARID4B)	OTYLPILE	ARI4B_HUMAN	Increases Response To Substance	[71]
PRA1 family protein 3 (ARL6IP5)	OTYZ6BEQ	PRAF3_HUMAN	Increases Response To Substance	[288]
Envoplakin (EVPL)	OTZIAFEK	EVPL_HUMAN	Decreases Response To Substance	[71]
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)	OTZPZX11	MP2K4_HUMAN	Increases Response To Substance	[289]
Pleckstrin homology domain-containing family G member 6 (PLEKHG6)	OTZWA27A	PKHG6_HUMAN	Decreases Response To Substance	[71]

Test Results of This Drug Combination in Other Disease Systems

Indication	DrugCom ID	Cell Line	Status	REF
Large cell lung carcinoma	DCZ33RS	NCI-H460	Investigative	[1]

References

• [1] Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4903).
• [3] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 078729.
• [4] Arsenic trioxide FDA Label
• [5] Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. Curr Pharm Des. 2013;19(5):940-50.
• [6] Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther. 2012 Jul;11(7):1557-64. doi: 10.1158/1535-7163.MCT-11-0934. Epub 2012 Jun 22.
• [7] Aberrant expression of the transcriptional factor Twist1 promotes invasiveness in ALK-positive anaplastic large cell lymphoma. Cell Signal. 2012 Apr;24(4):852-8. doi: 10.1016/j.cellsig.2011.11.020. Epub 2011 Dec 8.
• [8] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [9] Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.Drug Des Devel Ther. 2015 Aug 26;9:4897-907.
• [10] Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar. Int J Cancer. 2014 Mar 15;134(6):1484-94.
• [11] Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide. Clin Cancer Res. 2013 Mar 15;19(6):1458-66.
• [12] Crizotinib for the treatment of non-small-cell lung cancer. Am J Health Syst Pharm. 2013 Jun 1;70(11):943-7.
• [13] Prediction of crizotinib-midazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent inhibition between human liver microsomes versus hepatocytes. Drug Metab Dispos. 2013 Feb;41(2):343-52.
• [14] Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
• [15] Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers. Sci Transl Med. 2012 Feb 8;4(120):120ra17. doi: 10.1126/scitranslmed.3003316. Epub 2012 Jan 25.
• [16] Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):245-55.
• [17] Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer. Cancer. 2012 Nov 1;118(21):5302-9. doi: 10.1002/cncr.27450. Epub 2012 Apr 4.
• [18] Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). J Med Chem. 2011 Sep 22;54(18):6342-63. doi: 10.1021/jm2007613. Epub 2011 Aug 18.
• [19] ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway. Toxicol Appl Pharmacol. 2019 Nov 15;383:114768. doi: 10.1016/j.taap.2019.114768. Epub 2019 Oct 19.
• [20] Elucidating mechanisms of toxicity using phenotypic data from primary human cell systems--a chemical biology approach for thrombosis-related side effects. Int J Mol Sci. 2015 Jan 5;16(1):1008-29. doi: 10.3390/ijms16011008.
• [21] Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes. Toxicol Lett. 2018 Jul;291:138-148. doi: 10.1016/j.toxlet.2018.04.010. Epub 2018 Apr 12.
• [22] Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7535-40. doi: 10.1073/pnas.1019559108. Epub 2011 Apr 18.
• [23] Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells. Clin Cancer Res. 2012 Jul 1;18(13):3592-602. doi: 10.1158/1078-0432.CCR-11-2972. Epub 2012 May 2.
• [24] Crizotinib-resistant mutants of EML4-ALK identified through an accelerated mutagenesis screen. Chem Biol Drug Des. 2011 Dec;78(6):999-1005. doi: 10.1111/j.1747-0285.2011.01239.x. Epub 2011 Oct 31.
• [25] Tyrosine phosphorylation of the scaffold protein IQGAP1 in the MET pathway alters function. J Biol Chem. 2020 Dec 25;295(52):18105-18121. doi: 10.1074/jbc.RA120.015891. Epub 2020 Oct 21.
• [26] Keratinocytes apoptosis contributes to crizotinib induced-erythroderma. Toxicol Lett. 2020 Feb 1;319:102-110. doi: 10.1016/j.toxlet.2019.11.007. Epub 2019 Nov 7.
• [27] Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer. Clin Cancer Res. 2012 Mar 1;18(5):1472-82. doi: 10.1158/1078-0432.CCR-11-2906. Epub 2012 Jan 10.
• [28] Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
• [29] Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
• [30] Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
• [31] Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
• [32] Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
• [33] Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
• [34] Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J Proteome Res. 2009 Jun;8(6):3006-19.
• [35] Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
• [36] Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU. Anticancer Res. 2010 Apr;30(4):1157-62.
• [37] Aberrantly expressed genes in HaCaT keratinocytes chronically exposed to arsenic trioxide. Biomark Insights. 2011 Feb 8;6:7-16.
• [38] Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
• [39] Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
• [40] Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
• [41] Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
• [42] Synergistic effects of arsenic trioxide combined with ascorbic acid in human osteosarcoma MG-63 cells: a systems biology analysis. Eur Rev Med Pharmacol Sci. 2014;18(24):3877-88.
• [43] Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
• [44] Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
• [45] Effect of subchronic exposure to inorganic arsenic on the structure and function of the intestinal epithelium. Toxicol Lett. 2018 Apr;286:80-88.
• [46] A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
• [47] Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells. Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1127-1134. doi: 10.22034/APJCP.2018.19.4.1127.
• [48] Gene expression profile of multiple myeloma cell line treated by arsenic trioxide. J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):646-9. doi: 10.1007/s11596-007-0606-z.
• [49] Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Nat Commun. 2018 Aug 9;9(1):3069. doi: 10.1038/s41467-018-05402-2.
• [50] [Inhibited proliferation of B-lymphoma Raji cells and down-regulated expression of VEGF by arsenic trioxide]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):704-7.
• [51] Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug-sensitive and -resistant leukemia cells. Leuk Res. 2012 Dec;36(12):1526-35. doi: 10.1016/j.leukres.2012.08.018. Epub 2012 Sep 7.
• [52] Arsenic and fluoride induce apoptosis, inflammation and oxidative stress in cultured human umbilical vein endothelial cells. Chemosphere. 2017 Jan;167:454-461. doi: 10.1016/j.chemosphere.2016.10.025. Epub 2016 Oct 14.
• [53] Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds. Leuk Lymphoma. 2006 Aug;47(8):1629-38. doi: 10.1080/10428190600625398.
• [54] Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents. Biochem Pharmacol. 2012 May 1;83(9):1172-82. doi: 10.1016/j.bcp.2012.01.017. Epub 2012 Jan 21.
• [55] Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic. Oncotarget. 2015 Aug 28;6(25):21493-506. doi: 10.18632/oncotarget.4085.
• [56] YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide. Int J Gynecol Cancer. 2011 Aug;21(6):1097-104. doi: 10.1097/IGC.0b013e31821d2525.
• [57] [Effect of arsenic trioxide and 5-aza-2'-deoxycytidine on SHP-1, JAK3, TYK2 gene expression in K562 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):323-8. doi: 10.7534/j.issn.1009-2137.2014.02.011.
• [58] [Effect of arsenic trioxide on the expression of apoptosis-related genes in NB4 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Dec;15(6):1191-5.
• [59] Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9. BMC Biotechnol. 2009 Oct 5;9:84. doi: 10.1186/1472-6750-9-84.
• [60] Arsenic trioxide (As(2)O(3)) induced apoptosis and its mechanisms in a human esophageal squamous carcinoma cell line. Chin Med J (Engl). 2002 Feb;115(2):280-5.
• [61] Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. J Pharmacol Exp Ther. 2006 Jan;316(1):304-14. doi: 10.1124/jpet.105.092874. Epub 2005 Sep 20.
• [62] Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway. Chem Biol Interact. 2013 Oct 5;205(3):198-211. doi: 10.1016/j.cbi.2013.07.011. Epub 2013 Aug 2.
• [63] Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells. Toxicol Lett. 2015 Jan 22;232(2):481-9. doi: 10.1016/j.toxlet.2014.11.028. Epub 2014 Nov 28.
• [64] MARVELD1 attenuates arsenic trioxide-induced apoptosis in liver cancer cells by inhibiting reactive oxygen species production. Ann Transl Med. 2019 May;7(9):200. doi: 10.21037/atm.2019.04.38.
• [65] Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State. Sci Rep. 2016 Mar 15;6:23071. doi: 10.1038/srep23071.
• [66] Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. J Immunother. 2008 Jun;31(5):475-86. doi: 10.1097/CJI.0b013e3181755deb.
• [67] Arsenic trioxide induces autophagic cell death in osteosarcoma cells via the ROS-TFEB signaling pathway. Biochem Biophys Res Commun. 2018 Jan 29;496(1):167-175. doi: 10.1016/j.bbrc.2018.01.018. Epub 2018 Jan 4.
• [68] ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML. Exp Cell Res. 2006 Nov 15;312(19):3739-51. doi: 10.1016/j.yexcr.2006.06.037. Epub 2006 Aug 14.
• [69] Arsenic-induced sumoylation of Mus81 is involved in regulating genomic stability. Cell Cycle. 2017 Apr 18;16(8):802-811. doi: 10.1080/15384101.2017.1302628. Epub 2017 Mar 20.
• [70] Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin. Med Oncol. 2010 Sep;27(3):833-42. doi: 10.1007/s12032-009-9294-9. Epub 2009 Sep 10.
• [71] The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics. 2010 Aug 13;3:37. doi: 10.1186/1755-8794-3-37.
• [72] XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage. Toxicol Sci. 2010 Jul;116(1):183-93. doi: 10.1093/toxsci/kfq113. Epub 2010 Apr 19.
• [73] Functional Profiling Identifies Determinants of Arsenic Trioxide Cellular Toxicity. Toxicol Sci. 2019 May 1;169(1):108-121. doi: 10.1093/toxsci/kfz024.
• [74] How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer. 2002 Sep;2(9):705-13.
• [75] MRP2 and acquired tolerance to inorganic arsenic in the kidney of killifish (Fundulus heteroclitus). Toxicol Sci. 2007 May;97(1):103-10.
• [76] Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells. Cancer Chemother Pharmacol. 2003 Feb;51(2):119-26.
• [77] In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem Res Toxicol. 2012 Feb 20;25(2):446-53. doi: 10.1021/tx200491f. Epub 2012 Jan 26.
• [78] Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway. Pharmacol Res. 2005 Nov;52(5):376-85. doi: 10.1016/j.phrs.2005.05.010. Epub 2005 Jun 24.
• [79] Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem. 2001 Jun;222(1-2):49-59.
• [80] Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol Cancer Ther. 2009 May;8(5):1197-206.
• [81] Quantitative analysis of gene expression changes in response to genotoxic compounds. Toxicol In Vitro. 2017 Mar;39:15-28. doi: 10.1016/j.tiv.2016.11.004. Epub 2016 Nov 5.
• [82] [Mechanisms underlying the effect of arsenic trioxide on proliferation inhibition and apoptosis induction in myeloma cell line u266]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):982-5.
• [83] Arsenic induces functional re-expression of estrogen receptor by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS One. 2012;7(4):e35957. doi: 10.1371/journal.pone.0035957. Epub 2012 Apr 27.
• [84] Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity. Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):28-31.
• [85] Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4578-83.
• [86] 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. Cancer Res. 2005 Mar 15;65(6):2488-97.
• [87] Detection of gene expression alteration of myeloma cells treated with arsenic trioxide. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):209-13.
• [88] Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Hum Pathol. 2006 Mar;37(3):298-311.
• [89] Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol Sin. 2006 Aug;27(8):1078-84.
• [90] An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp Hematol. 2007 Feb;35(2):252-62.
• [91] Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic acid (roxarsone). Environ Health Perspect. 2008 Apr;116(4):520-3.
• [92] Effect of As(2)O(3) on expressions of COX-2 and matrix metalloproteinases in SGC7901 and K562 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):69-73.
• [93] Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer. Cancer Sci. 2009 Dec;100(12):2459-64.
• [94] Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase. Med Oncol. 2012 Jun;29(2):1328-34.
• [95] Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer. Clin Cancer Res. 2012 Jun 15;18(12):3366-76.
• [96] Arsenic trioxide (ATO) influences the gene expression of metallothioneins in human glioblastoma cells. Biol Trace Elem Res. 2012 Dec;149(3):331-9.
• [97] Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide. Cancer Res. 2012 Aug 15;72(16):4214-24.
• [98] Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines. BMC Cancer. 2012 Sep 10;12:402.
• [99] Toxicogenomics-based identification of mechanisms for direct immunotoxicity. Toxicol Sci. 2013 Oct;135(2):328-46.
• [100] Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro. J Appl Toxicol. 2015 Jul;35(7):831-41.
• [101] The role of NF-B in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells. J Toxicol Sci. 2015 Jun;40(3):349-63.
• [102] Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling. Neurotoxicology. 2015 Sep;50:56-70.
• [103] Mitophagy inhibits proliferation by decreasing cyclooxygenase-2 (COX-2) in arsenic trioxide-treated HepG2 cells. Environ Toxicol Pharmacol. 2016 Jul;45:212-21.
• [104] miR-155/BACH1 signaling pathway in human lung adenocarcinoma cell death induced by arsenic trioxide. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Nov;48(6):828-833.
• [105] Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia. J Cell Mol Med. 2018 Mar;22(3):1614-1626.
• [106] Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells. Int J Cancer. 2018 Jul 1;143(1):113-126.
• [107] Different administration patterns of docosahexaenoic acid in combating cytotoxic manifestations due to arsenic trioxide (acute promyelocytic leukemia drug) induced redox imbalance in hepatocytes. Prostaglandins Other Lipid Mediat. 2018 May;136:64-75.
• [108] Modulation of cellular response to arsenic trioxide toxicity by resveratrol. ACS Omega. 2018 May 31;3(5):5511-5515.
• [109] Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Cancer Genet Cytogenet. 2010 Jun;199(2):110-20. doi: 10.1016/j.cancergencyto.2010.02.010.
• [110] Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells. Asian Pac J Cancer Prev. 2013;14(11):6469-73. doi: 10.7314/apjcp.2013.14.11.6469.
• [111] Arsenic downregulates tight junction claudin proteins through p38 and NF-B in intestinal epithelial cell line, HT-29. Toxicology. 2017 Mar 15;379:31-39. doi: 10.1016/j.tox.2017.01.011. Epub 2017 Jan 20.
• [112] Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation. J Cell Biochem. 2010 Dec 15;111(6):1546-55. doi: 10.1002/jcb.22886.
• [113] Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4. Med Oncol. 2012 Jun;29(2):1209-16. doi: 10.1007/s12032-011-9946-4. Epub 2011 May 5.
• [114] ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis. J Biol Chem. 2006 Sep 29;281(39):28764-71. doi: 10.1074/jbc.M604392200. Epub 2006 Aug 3.
• [115] Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer. Cancer Lett. 2006 Sep 8;241(1):93-101. doi: 10.1016/j.canlet.2005.10.014. Epub 2005 Dec 9.
• [116] Gene expression profile changes in NB4 cells induced by arsenic trioxide. Acta Pharmacol Sin. 2003 Jul;24(7):646-50.
• [117] Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6. PLoS One. 2012;7(2):e32215. doi: 10.1371/journal.pone.0032215. Epub 2012 Feb 22.
• [118] microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. J Gastroenterol Hepatol. 2011 Jan;26(1):186-93. doi: 10.1111/j.1440-1746.2010.06317.x.
• [119] [Alteration of expression of survivin in HL-60 cells treated with chemotherapeutic drugs]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):347-50.
• [120] Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs. Int J Cancer. 2009 May 15;124(10):2303-11. doi: 10.1002/ijc.24207.
• [121] [Correlation of cell cycle alteration to SOCS-1 gene demethylation induced by arsenic trioxide in myeloma cell lines]. Ai Zheng. 2008 Nov;27(11):1150-4.
• [122] Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells. Cancer Res. 2003 Nov 15;63(22):7950-8.
• [123] DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway. Oncotarget. 2017 Aug 16;8(52):89643-89654. doi: 10.18632/oncotarget.20288. eCollection 2017 Oct 27.
• [124] Down-regulation of beta1,4GalT V at protein level contributes to arsenic trioxide-induced glioma cell apoptosis. Cancer Lett. 2008 Aug 18;267(1):96-105. doi: 10.1016/j.canlet.2008.03.019. Epub 2008 Apr 24.
• [125] Musashi-1 promotes chemoresistant granule formation by PKR/eIF2 signalling cascade in refractory glioblastoma. Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1850-1861. doi: 10.1016/j.bbadis.2018.02.017. Epub 2018 Feb 24.
• [126] Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma. Cancer Lett. 2011 Nov 28;310(2):181-7. doi: 10.1016/j.canlet.2011.06.035. Epub 2011 Jul 5.
• [127] Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide. Leuk Res. 2016 Nov;50:116-122. doi: 10.1016/j.leukres.2016.10.003. Epub 2016 Oct 3.
• [128] Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clin Transl Med. 2021 Feb;11(2):e335. doi: 10.1002/ctm2.335.
• [129] Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene. 2005 Feb 3;24(6):980-91. doi: 10.1038/sj.onc.1208095.
• [130] Heat shock protein inhibitors, 17-DMAG and KNK437, enhance arsenic trioxide-induced mitotic apoptosis. Toxicol Appl Pharmacol. 2009 Apr 15;236(2):231-8. doi: 10.1016/j.taap.2009.02.003. Epub 2009 Feb 12.
• [131] Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells. Exp Eye Res. 2007 Dec;85(6):825-35. doi: 10.1016/j.exer.2007.08.018. Epub 2007 Aug 29.
• [132] Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro. Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1228-36. doi: 10.1161/ATVBAHA.110.205500. Epub 2010 Mar 25.
• [133] Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Clin Cancer Res. 2004 May 1;10(9):3179-88. doi: 10.1158/1078-0432.ccr-03-0309.
• [134] Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Toxicol Sci. 2015 Jan;143(1):156-64. doi: 10.1093/toxsci/kfu218. Epub 2014 Oct 10.
• [135] Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res. 2010 Aug 1;316(13):2174-88. doi: 10.1016/j.yexcr.2010.04.027. Epub 2010 May 8.
• [136] Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemia. Chin Med J (Engl). 2009 Sep 5;122(17):1969-73.
• [137] Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J Cell Biochem. 2005 Aug 1;95(5):955-69. doi: 10.1002/jcb.20452.
• [138] Arsenic inhibition of telomerase transcription leads to genetic instability. J Clin Invest. 2001 Nov;108(10):1541-7. doi: 10.1172/JCI14064.
• [139] [Effect of endogenous TGF-beta1 and TNF-alpha on the As(2)O(3) inducing apoptosis of HL-60 cells]. Zhonghua Xue Ye Xue Za Zhi. 2003 May;24(5):231-4.
• [140] Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Biochem Biophys Res Commun. 2000 Oct 14;277(1):179-85. doi: 10.1006/bbrc.2000.3651.
• [141] Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Blood. 2003 Jun 1;101(11):4576-82. doi: 10.1182/blood-2002-09-2986. Epub 2003 Jan 30.
• [142] Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus. Biol Trace Elem Res. 2018 Aug;184(2):391-397. doi: 10.1007/s12011-017-1206-9. Epub 2017 Nov 20.
• [143] Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2-like 2 (NFE2L2) protein and the Smad2/3 pathway. J Cell Physiol. 2019 Mar;234(3):2606-2617. doi: 10.1002/jcp.27073. Epub 2018 Oct 14.
• [144] In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation. Blood Cells Mol Dis. 2006 Jan-Feb;36(1):59-76. doi: 10.1016/j.bcmd.2005.10.005. Epub 2005 Dec 15.
• [145] Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells. PLoS One. 2013;8(1):e54774. doi: 10.1371/journal.pone.0054774. Epub 2013 Jan 30.
• [146] [Construction of subtracted cDNA library in human Jurkat T cell line induced by arsenic trioxide in vitro]. Zhonghua Yu Fang Yi Xue Za Zhi. 2003 Nov;37(6):403-7.
• [147] [Arsenic trioxide restores ER expression in ER-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice]. Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):645-51. doi: 10.3760/cma.j.issn.0253-3766.2012.09.002.
• [148] E2F1 downregulation by arsenic trioxide in lung adenocarcinoma. Int J Oncol. 2014 Nov;45(5):2033-43. doi: 10.3892/ijo.2014.2609. Epub 2014 Aug 19.
• [149] [Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line]. Ai Zheng. 2002 Aug;21(8):863-7.
• [150] Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells. Biol Res. 2018 Jun 13;51(1):18. doi: 10.1186/s40659-018-0167-6.
• [151] Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: A role of heme oxygenase 1. Chem Biol Interact. 2022 Sep 1;364:110049. doi: 10.1016/j.cbi.2022.110049. Epub 2022 Jul 21.
• [152] [As(2)O(3) Up-Regulates the Proportion of CD4(+)CD25(+)CD127(low) Tregs in Peripheral Blood of Patients with Severe Aplastic Anemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):854-858. doi: 10.7534/j.issn.1009-2137.2018.03.037.
• [153] [Effects of As2O3 on tissue factor, plasminogen activator inhibitor-1 and -2 expression in NB4, HL-60 and THP-1 cells]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Oct;34(4):645-9.
• [154] Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Oncol Rep. 2012 Nov;28(5):1851-8. doi: 10.3892/or.2012.1977. Epub 2012 Aug 22.
• [155] Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2. Cancer Biol Ther. 2010 Dec 1;10(11):1201-14. doi: 10.4161/cbt.10.11.13669. Epub 2010 Dec 1.
• [156] Time-series analysis in imatinib-resistant chronic myeloid leukemia K562-cells under different drug treatments. J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):621-627. doi: 10.1007/s11596-017-1781-1. Epub 2017 Aug 8.
• [157] Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation. Mol Cancer Res. 2018 Jan;16(1):32-46. doi: 10.1158/1541-7786.MCR-17-0397. Epub 2017 Oct 17.
• [158] Arsenic trioxide and reduced glutathione act synergistically to augment inhibition of thyroid peroxidase activity in vitro. Biol Trace Elem Res. 2015 May;165(1):110-7. doi: 10.1007/s12011-015-0230-x. Epub 2015 Jan 17.
• [159] Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line. Cancer Res Treat. 2013 Jun;45(2):126-33. doi: 10.4143/crt.2013.45.2.126. Epub 2013 Jun 30.
• [160] [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2009 Mar;30(3):145-9.
• [161] Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line. Neurochem Res. 2012 Feb;37(2):370-80. doi: 10.1007/s11064-011-0620-1. Epub 2011 Oct 4.
• [162] Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. PLoS One. 2013 Jul 8;8(7):e69466. doi: 10.1371/journal.pone.0069466. Print 2013.
• [163] Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface. Mol Cancer. 2014 Nov 19;13:251. doi: 10.1186/1476-4598-13-251.
• [164] Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment. Chin Med J (Engl). 2000 Mar;113(3):236-40.
• [165] Arsenic induces cell apoptosis in cultured osteoblasts through endoplasmic reticulum stress. Toxicol Appl Pharmacol. 2009 Dec 1;241(2):173-81. doi: 10.1016/j.taap.2009.08.011. Epub 2009 Aug 18.
• [166] Arsenic trioxide induces de novo protein synthesis of annexin-1 in neutrophils: association with a heat shock-like response and not apoptosis. Br J Haematol. 2008 Feb;140(4):454-63. doi: 10.1111/j.1365-2141.2007.06941.x. Epub 2007 Dec 13.
• [167] Overexpression of Bcl-2 partly inhibits apoptosis of human cervical cancer SiHa cells induced by arsenic trioxide. Chin Med J (Engl). 2000 Jan;113(1):84-8.
• [168] [Demethylation effect of inhibitor As2O3 on expression of SHP-1 and C-kit genes in leukemia HL-60 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):613-6. doi: 10.7534/j.issn.1009-2137.2013.03.015.
• [169] Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia. 2000 Feb;14(2):262-70. doi: 10.1038/sj.leu.2401650.
• [170] JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells. J Biomed Sci. 2006 May;13(3):357-71. doi: 10.1007/s11373-005-9068-0. Epub 2006 Feb 9.
• [171] Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1552-6. doi: 10.1111/j.1525-1438.2006.00626.x.
• [172] Arsenic trioxide suppresses liver X receptor and enhances cholesteryl ester transfer protein expression without affecting the liver X receptor in HepG2 cells. Chem Biol Interact. 2016 Oct 25;258:288-96. doi: 10.1016/j.cbi.2016.09.009. Epub 2016 Sep 10.
• [173] [Effect of arsenic trioxide on the expression of cyclins gene in HL60 cells]. Zhonghua Nei Ke Za Zhi. 2003 Feb;42(2):113-6.
• [174] The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation. Int J Hematol. 2015 Jul;102(1):12-24. doi: 10.1007/s12185-015-1776-2. Epub 2015 Mar 11.
• [175] Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis. Mol Cell Endocrinol. 2013 Sep 5;377(1-2):84-92. doi: 10.1016/j.mce.2013.07.002. Epub 2013 Jul 10.
• [176] Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia. 1999 Jul;13(7):1062-70. doi: 10.1038/sj.leu.2401448.
• [177] Taurine improves low-level inorganic arsenic-induced insulin resistance by activating PPAR-mTORC2 signalling and inhibiting hepatic autophagy. J Cell Physiol. 2019 Apr;234(4):5143-5152. doi: 10.1002/jcp.27318. Epub 2018 Oct 26.
• [178] Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2. Biochem Biophys Res Commun. 2019 Jun 11;513(4):834-840. doi: 10.1016/j.bbrc.2019.04.081. Epub 2019 Apr 16.
• [179] PLK1 targets NOTCH1 during DNA damage and mitotic progression. J Biol Chem. 2019 Nov 22;294(47):17941-17950. doi: 10.1074/jbc.RA119.009881. Epub 2019 Oct 9.
• [180] Arsenic induces human chondrocyte senescence and accelerates rat articular cartilage aging. Arch Toxicol. 2020 Jan;94(1):89-101. doi: 10.1007/s00204-019-02607-2. Epub 2019 Nov 16.
• [181] Low dosage of arsenic trioxide (As(2)O(3)) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis. J Biol Inorg Chem. 2018 Aug;23(6):939-947. doi: 10.1007/s00775-018-1595-z. Epub 2018 Jul 16.
• [182] Arsenic trioxide induces endoplasmic reticulum stress-related events in neutrophils. Int Immunopharmacol. 2010 Apr;10(4):508-12. doi: 10.1016/j.intimp.2010.01.013. Epub 2010 Feb 4.
• [183] Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade. Transl Res. 2010 Feb;155(2):97-108. doi: 10.1016/j.trsl.2009.08.005. Epub 2009 Sep 15.
• [184] Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway. Cancer Biol Ther. 2010 Sep 15;10(6):632-43. doi: 10.4161/cbt.10.6.12654. Epub 2010 Sep 13.
• [185] Arsenic trioxide induces Hsp70 expression via reactive oxygen species and JNK pathway in MDA231 cells. Life Sci. 2005 Oct 14;77(22):2783-93. doi: 10.1016/j.lfs.2005.04.024.
• [186] Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep. 2016 Sep;36(3):1233-42. doi: 10.3892/or.2016.4944. Epub 2016 Jul 15.
• [187] Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World J Gastroenterol. 2007 Dec 28;13(48):6498-505. doi: 10.3748/wjg.v13.i48.6498.
• [188] Arsenite-induced downregulation of occludin in mouse lungs and BEAS-2B cells via the ROS/ERK/ELK1/MLCK and ROS/p38 MAPK signaling pathways. Toxicol Lett. 2020 Oct 10;332:146-154. doi: 10.1016/j.toxlet.2020.07.010. Epub 2020 Jul 16.
• [189] NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes. Arch Toxicol. 2012 Jun;86(6):935-45. doi: 10.1007/s00204-012-0856-9. Epub 2012 Apr 25.
• [190] Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation. Cancer Lett. 2009 Nov 1;284(2):208-15. doi: 10.1016/j.canlet.2009.04.035. Epub 2009 May 19.
• [191] Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma. J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):43-6. doi: 10.1007/BF02828035.
• [192] [P27(Kip1), cyclin E and endogenous TGF-beta1 changes in apoptosis of NB4 cells induced by As(2)O(3) and/or TGF-beta1 and their significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):74-9.
• [193] Radiation-induced cathepsin S is involved in radioresistance. Int J Cancer. 2009 Apr 15;124(8):1794-801. doi: 10.1002/ijc.24095.
• [194] The effect to IL-3Ralpha, downstream PI3k/Akt signaling of all-trans retinoic acid and arsenic trioxide in NB4 cells. Pharmazie. 2014 Apr;69(4):297-300.
• [195] Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells. Environ Toxicol. 2021 Sep;36(9):1785-1792. doi: 10.1002/tox.23299. Epub 2021 May 27.
• [196] Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4). Ann Hematol. 2018 Jan;97(1):83-93. doi: 10.1007/s00277-017-3163-y. Epub 2017 Nov 20.
• [197] Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. J Exp Clin Cancer Res. 2019 Jul 15;38(1):308. doi: 10.1186/s13046-019-1295-8.
• [198] [As2O3 induces demethylation and up-regulates transcription of SHP-1 gene in human lymphoma cell line T2 cells]. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):423-7.
• [199] Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment. J Pharmacol Exp Ther. 2014 Mar;348(3):360-71. doi: 10.1124/jpet.113.210054. Epub 2013 Dec 17.
• [200] Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Int J Cancer. 2009 Jul 15;125(2):264-75. doi: 10.1002/ijc.24341.
• [201] Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res. 2000 Jun 1;60(11):3065-71.
• [202] HOXA9 is critical in the proliferation, differentiation, and malignancy of leukaemia cells both in vitro and in vivo. Cell Biochem Funct. 2017 Oct;35(7):433-440. doi: 10.1002/cbf.3293. Epub 2017 Sep 29.
• [203] Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib. Leuk Res. 2008 Nov;32(11):1674-83. doi: 10.1016/j.leukres.2008.03.039. Epub 2008 May 15.
• [204] Inhibition of interleukin-13 gene expression in T cells through GATA-3 pathway by arsenic trioxide. Chin Med J (Engl). 2008 Nov 20;121(22):2346-9.
• [205] [Inhibitory effect of arsenic trioxide on invasion in human hepatocellular carcinoma SMMC-7721 cells and its mechanism]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Dec;28(12):1254-7.
• [206] [Effect of arsenic trioxide on vascular endothelial growth factor-C and its receptor (VEGFR-3) in nude mice with gastric cancer]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1303-7.
• [207] Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer. 2001 May 15;92(4):518-26. doi: 10.1002/ijc.1220.
• [208] Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation. Clin Cancer Res. 2006 Nov 15;12(22):6817-25. doi: 10.1158/1078-0432.CCR-06-1354.
• [209] Regulatory role of KEAP1 and NRF2 in PPAR expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radic Biol Med. 2012 Aug 15;53(4):758-68. doi: 10.1016/j.freeradbiomed.2012.05.041. Epub 2012 Jun 7.
• [210] Study of As(2)O(3) regulating proliferation and apoptosis of Tca8113 cells by inhibiting the expression of Id-1. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1932-1937. doi: 10.1080/21691401.2019.1613419.
• [211] Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Ann Oncol. 2008 Aug;19(8):1488-1494. doi: 10.1093/annonc/mdn056. Epub 2008 Mar 17.
• [212] [Re-expression of p16 gene in myeloma cell line U266 by arsenic trioxide]. Ai Zheng. 2004 Jun;23(6):626-30.
• [213] Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma. Toxicol Appl Pharmacol. 2017 Sep 15;331:54-61. doi: 10.1016/j.taap.2017.05.008. Epub 2017 May 10.
• [214] Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase. J Biochem Mol Biol. 2002 Jul 31;35(4):377-83. doi: 10.5483/bmbrep.2002.35.4.377.
• [215] Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. Int J Mol Sci. 2012;13(8):9627-9641. doi: 10.3390/ijms13089627. Epub 2012 Aug 2.
• [216] Effect of chronic exposure to inorganic arsenic on intestinal cells. J Appl Toxicol. 2019 Jun;39(6):899-907. doi: 10.1002/jat.3778. Epub 2019 Feb 12.
• [217] Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres. Acta Neuropathol Commun. 2014 Mar 31;2:31. doi: 10.1186/2051-5960-2-31.
• [218] Arsenic trioxide promotes senescence and regulates the balance of adipogenic and osteogenic differentiation in human mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai). 2011 Mar;43(3):204-9. doi: 10.1093/abbs/gmq130. Epub 2011 Jan 21.
• [219] Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic. Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15084-9. doi: 10.1073/pnas.1521316112. Epub 2015 Nov 23.
• [220] Up-regulation of telomere-binding TRF1, TRF2 related to reactive oxygen species induced by As(2)O(3) in MGC-803 cells. Eur J Pharmacol. 2005 May 23;516(1):1-9. doi: 10.1016/j.ejphar.2005.04.022.
• [221] Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol. 2002 Sep;62(3):529-38. doi: 10.1124/mol.62.3.529.
• [222] Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells. Cell Biol Int. 2011 Aug;35(8):803-10. doi: 10.1042/CBI20100739.
• [223] Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway. Cancer Cell Int. 2013 Mar 13;13(1):25. doi: 10.1186/1475-2867-13-25.
• [224] Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-B signaling in cervical cancer. Ann Surg Oncol. 2014 Dec;21 Suppl 4:S687-95. doi: 10.1245/s10434-014-3812-5. Epub 2014 Jul 22.
• [225] Protein kinase C-delta mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction. Exp Cell Res. 2009 Nov 15;315(19):3250-8. doi: 10.1016/j.yexcr.2009.09.005. Epub 2009 Sep 10.
• [226] Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies. Mol Biol Cell. 2010 Dec;21(23):4227-39. doi: 10.1091/mbc.E10-05-0449. Epub 2010 Oct 13.
• [227] Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Apoptosis. 2008 Jul;13(7):915-28. doi: 10.1007/s10495-008-0222-9.
• [228] Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 2009 Dec 24;114(27):5512-21. doi: 10.1182/blood-2009-02-204834. Epub 2009 Oct 14.
• [229] Inhibition of TGF-/SMAD3/NF-B signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Toxicol Lett. 2014 Nov 18;231(1):55-61. doi: 10.1016/j.toxlet.2014.08.024. Epub 2014 Sep 6.
• [230] A Gene Expression Biomarker Predicts Heat Shock Factor 1 Activation in a Gene Expression Compendium. Chem Res Toxicol. 2021 Jul 19;34(7):1721-1737. doi: 10.1021/acs.chemrestox.0c00510. Epub 2021 Jun 25.
• [231] Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes. Skin Pharmacol Physiol. 2010;23(2):68-78. doi: 10.1159/000265677. Epub 2009 Dec 14.
• [232] Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia. Int J Oncol. 2005 Aug;27(2):537-45.
• [233] [Effect of arsenic trioxide on apoptosis in lymphoblastoid Raji cell line with relation to expression of mcl-1 gene]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):597-601.
• [234] [Effects of Arsenic Trioxide on Cdc20 and Mad2 in Acute Myeloid Leukemia HL-60 Cell Line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):710-715. doi: 10.7534/j.issn.1009-2137.2018.03.013.
• [235] Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res. 2003 Dec 1;63(23):8138-44.
• [236] The role of Fas-FasL-FADD signaling pathway in arsenic-mediated neuronal apoptosis in vivo and in vitro. Toxicol Lett. 2022 Mar 1;356:143-150. doi: 10.1016/j.toxlet.2021.11.012. Epub 2021 Dec 22.
• [237] Evaluation of gene expression changes in human primary lung epithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites and to arsenic trioxide. Environ Mol Mutagen. 2015 Jun;56(5):477-90. doi: 10.1002/em.21937. Epub 2015 Apr 14.
• [238] Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO). Int J Biochem Cell Biol. 2019 Nov;116:105615. doi: 10.1016/j.biocel.2019.105615. Epub 2019 Sep 17.
• [239] Targeting of EGFR increase?anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform. Eur J Pharmacol. 2018 Feb 5;820:274-285. doi: 10.1016/j.ejphar.2017.12.041. Epub 2017 Dec 20.
• [240] Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation. Tumour Biol. 2015 Apr;36(4):2323-34. doi: 10.1007/s13277-014-2839-3. Epub 2014 Nov 22.
• [241] RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells. Apoptosis. 2004 Sep;9(5):561-71. doi: 10.1023/B:APPT.0000038030.47068.49.
• [242] AS3MT facilitates NLRP3 inflammasome activation by m(6)A modification during arsenic-induced hepatic insulin resistance. Cell Biol Toxicol. 2023 Oct;39(5):2165-2181. doi: 10.1007/s10565-022-09703-7. Epub 2022 Feb 28.
• [243] Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy. Toxicol Mech Methods. 2012 Sep;22(7):512-9. doi: 10.3109/15376516.2012.686534. Epub 2012 May 22.
• [244] Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Biochem J. 2011 Sep 1;438(2):349-58. doi: 10.1042/BJ20101653.
• [245] Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide. J Biol Chem. 2002 Nov 22;277(47):44988-95. doi: 10.1074/jbc.M207176200. Epub 2002 Sep 17.
• [246] Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs. Life Sci. 2020 Jun 15;251:117607. doi: 10.1016/j.lfs.2020.117607. Epub 2020 Mar 30.
• [247] Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells. Cell Biol Toxicol. 2019 Aug;35(4):361-371. doi: 10.1007/s10565-018-09458-0. Epub 2019 Jan 5.
• [248] Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIM(EL) to attenuate apoptosis in BEAS-2B cells. Chem Biol Interact. 2023 Jan 5;369:110304. doi: 10.1016/j.cbi.2022.110304. Epub 2022 Dec 10.
• [249] Arsenic trioxide increases expression of secreted frizzled-related protein 1 gene and inhibits the WNT/-catenin signaling pathway in Jurkat cells. Exp Ther Med. 2017 May;13(5):2050-2055. doi: 10.3892/etm.2017.4184. Epub 2017 Mar 6.
• [250] Transient receptor potential melastatin 4 contributes to early-stage endothelial injury induced by arsenic trioxide. Toxicol Lett. 2019 Sep 15;312:98-108. doi: 10.1016/j.toxlet.2019.04.035. Epub 2019 May 1.
• [251] Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide. Exp Biol Med (Maywood). 2013 Aug 1;238(8):932-42. doi: 10.1177/1535370213492689. Epub 2013 Jul 24.
• [252] E2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitro. Environ Health Perspect. 2015 May;123(5):484-92. doi: 10.1289/ehp.1408302. Epub 2015 Jan 9.
• [253] Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells. J Biol Chem. 2002 Dec 20;277(51):49504-10. doi: 10.1074/jbc.M207836200. Epub 2002 Oct 17.
• [254] Arsenic trioxide induces regulatory functions of plasmacytoid dendritic cells through interferon- inhibition. Acta Pharm Sin B. 2020 Jun;10(6):1061-1072. doi: 10.1016/j.apsb.2020.01.016. Epub 2020 Jan 31.
• [255] Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis. Cell Cycle. 2014;13(13):2046-55. doi: 10.4161/cc.29079. Epub 2014 May 6.
• [256] Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFk-dependent induction of hTERT due to down-regulation of Pin1 transcription. Hematology. 2012 Jul;17(4):198-206. doi: 10.1179/1607845412Y.0000000008.
• [257] Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of Np63 protein. J Biol Chem. 2013 Feb 1;288(5):2907-13. doi: 10.1074/jbc.M112.428607. Epub 2012 Dec 27.
• [258] [Hypermethylation of CpG island of DLC-1 gene and arsenic trioxide-induced DLC-1 gene demethylation in multiple myeloma]. Zhonghua Yi Xue Za Zhi. 2014 Sep 30;94(36):2816-21.
• [259] PRAM-1 potentiates arsenic trioxide-induced JNK activation. J Biol Chem. 2005 Mar 11;280(10):9043-8. doi: 10.1074/jbc.M413564200. Epub 2005 Jan 6.
• [260] Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014 Jul;46(7):722-5. doi: 10.1038/ng.2986. Epub 2014 May 25.
• [261] Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. Br J Haematol. 2009 Jan;144(2):251-62. doi: 10.1111/j.1365-2141.2008.07441.x. Epub 2008 Nov 19.
• [262] Patterns of gene expressions induced by arsenic trioxide in cultured human fibroblasts. Toxicol Lett. 2003 Jul 20;143(2):155-62. doi: 10.1016/s0378-4274(03)00171-1.
• [263] [Mechanism of arsenic trioxide induced apoptosis in cultured human lens epithelium cells]. Zhonghua Yan Ke Za Zhi. 2008 Oct;44(10):916-20.
• [264] GLI inhibitors overcome Erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. J Chemother. 2019 May;31(3):141-149. doi: 10.1080/1120009X.2019.1584422. Epub 2019 Apr 14.
• [265] AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib. Leuk Res. 2011 Oct;35(10):1355-9. doi: 10.1016/j.leukres.2011.04.020. Epub 2011 May 13.
• [266] [Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706]. Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):570-3.
• [267] Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis. Autophagy. 2010 Apr;6(3):353-65. doi: 10.4161/auto.6.3.11229. Epub 2010 Apr 11.
• [268] PML-RAR interaction with TRIB3 impedes PPAR/RXR function and triggers dyslipidemia in acute promyelocytic leukemia. Theranostics. 2020 Aug 15;10(22):10326-10340. doi: 10.7150/thno.45924. eCollection 2020.
• [269] Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis. Curr Cancer Drug Targets. 2014;14(6):557-66. doi: 10.2174/1568009614666140725090000.
• [270] [Induced RAS association domain family gene 1A gene expression by arsenic trioxide in nasopharyngeal carcinoma cell]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Oct;44(10):866-70.
• [271] [Arsenic trioxide induced p15INK4B gene expression in myelodysplastic syndrome cell line MUTZ-1]. Zhonghua Xue Ye Xue Za Zhi. 2002 Dec;23(12):638-41.
• [272] Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta. J Biol Chem. 2009 Oct 16;284(42):28783-94. doi: 10.1074/jbc.M109.041186. Epub 2009 Aug 18.
• [273] Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL. J Leukoc Biol. 2017 Dec;102(6):1357-1370. doi: 10.1189/jlb.1A0317-132R. Epub 2017 Oct 4.
• [274] Arsenic trioxide decreases AKT protein in a caspase-dependent manner. Mol Cancer Ther. 2008 Jun;7(6):1680-7. doi: 10.1158/1535-7163.MCT-07-2164.
• [275] Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells. J Mol Med (Berl). 2014 Mar;92(3):277-90. doi: 10.1007/s00109-013-1105-2. Epub 2013 Nov 26.
• [276] Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia. Br J Haematol. 2016 Mar;172(6):909-13. doi: 10.1111/bjh.13910. Epub 2016 Jan 5.
• [277] The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):302-10. doi: 10.1016/j.taap.2012.01.006. Epub 2012 Jan 17.
• [278] Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses. J Biol Chem. 2008 Jan 25;283(4):1992-2001. doi: 10.1074/jbc.M705227200. Epub 2007 Nov 29.
• [279] Downregulation of ROS1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines. Oncol Lett. 2018 Jun;15(6):9392-9396. doi: 10.3892/ol.2018.8458. Epub 2018 Apr 10.
• [280] Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells. Int J Mol Med. 2008 Jul;22(1):61-8.
• [281] Arsenic trioxide induces abnormal mitotic spindles through a PIP4KII/Rho pathway. Toxicol Sci. 2012 Jul;128(1):115-25. doi: 10.1093/toxsci/kfs129. Epub 2012 Apr 10.
• [282] Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells. Blood. 2007 Jan 15;109(2):740-6. doi: 10.1182/blood-2006-04-019588. Epub 2006 Sep 12.
• [283] Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2. J Biol Chem. 2008 May 2;283(18):12034-42. doi: 10.1074/jbc.M708816200. Epub 2008 Feb 25.
• [284] ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
• [285] BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression. J Cell Mol Med. 2014 Jun;18(6):1004-17. doi: 10.1111/jcmm.12246. Epub 2014 Feb 27.
• [286] Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide. Int J Med Sci. 2014 Oct 2;11(12):1262-9. doi: 10.7150/ijms.10038. eCollection 2014.
• [287] 8-Oxoguanine DNA glycosylase and MutY homolog are involved in the incision of arsenite-induced DNA adducts. Toxicol Sci. 2007 Feb;95(2):376-82. doi: 10.1093/toxsci/kfl166. Epub 2006 Nov 13.
• [288] JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Toxicol Appl Pharmacol. 2008 Jul 1;230(1):33-40. doi: 10.1016/j.taap.2008.01.041. Epub 2008 Feb 20.
• [289] JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells. Blood. 2004 May 1;103(9):3496-502. doi: 10.1182/blood-2003-05-1412. Epub 2003 Dec 30.